Large Solitary Glomus Tumor of the Wrist Involving the Radial Artery

Article Type
Changed
Display Headline
Large Solitary Glomus Tumor of the Wrist Involving the Radial Artery

Glomus tumors are neoplasms that originate from normal glomus bodies in the skin and are most commonly found in the subungual areas of the digits.1 Glomus bodies are neuromyoarterial structures in the reticular dermis that serve as specialized arteriovenous anastomoses. These bodies contain afferent arterioles and efferent veins with multiple connections, and glomus cells have contractile properties because of their similarity to smooth muscle cells.1,2 Glomus bodies help regulate blood flow and temperature of the skin and are found in their largest concentration in the fingertips, palms of the hands, and soles of the feet.3,4

Glomus tumors represent hyperplastic glomus bodies and make up 1% to 4.5% of upper extremity neoplasms, with approximately 75% in the hand and 50% in the subungual area.1,5,6 These tumors can also present in multiple locations at once and can occur in atypical and ectopic locations.3 Although generally benign, glomus tumors can also exhibit malignant and metastatic potential in rare cases.7,8 They can also be locally aggressive with bony destruction of the distal phalynx.2,9,10 Tumors typically present as painful solitary soft-tissue lesions that are exquisitely tender to palpation, dark red-purple or bluish, and hypersensitive to cold.5,10 Van Geertruyden and colleagues10 reported that the diagnosis of glomus tumor can be made clinically in 90% of cases. However, glomus tumors can easily be mistaken for other lesions, such as hemangiomas, angiomas, neuromas, neurofibromas, lipomas, and ganglion cysts. An inaccurate or incomplete workup can result in persistent pain and symptoms along with intraoperative complications.3 Magnetic resonance imaging (MRI), the most sensitive imaging modality for detecting glomus tumors of the hand, can assist in the workup.3,11,12

Extradigital glomus tumors are difficult to diagnose because of their rarity and unspecific symptoms and presentation.13 Misdiagnosis and delayed diagnosis can result in significant chronic pain, disuse syndromes, and disability.1,10 Correct diagnosis and surgical resection are generally curative with complete resolution of symptoms.

In this article, we report a case of a large atypical glomus tumor that occurred on the wrist and involved the radial artery. This tumor was successfully treated with surgical excision. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

A 63-year-old man presented to clinic with an extremely tender soft-tissue mass on his nondominant, left wrist. The mass had been increasing in size for a year. It was painless at rest but very painful to light palpation, with referred pain proximally up to the shoulder.

The patient did not recall any traumatic or inciting event, had not undergone any prior workup or treatment for symptoms, and had no history of masses elsewhere on the body. Past medical history was significant for type 2 diabetes and colon and prostate cancer, which had been treated with chemotherapy and was now in remission.

Physical examination revealed a 2×2.5-cm well-circumscribed soft-tissue mass on the volar-radial aspect of the left wrist proximal to the thenar eminence and radial to the flexor carpi radialis tendon (Figure 1). The mass was soft, mobile, and nonfluctuant and did not transilluminate. The overlying skin was normal in color and appearance—no discoloration, erythema, wounds, or drainage. The radial artery was palpable, and the mass did not pulsate or have a bruit. The patient had normal wrist range of motion limited by pain on compression of the mass with motor and sensation intact throughout the hand. Plain radiographs of the wrist showed no bony pathology or involvement from the mass. A soft-tissue shadow was visible around the wrist without calcifications. A wrist MRI was performed to better evaluate the mass, and the T2-weighted images showed a heterogeneous subcutaneous mass adjacent to the radial artery with increased signal intensity from surrounding feeding vessels (Figure 2).

Given the clinical and imaging findings, there was concern for a possible vascular tumor. Therefore, excisional biopsy was recommended over needle biopsy because of the bleeding risk. With the patient under general anesthesia, and a tourniquet used without exsanguination, a Brunner-type zigzag incision was made centered over the mass with elevated skin flaps. The 2.7×2.6×1.1-cm mass was superficial and involved the radial artery (Figure 3). After the radial artery was dissected proximally and distally, 2 perforating vessels were found entering the mass. These vessels were ligated, which allowed the mass to be peeled completely off the artery. Histology with hematoxylin-eosin staining showed solid sheets of uniform round cells with interspersed capillaries and centrally placed nuclei without evidence of malignancy (Figure 4).

The tourniquet was released before skin closure, and adequate hemostasis was obtained. The wound was closed, and the patient was placed in a volar wrist splint for immobilization. Pain relief after excision of the mass was immediate, and the postoperative course uneventful. After surgery, immunohistochemistry of the mass showed minimal mitotic activity, with a positive immunoperoxidase stain for smooth muscle actin confirming a diagnosis of glomus tumor (Figure 5). At 3-year follow-up, the patient had no pain, symptoms, or tumor recurrence.

 

 

Discussion

Glomus tumors are an established cause of pain in the subungual areas of the hand; numerous cases have been reported.1,5,10,14 However, extradigital glomus tumors, particularly those involving the wrist, are rare, and only a few have been described. Given the lack of consistent findings and presentations, diagnosis is difficult. Case series have documented an overall 2:1 female-to-male predominance of glomus tumors,6 but extradigital tumors are more common in men (4.6:1 male-to-female ratio).3 Extradigital glomus tumors are commonly diagnosed between ages 40 and 80 years. Classic symptoms of subungual tumors include pain, localized tenderness, and cold hypersensitivity,1,10 but symptoms are much more variable with extradigital locations. Previous trauma or injury to the lesion area is reported in 20% to 30% of cases before symptom onset.3,15 Intravascular locations of glomus tumors are extremely rare; only 4 cases of tumors involving venous structures have been reported.16-19 In the present case, the patient’s main complaints were pain and localized tenderness associated with a progressively increasing mass without any history of trauma. The large size of his mass (~2.5 cm in diameter) on examination was unique, as was involvement of the radial artery.

Misdiagnosis and delayed diagnosis of extradigital glomus tumors are common, and symptoms such as chronic pain typically persist for 7 to 11 years before the correct diagnosis is made.1,10 On average, 2.5 physician consultants (including psychiatrists) evaluate the patient before glomus tumor is identified.10 There are other reports of atypical or ectopic glomus tumors taking 5 to 25 years to be diagnosed.20-22 The differential diagnosis for glomus tumors includes hemangiomas, cellular or cavernous hemangiomas, vascular tumors, neuromas, neurofibromas, lipomas, paragangliomas, ganglion cysts, pigmented nevi, Pacinian corpuscle hyperplasia, and foreign bodies. A key element of clinical diagnosis is the disproportionate amount of pain and localized tenderness caused by the lesion relative to its size. The hypersensitivity of this tumor is thought to result from enlargement of the tumor and impingement on nearby Pacinian corpuscles, nerve endings in the skin that are responsible for sensitivity to vibration and pressure.2,9

Plain radiographs can be useful in detecting glomus tumors of the hand but are less helpful with extradigital tumors, with identification rates of 24% in certain series.3 MRI is the most sensitive imaging modality for diagnosing glomus tumors of the hand; a detection rate of 80% to 100% has been reported in various case series.3,11,12 Specificity of MRI for glomus tumors has been reported at 50%.11,23 Placement of a radiographic marker directly over the area of most pain can assist in tumor localization.3 Glomus tumors typically have decreased signal intensity on T1-weighted images and increased intensity on T2-weighted images, but signal patterns are variable and particularly difficult to differentiate with small tumors. MRI is useful in the setting of recurrent glomus tumors, where incomplete excision is possible. In 24 cases of continued pain after glomus tumor excision, Theumann and colleagues24 used MRI to identify a nodule consistent with recurrent glomus tumor in all patients. Three-dimensional contrast-enhanced magnetic resonance angiography (MRA) can also help diagnose glomus tumors while providing valuable information regarding size and location for surgical planning.25,26 With MRA, it is crucial to evaluate the arterial or arteriovenous phase of imaging, as the glomus tumor is richly vascularized and shows contrast enhancement after intravenous injection of gadolinium.27 Angiography, ultrasonography, thermography, and scintigraphy have all been used to diagnose glomus tumors but have shown limited utility and accuracy.11

Treatment of glomus tumors is complete surgical excision because of their relatively small size and subcutaneous location. Resection success rates are consistently higher than 95%, with resolution of all symptoms.1,10,14 Local recurrence of tumors after excision occurs in 1% to 33% of cases, depending on series, and may be immediate or delayed, with immediate recurrence commonly caused by inadequate excision.1,10,15,28 Delayed recurrence is less common and presents several years after excision, typically with a new growth near the previous excision.10 Recurrence years after surgery may also represent multiple tumors unrecognized during initial workup and can be treated with repeat excision or radiotherapy.

Robert and colleagues29 recently reported the case of a glomus tumor, on the dorsal aspect of the wrist, discovered incidentally in a 71-year-old patient and treated with surgical excision. Several years earlier, Chim and colleagues30 described a similar case, of a large wrist glomus tumor worked up with MRI. In a retrospective review of all extradigital glomus tumors seen over a 20-year period, Schiefer and colleagues3 reported 4 glomus tumors of the wrist out of 56 tumors total. The most common sites were forearm (11 cases) and knee (10 cases), and the majority of patients presented with pain and localized tenderness. Mean tumor size was 0.66 cm (range, 0.1-0.3 cm), with 77% of tumors less than 1 cm. Our patient’s 2.7×2.6×1.1-cm tumor was large for a glomus tumor. Its involvement with the radial artery feeding vessels likely contributed to its large and progressively increasing size. It is worth noting that, in the series by Schiefer and colleagues,3 the only patient with symptoms persisting after excision had a large (3 cm in diameter) deep tumor of the foot; the entire tumor was removed, and there was no recurrence by 10-year follow-up. Folpe and colleagues7 suggested that deep tumors larger than 2 cm should be at higher suspicion for malignancy. Joseph and Posner21 reported 3 cases of glomus tumors, on the ulnar side of the wrist, diagnosed with help of a provocative test using ethyl chloride spray.

 

 

Conclusion

Overall, glomus tumors are rare and challenging to diagnosis and should be in the differential in any symptomatic patient with a painful soft-tissue mass of the wrist. Advanced imaging studies, such as MRI, can assist in localization, diagnosis, and preoperative planning. Histology and immunohistochemistry are essential to differentiate glomus tumor from other vascular tumors, and complete excision is necessary to prevent local recurrence.

References

1.    Carroll RE, Berman AT. Glomus tumors of the hand: review of the literature and report on twenty-eight cases. J Bone Joint Surg Am. 1972;54(4):691-703.

2.    Riddell DH, Martin RS. Glomus tumor of unusual size; case report. Ann Surg. 1951;133(3):401-403.

3.    Schiefer TK, Parker WL, Anakwenze OA, Amadio PC, Inwards CY, Spinner RJ. Extradigital glomus tumors: a 20-year experience. Mayo Clin Proc. 2006;81(10):1337-1344.

4.    Tuncali D, Yilmaz AC, Terzioglu A, Aslan G. Multiple occurrences of different histologic types of the glomus tumor. J Hand Surg Am. 2005;30(1):161-164.

5.    Greene RG. Soft tissue tumors of the hand and wrist. A 10 year survey. J Med Soc N J. 1964;61:495-498.

6.    Maxwell GP, Curtis RM, Wilgis EF. Multiple digital glomus tumors. J Hand Surg Am. 1979;4(4):363-367.

7.    Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss SW. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol. 2001;25(1):1-12.

8.    De Chiara A, Apice G, Mori S, et al. Malignant glomus tumour: a case report and review of the literature. Sarcoma. 2003;7(2):87-91.

9.    Riveros M, Pack GT. The glomus tumor; report of 20 cases. Ann Surg. 1951;133(3):394-400.

10.  Van Geertruyden J, Lorea P, Goldschmidt D, et al. Glomus tumours of the hand. A retrospective study of 51 cases. J Hand Surg Br. 1996;21(2):257-260.

11.  Al-Qattan MM, Al-Namla A, Al-Thunayan A, Al-Subhi F, El-Shayeb AF. Magnetic resonance imaging in the diagnosis of glomus tumours of the hand. J Hand Surg Br. 2005;30(5):535-540.

12.  Drape JL, Idy-Peretti I, Goettmann S, et al. Subungual glomus tumors: evaluation with MR imaging. Radiology. 1995;195(2):507-515.

13.  Heys SD, Brittenden J, Atkinson P, Eremin O. Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg. 1992;79(4):345-347.

14.  Bhaskaranand K, Navadgi BC. Glomus tumour of the hand. J Hand Surg Br. 2002;27(3):229-231.

15.  Rettig AC, Strickland JW. Glomus tumor of the digits. J Hand Surg Am. 1977;2(4):261-265.

16.  Beham A, Fletcher CD. Intravascular glomus tumour: a previously undescribed phenomenon. Virchows Arch A Pathol Anat Histopathol. 1991;418(2):175-177.

17.  Googe PB, Griffin WC. Intravenous glomus tumor of the forearm. J Cutan Pathol. 1993;20(4):359-363.

18.   Koibuchi H, Fujii Y, Taniguchi N. An unusual case of a glomus tumor developing in a subcutaneous vein of the wrist. J Clin Ultrasound. 2008;36(6):369-370.

19.  Acebo E, Val-Bernal JF, Arce F. Giant intravenous glomus tumor. J Cutan Pathol. 1997;24(6):384-389.

20.  Ghaly RF, Ring AM. Supraclavicular glomus tumor, 20 year history of undiagnosed shoulder pain: a case report. Pain. 1999;83(2):379-382.

21.  Joseph FR, Posner MA. Glomus tumors of the wrist. J Hand Surg Am. 1983;8(6):918-920.

22.  Abou Jaoude JF, Roula Farah A, Sargi Z, Khairallah S, Fakih C. Glomus tumors: report on eleven cases and a review of the literature. Chir Main. 2000;19(4):243-252.

23.  Jablon M, Horowitz A, Bernstein DA. Magnetic resonance imaging of a glomus tumor of the fingertip. J Hand Surg Am. 1990;15(3):507-509.

24.  Theumann NH, Goettmann S, Le Viet D, et al. Recurrent glomus tumors of fingertips: MR imaging evaluation. Radiology. 2002;223(1):143-151.

25.  Boudghene FP, Gouny P, Tassart M, Callard P, Le Breton C, Vayssairat M. Subungual glomus tumor: combined use of MRI and three-dimensional contrast MR angiography. J Magn Reson Imaging. 1998;8(6):1326-1328.

26.  Van Ruyssevelt CE, Vranckx P. Subungual glomus tumor: emphasis on MR angiography. AJR Am J Roentgenol. 2004;182(1):263-264.

27.  Connell DA, Koulouris G, Thorn DA, Potter HG. Contrast-enhanced MR angiography of the hand. Radiographics. 2002;22(3):583-599.

28.  Varian JP, Cleak DK. Glomus tumours in the hand. Hand. 1980;12(3):293-299.

29.  Robert G, Sawaya E, Pelissier P. Glomus tumor of the dorsal aspect of the wrist: a case report [in French]. Chir Main. 2012;31(4):214-216.

30.   Chim H, Lahiri A, Chew WY. Atypical glomus tumour of the wrist: a case report. Hand Surg. 2009;14(2-3):121-123.

Article PDF
Author and Disclosure Information

Ajay K. Balaram, MD, Andrew R. Hsu, MD, Timothy B. Rapp, MD, Vikas Mehta, MD, and Randip R. Bindra, MD

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article. 

Issue
The American Journal of Orthopedics - 43(12)
Publications
Topics
Page Number
567-570
Legacy Keywords
american journal of orthopedics, AJO, case report and literature review, case report, oncology, glomus tumor, tumor, wrist, radial artery, artery, lesions, soft-tissue, hsu, balaram, rapp, mehta, bindra
Sections
Author and Disclosure Information

Ajay K. Balaram, MD, Andrew R. Hsu, MD, Timothy B. Rapp, MD, Vikas Mehta, MD, and Randip R. Bindra, MD

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article. 

Author and Disclosure Information

Ajay K. Balaram, MD, Andrew R. Hsu, MD, Timothy B. Rapp, MD, Vikas Mehta, MD, and Randip R. Bindra, MD

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article. 

Article PDF
Article PDF

Glomus tumors are neoplasms that originate from normal glomus bodies in the skin and are most commonly found in the subungual areas of the digits.1 Glomus bodies are neuromyoarterial structures in the reticular dermis that serve as specialized arteriovenous anastomoses. These bodies contain afferent arterioles and efferent veins with multiple connections, and glomus cells have contractile properties because of their similarity to smooth muscle cells.1,2 Glomus bodies help regulate blood flow and temperature of the skin and are found in their largest concentration in the fingertips, palms of the hands, and soles of the feet.3,4

Glomus tumors represent hyperplastic glomus bodies and make up 1% to 4.5% of upper extremity neoplasms, with approximately 75% in the hand and 50% in the subungual area.1,5,6 These tumors can also present in multiple locations at once and can occur in atypical and ectopic locations.3 Although generally benign, glomus tumors can also exhibit malignant and metastatic potential in rare cases.7,8 They can also be locally aggressive with bony destruction of the distal phalynx.2,9,10 Tumors typically present as painful solitary soft-tissue lesions that are exquisitely tender to palpation, dark red-purple or bluish, and hypersensitive to cold.5,10 Van Geertruyden and colleagues10 reported that the diagnosis of glomus tumor can be made clinically in 90% of cases. However, glomus tumors can easily be mistaken for other lesions, such as hemangiomas, angiomas, neuromas, neurofibromas, lipomas, and ganglion cysts. An inaccurate or incomplete workup can result in persistent pain and symptoms along with intraoperative complications.3 Magnetic resonance imaging (MRI), the most sensitive imaging modality for detecting glomus tumors of the hand, can assist in the workup.3,11,12

Extradigital glomus tumors are difficult to diagnose because of their rarity and unspecific symptoms and presentation.13 Misdiagnosis and delayed diagnosis can result in significant chronic pain, disuse syndromes, and disability.1,10 Correct diagnosis and surgical resection are generally curative with complete resolution of symptoms.

In this article, we report a case of a large atypical glomus tumor that occurred on the wrist and involved the radial artery. This tumor was successfully treated with surgical excision. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

A 63-year-old man presented to clinic with an extremely tender soft-tissue mass on his nondominant, left wrist. The mass had been increasing in size for a year. It was painless at rest but very painful to light palpation, with referred pain proximally up to the shoulder.

The patient did not recall any traumatic or inciting event, had not undergone any prior workup or treatment for symptoms, and had no history of masses elsewhere on the body. Past medical history was significant for type 2 diabetes and colon and prostate cancer, which had been treated with chemotherapy and was now in remission.

Physical examination revealed a 2×2.5-cm well-circumscribed soft-tissue mass on the volar-radial aspect of the left wrist proximal to the thenar eminence and radial to the flexor carpi radialis tendon (Figure 1). The mass was soft, mobile, and nonfluctuant and did not transilluminate. The overlying skin was normal in color and appearance—no discoloration, erythema, wounds, or drainage. The radial artery was palpable, and the mass did not pulsate or have a bruit. The patient had normal wrist range of motion limited by pain on compression of the mass with motor and sensation intact throughout the hand. Plain radiographs of the wrist showed no bony pathology or involvement from the mass. A soft-tissue shadow was visible around the wrist without calcifications. A wrist MRI was performed to better evaluate the mass, and the T2-weighted images showed a heterogeneous subcutaneous mass adjacent to the radial artery with increased signal intensity from surrounding feeding vessels (Figure 2).

Given the clinical and imaging findings, there was concern for a possible vascular tumor. Therefore, excisional biopsy was recommended over needle biopsy because of the bleeding risk. With the patient under general anesthesia, and a tourniquet used without exsanguination, a Brunner-type zigzag incision was made centered over the mass with elevated skin flaps. The 2.7×2.6×1.1-cm mass was superficial and involved the radial artery (Figure 3). After the radial artery was dissected proximally and distally, 2 perforating vessels were found entering the mass. These vessels were ligated, which allowed the mass to be peeled completely off the artery. Histology with hematoxylin-eosin staining showed solid sheets of uniform round cells with interspersed capillaries and centrally placed nuclei without evidence of malignancy (Figure 4).

The tourniquet was released before skin closure, and adequate hemostasis was obtained. The wound was closed, and the patient was placed in a volar wrist splint for immobilization. Pain relief after excision of the mass was immediate, and the postoperative course uneventful. After surgery, immunohistochemistry of the mass showed minimal mitotic activity, with a positive immunoperoxidase stain for smooth muscle actin confirming a diagnosis of glomus tumor (Figure 5). At 3-year follow-up, the patient had no pain, symptoms, or tumor recurrence.

 

 

Discussion

Glomus tumors are an established cause of pain in the subungual areas of the hand; numerous cases have been reported.1,5,10,14 However, extradigital glomus tumors, particularly those involving the wrist, are rare, and only a few have been described. Given the lack of consistent findings and presentations, diagnosis is difficult. Case series have documented an overall 2:1 female-to-male predominance of glomus tumors,6 but extradigital tumors are more common in men (4.6:1 male-to-female ratio).3 Extradigital glomus tumors are commonly diagnosed between ages 40 and 80 years. Classic symptoms of subungual tumors include pain, localized tenderness, and cold hypersensitivity,1,10 but symptoms are much more variable with extradigital locations. Previous trauma or injury to the lesion area is reported in 20% to 30% of cases before symptom onset.3,15 Intravascular locations of glomus tumors are extremely rare; only 4 cases of tumors involving venous structures have been reported.16-19 In the present case, the patient’s main complaints were pain and localized tenderness associated with a progressively increasing mass without any history of trauma. The large size of his mass (~2.5 cm in diameter) on examination was unique, as was involvement of the radial artery.

Misdiagnosis and delayed diagnosis of extradigital glomus tumors are common, and symptoms such as chronic pain typically persist for 7 to 11 years before the correct diagnosis is made.1,10 On average, 2.5 physician consultants (including psychiatrists) evaluate the patient before glomus tumor is identified.10 There are other reports of atypical or ectopic glomus tumors taking 5 to 25 years to be diagnosed.20-22 The differential diagnosis for glomus tumors includes hemangiomas, cellular or cavernous hemangiomas, vascular tumors, neuromas, neurofibromas, lipomas, paragangliomas, ganglion cysts, pigmented nevi, Pacinian corpuscle hyperplasia, and foreign bodies. A key element of clinical diagnosis is the disproportionate amount of pain and localized tenderness caused by the lesion relative to its size. The hypersensitivity of this tumor is thought to result from enlargement of the tumor and impingement on nearby Pacinian corpuscles, nerve endings in the skin that are responsible for sensitivity to vibration and pressure.2,9

Plain radiographs can be useful in detecting glomus tumors of the hand but are less helpful with extradigital tumors, with identification rates of 24% in certain series.3 MRI is the most sensitive imaging modality for diagnosing glomus tumors of the hand; a detection rate of 80% to 100% has been reported in various case series.3,11,12 Specificity of MRI for glomus tumors has been reported at 50%.11,23 Placement of a radiographic marker directly over the area of most pain can assist in tumor localization.3 Glomus tumors typically have decreased signal intensity on T1-weighted images and increased intensity on T2-weighted images, but signal patterns are variable and particularly difficult to differentiate with small tumors. MRI is useful in the setting of recurrent glomus tumors, where incomplete excision is possible. In 24 cases of continued pain after glomus tumor excision, Theumann and colleagues24 used MRI to identify a nodule consistent with recurrent glomus tumor in all patients. Three-dimensional contrast-enhanced magnetic resonance angiography (MRA) can also help diagnose glomus tumors while providing valuable information regarding size and location for surgical planning.25,26 With MRA, it is crucial to evaluate the arterial or arteriovenous phase of imaging, as the glomus tumor is richly vascularized and shows contrast enhancement after intravenous injection of gadolinium.27 Angiography, ultrasonography, thermography, and scintigraphy have all been used to diagnose glomus tumors but have shown limited utility and accuracy.11

Treatment of glomus tumors is complete surgical excision because of their relatively small size and subcutaneous location. Resection success rates are consistently higher than 95%, with resolution of all symptoms.1,10,14 Local recurrence of tumors after excision occurs in 1% to 33% of cases, depending on series, and may be immediate or delayed, with immediate recurrence commonly caused by inadequate excision.1,10,15,28 Delayed recurrence is less common and presents several years after excision, typically with a new growth near the previous excision.10 Recurrence years after surgery may also represent multiple tumors unrecognized during initial workup and can be treated with repeat excision or radiotherapy.

Robert and colleagues29 recently reported the case of a glomus tumor, on the dorsal aspect of the wrist, discovered incidentally in a 71-year-old patient and treated with surgical excision. Several years earlier, Chim and colleagues30 described a similar case, of a large wrist glomus tumor worked up with MRI. In a retrospective review of all extradigital glomus tumors seen over a 20-year period, Schiefer and colleagues3 reported 4 glomus tumors of the wrist out of 56 tumors total. The most common sites were forearm (11 cases) and knee (10 cases), and the majority of patients presented with pain and localized tenderness. Mean tumor size was 0.66 cm (range, 0.1-0.3 cm), with 77% of tumors less than 1 cm. Our patient’s 2.7×2.6×1.1-cm tumor was large for a glomus tumor. Its involvement with the radial artery feeding vessels likely contributed to its large and progressively increasing size. It is worth noting that, in the series by Schiefer and colleagues,3 the only patient with symptoms persisting after excision had a large (3 cm in diameter) deep tumor of the foot; the entire tumor was removed, and there was no recurrence by 10-year follow-up. Folpe and colleagues7 suggested that deep tumors larger than 2 cm should be at higher suspicion for malignancy. Joseph and Posner21 reported 3 cases of glomus tumors, on the ulnar side of the wrist, diagnosed with help of a provocative test using ethyl chloride spray.

 

 

Conclusion

Overall, glomus tumors are rare and challenging to diagnosis and should be in the differential in any symptomatic patient with a painful soft-tissue mass of the wrist. Advanced imaging studies, such as MRI, can assist in localization, diagnosis, and preoperative planning. Histology and immunohistochemistry are essential to differentiate glomus tumor from other vascular tumors, and complete excision is necessary to prevent local recurrence.

Glomus tumors are neoplasms that originate from normal glomus bodies in the skin and are most commonly found in the subungual areas of the digits.1 Glomus bodies are neuromyoarterial structures in the reticular dermis that serve as specialized arteriovenous anastomoses. These bodies contain afferent arterioles and efferent veins with multiple connections, and glomus cells have contractile properties because of their similarity to smooth muscle cells.1,2 Glomus bodies help regulate blood flow and temperature of the skin and are found in their largest concentration in the fingertips, palms of the hands, and soles of the feet.3,4

Glomus tumors represent hyperplastic glomus bodies and make up 1% to 4.5% of upper extremity neoplasms, with approximately 75% in the hand and 50% in the subungual area.1,5,6 These tumors can also present in multiple locations at once and can occur in atypical and ectopic locations.3 Although generally benign, glomus tumors can also exhibit malignant and metastatic potential in rare cases.7,8 They can also be locally aggressive with bony destruction of the distal phalynx.2,9,10 Tumors typically present as painful solitary soft-tissue lesions that are exquisitely tender to palpation, dark red-purple or bluish, and hypersensitive to cold.5,10 Van Geertruyden and colleagues10 reported that the diagnosis of glomus tumor can be made clinically in 90% of cases. However, glomus tumors can easily be mistaken for other lesions, such as hemangiomas, angiomas, neuromas, neurofibromas, lipomas, and ganglion cysts. An inaccurate or incomplete workup can result in persistent pain and symptoms along with intraoperative complications.3 Magnetic resonance imaging (MRI), the most sensitive imaging modality for detecting glomus tumors of the hand, can assist in the workup.3,11,12

Extradigital glomus tumors are difficult to diagnose because of their rarity and unspecific symptoms and presentation.13 Misdiagnosis and delayed diagnosis can result in significant chronic pain, disuse syndromes, and disability.1,10 Correct diagnosis and surgical resection are generally curative with complete resolution of symptoms.

In this article, we report a case of a large atypical glomus tumor that occurred on the wrist and involved the radial artery. This tumor was successfully treated with surgical excision. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

A 63-year-old man presented to clinic with an extremely tender soft-tissue mass on his nondominant, left wrist. The mass had been increasing in size for a year. It was painless at rest but very painful to light palpation, with referred pain proximally up to the shoulder.

The patient did not recall any traumatic or inciting event, had not undergone any prior workup or treatment for symptoms, and had no history of masses elsewhere on the body. Past medical history was significant for type 2 diabetes and colon and prostate cancer, which had been treated with chemotherapy and was now in remission.

Physical examination revealed a 2×2.5-cm well-circumscribed soft-tissue mass on the volar-radial aspect of the left wrist proximal to the thenar eminence and radial to the flexor carpi radialis tendon (Figure 1). The mass was soft, mobile, and nonfluctuant and did not transilluminate. The overlying skin was normal in color and appearance—no discoloration, erythema, wounds, or drainage. The radial artery was palpable, and the mass did not pulsate or have a bruit. The patient had normal wrist range of motion limited by pain on compression of the mass with motor and sensation intact throughout the hand. Plain radiographs of the wrist showed no bony pathology or involvement from the mass. A soft-tissue shadow was visible around the wrist without calcifications. A wrist MRI was performed to better evaluate the mass, and the T2-weighted images showed a heterogeneous subcutaneous mass adjacent to the radial artery with increased signal intensity from surrounding feeding vessels (Figure 2).

Given the clinical and imaging findings, there was concern for a possible vascular tumor. Therefore, excisional biopsy was recommended over needle biopsy because of the bleeding risk. With the patient under general anesthesia, and a tourniquet used without exsanguination, a Brunner-type zigzag incision was made centered over the mass with elevated skin flaps. The 2.7×2.6×1.1-cm mass was superficial and involved the radial artery (Figure 3). After the radial artery was dissected proximally and distally, 2 perforating vessels were found entering the mass. These vessels were ligated, which allowed the mass to be peeled completely off the artery. Histology with hematoxylin-eosin staining showed solid sheets of uniform round cells with interspersed capillaries and centrally placed nuclei without evidence of malignancy (Figure 4).

The tourniquet was released before skin closure, and adequate hemostasis was obtained. The wound was closed, and the patient was placed in a volar wrist splint for immobilization. Pain relief after excision of the mass was immediate, and the postoperative course uneventful. After surgery, immunohistochemistry of the mass showed minimal mitotic activity, with a positive immunoperoxidase stain for smooth muscle actin confirming a diagnosis of glomus tumor (Figure 5). At 3-year follow-up, the patient had no pain, symptoms, or tumor recurrence.

 

 

Discussion

Glomus tumors are an established cause of pain in the subungual areas of the hand; numerous cases have been reported.1,5,10,14 However, extradigital glomus tumors, particularly those involving the wrist, are rare, and only a few have been described. Given the lack of consistent findings and presentations, diagnosis is difficult. Case series have documented an overall 2:1 female-to-male predominance of glomus tumors,6 but extradigital tumors are more common in men (4.6:1 male-to-female ratio).3 Extradigital glomus tumors are commonly diagnosed between ages 40 and 80 years. Classic symptoms of subungual tumors include pain, localized tenderness, and cold hypersensitivity,1,10 but symptoms are much more variable with extradigital locations. Previous trauma or injury to the lesion area is reported in 20% to 30% of cases before symptom onset.3,15 Intravascular locations of glomus tumors are extremely rare; only 4 cases of tumors involving venous structures have been reported.16-19 In the present case, the patient’s main complaints were pain and localized tenderness associated with a progressively increasing mass without any history of trauma. The large size of his mass (~2.5 cm in diameter) on examination was unique, as was involvement of the radial artery.

Misdiagnosis and delayed diagnosis of extradigital glomus tumors are common, and symptoms such as chronic pain typically persist for 7 to 11 years before the correct diagnosis is made.1,10 On average, 2.5 physician consultants (including psychiatrists) evaluate the patient before glomus tumor is identified.10 There are other reports of atypical or ectopic glomus tumors taking 5 to 25 years to be diagnosed.20-22 The differential diagnosis for glomus tumors includes hemangiomas, cellular or cavernous hemangiomas, vascular tumors, neuromas, neurofibromas, lipomas, paragangliomas, ganglion cysts, pigmented nevi, Pacinian corpuscle hyperplasia, and foreign bodies. A key element of clinical diagnosis is the disproportionate amount of pain and localized tenderness caused by the lesion relative to its size. The hypersensitivity of this tumor is thought to result from enlargement of the tumor and impingement on nearby Pacinian corpuscles, nerve endings in the skin that are responsible for sensitivity to vibration and pressure.2,9

Plain radiographs can be useful in detecting glomus tumors of the hand but are less helpful with extradigital tumors, with identification rates of 24% in certain series.3 MRI is the most sensitive imaging modality for diagnosing glomus tumors of the hand; a detection rate of 80% to 100% has been reported in various case series.3,11,12 Specificity of MRI for glomus tumors has been reported at 50%.11,23 Placement of a radiographic marker directly over the area of most pain can assist in tumor localization.3 Glomus tumors typically have decreased signal intensity on T1-weighted images and increased intensity on T2-weighted images, but signal patterns are variable and particularly difficult to differentiate with small tumors. MRI is useful in the setting of recurrent glomus tumors, where incomplete excision is possible. In 24 cases of continued pain after glomus tumor excision, Theumann and colleagues24 used MRI to identify a nodule consistent with recurrent glomus tumor in all patients. Three-dimensional contrast-enhanced magnetic resonance angiography (MRA) can also help diagnose glomus tumors while providing valuable information regarding size and location for surgical planning.25,26 With MRA, it is crucial to evaluate the arterial or arteriovenous phase of imaging, as the glomus tumor is richly vascularized and shows contrast enhancement after intravenous injection of gadolinium.27 Angiography, ultrasonography, thermography, and scintigraphy have all been used to diagnose glomus tumors but have shown limited utility and accuracy.11

Treatment of glomus tumors is complete surgical excision because of their relatively small size and subcutaneous location. Resection success rates are consistently higher than 95%, with resolution of all symptoms.1,10,14 Local recurrence of tumors after excision occurs in 1% to 33% of cases, depending on series, and may be immediate or delayed, with immediate recurrence commonly caused by inadequate excision.1,10,15,28 Delayed recurrence is less common and presents several years after excision, typically with a new growth near the previous excision.10 Recurrence years after surgery may also represent multiple tumors unrecognized during initial workup and can be treated with repeat excision or radiotherapy.

Robert and colleagues29 recently reported the case of a glomus tumor, on the dorsal aspect of the wrist, discovered incidentally in a 71-year-old patient and treated with surgical excision. Several years earlier, Chim and colleagues30 described a similar case, of a large wrist glomus tumor worked up with MRI. In a retrospective review of all extradigital glomus tumors seen over a 20-year period, Schiefer and colleagues3 reported 4 glomus tumors of the wrist out of 56 tumors total. The most common sites were forearm (11 cases) and knee (10 cases), and the majority of patients presented with pain and localized tenderness. Mean tumor size was 0.66 cm (range, 0.1-0.3 cm), with 77% of tumors less than 1 cm. Our patient’s 2.7×2.6×1.1-cm tumor was large for a glomus tumor. Its involvement with the radial artery feeding vessels likely contributed to its large and progressively increasing size. It is worth noting that, in the series by Schiefer and colleagues,3 the only patient with symptoms persisting after excision had a large (3 cm in diameter) deep tumor of the foot; the entire tumor was removed, and there was no recurrence by 10-year follow-up. Folpe and colleagues7 suggested that deep tumors larger than 2 cm should be at higher suspicion for malignancy. Joseph and Posner21 reported 3 cases of glomus tumors, on the ulnar side of the wrist, diagnosed with help of a provocative test using ethyl chloride spray.

 

 

Conclusion

Overall, glomus tumors are rare and challenging to diagnosis and should be in the differential in any symptomatic patient with a painful soft-tissue mass of the wrist. Advanced imaging studies, such as MRI, can assist in localization, diagnosis, and preoperative planning. Histology and immunohistochemistry are essential to differentiate glomus tumor from other vascular tumors, and complete excision is necessary to prevent local recurrence.

References

1.    Carroll RE, Berman AT. Glomus tumors of the hand: review of the literature and report on twenty-eight cases. J Bone Joint Surg Am. 1972;54(4):691-703.

2.    Riddell DH, Martin RS. Glomus tumor of unusual size; case report. Ann Surg. 1951;133(3):401-403.

3.    Schiefer TK, Parker WL, Anakwenze OA, Amadio PC, Inwards CY, Spinner RJ. Extradigital glomus tumors: a 20-year experience. Mayo Clin Proc. 2006;81(10):1337-1344.

4.    Tuncali D, Yilmaz AC, Terzioglu A, Aslan G. Multiple occurrences of different histologic types of the glomus tumor. J Hand Surg Am. 2005;30(1):161-164.

5.    Greene RG. Soft tissue tumors of the hand and wrist. A 10 year survey. J Med Soc N J. 1964;61:495-498.

6.    Maxwell GP, Curtis RM, Wilgis EF. Multiple digital glomus tumors. J Hand Surg Am. 1979;4(4):363-367.

7.    Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss SW. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol. 2001;25(1):1-12.

8.    De Chiara A, Apice G, Mori S, et al. Malignant glomus tumour: a case report and review of the literature. Sarcoma. 2003;7(2):87-91.

9.    Riveros M, Pack GT. The glomus tumor; report of 20 cases. Ann Surg. 1951;133(3):394-400.

10.  Van Geertruyden J, Lorea P, Goldschmidt D, et al. Glomus tumours of the hand. A retrospective study of 51 cases. J Hand Surg Br. 1996;21(2):257-260.

11.  Al-Qattan MM, Al-Namla A, Al-Thunayan A, Al-Subhi F, El-Shayeb AF. Magnetic resonance imaging in the diagnosis of glomus tumours of the hand. J Hand Surg Br. 2005;30(5):535-540.

12.  Drape JL, Idy-Peretti I, Goettmann S, et al. Subungual glomus tumors: evaluation with MR imaging. Radiology. 1995;195(2):507-515.

13.  Heys SD, Brittenden J, Atkinson P, Eremin O. Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg. 1992;79(4):345-347.

14.  Bhaskaranand K, Navadgi BC. Glomus tumour of the hand. J Hand Surg Br. 2002;27(3):229-231.

15.  Rettig AC, Strickland JW. Glomus tumor of the digits. J Hand Surg Am. 1977;2(4):261-265.

16.  Beham A, Fletcher CD. Intravascular glomus tumour: a previously undescribed phenomenon. Virchows Arch A Pathol Anat Histopathol. 1991;418(2):175-177.

17.  Googe PB, Griffin WC. Intravenous glomus tumor of the forearm. J Cutan Pathol. 1993;20(4):359-363.

18.   Koibuchi H, Fujii Y, Taniguchi N. An unusual case of a glomus tumor developing in a subcutaneous vein of the wrist. J Clin Ultrasound. 2008;36(6):369-370.

19.  Acebo E, Val-Bernal JF, Arce F. Giant intravenous glomus tumor. J Cutan Pathol. 1997;24(6):384-389.

20.  Ghaly RF, Ring AM. Supraclavicular glomus tumor, 20 year history of undiagnosed shoulder pain: a case report. Pain. 1999;83(2):379-382.

21.  Joseph FR, Posner MA. Glomus tumors of the wrist. J Hand Surg Am. 1983;8(6):918-920.

22.  Abou Jaoude JF, Roula Farah A, Sargi Z, Khairallah S, Fakih C. Glomus tumors: report on eleven cases and a review of the literature. Chir Main. 2000;19(4):243-252.

23.  Jablon M, Horowitz A, Bernstein DA. Magnetic resonance imaging of a glomus tumor of the fingertip. J Hand Surg Am. 1990;15(3):507-509.

24.  Theumann NH, Goettmann S, Le Viet D, et al. Recurrent glomus tumors of fingertips: MR imaging evaluation. Radiology. 2002;223(1):143-151.

25.  Boudghene FP, Gouny P, Tassart M, Callard P, Le Breton C, Vayssairat M. Subungual glomus tumor: combined use of MRI and three-dimensional contrast MR angiography. J Magn Reson Imaging. 1998;8(6):1326-1328.

26.  Van Ruyssevelt CE, Vranckx P. Subungual glomus tumor: emphasis on MR angiography. AJR Am J Roentgenol. 2004;182(1):263-264.

27.  Connell DA, Koulouris G, Thorn DA, Potter HG. Contrast-enhanced MR angiography of the hand. Radiographics. 2002;22(3):583-599.

28.  Varian JP, Cleak DK. Glomus tumours in the hand. Hand. 1980;12(3):293-299.

29.  Robert G, Sawaya E, Pelissier P. Glomus tumor of the dorsal aspect of the wrist: a case report [in French]. Chir Main. 2012;31(4):214-216.

30.   Chim H, Lahiri A, Chew WY. Atypical glomus tumour of the wrist: a case report. Hand Surg. 2009;14(2-3):121-123.

References

1.    Carroll RE, Berman AT. Glomus tumors of the hand: review of the literature and report on twenty-eight cases. J Bone Joint Surg Am. 1972;54(4):691-703.

2.    Riddell DH, Martin RS. Glomus tumor of unusual size; case report. Ann Surg. 1951;133(3):401-403.

3.    Schiefer TK, Parker WL, Anakwenze OA, Amadio PC, Inwards CY, Spinner RJ. Extradigital glomus tumors: a 20-year experience. Mayo Clin Proc. 2006;81(10):1337-1344.

4.    Tuncali D, Yilmaz AC, Terzioglu A, Aslan G. Multiple occurrences of different histologic types of the glomus tumor. J Hand Surg Am. 2005;30(1):161-164.

5.    Greene RG. Soft tissue tumors of the hand and wrist. A 10 year survey. J Med Soc N J. 1964;61:495-498.

6.    Maxwell GP, Curtis RM, Wilgis EF. Multiple digital glomus tumors. J Hand Surg Am. 1979;4(4):363-367.

7.    Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss SW. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol. 2001;25(1):1-12.

8.    De Chiara A, Apice G, Mori S, et al. Malignant glomus tumour: a case report and review of the literature. Sarcoma. 2003;7(2):87-91.

9.    Riveros M, Pack GT. The glomus tumor; report of 20 cases. Ann Surg. 1951;133(3):394-400.

10.  Van Geertruyden J, Lorea P, Goldschmidt D, et al. Glomus tumours of the hand. A retrospective study of 51 cases. J Hand Surg Br. 1996;21(2):257-260.

11.  Al-Qattan MM, Al-Namla A, Al-Thunayan A, Al-Subhi F, El-Shayeb AF. Magnetic resonance imaging in the diagnosis of glomus tumours of the hand. J Hand Surg Br. 2005;30(5):535-540.

12.  Drape JL, Idy-Peretti I, Goettmann S, et al. Subungual glomus tumors: evaluation with MR imaging. Radiology. 1995;195(2):507-515.

13.  Heys SD, Brittenden J, Atkinson P, Eremin O. Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg. 1992;79(4):345-347.

14.  Bhaskaranand K, Navadgi BC. Glomus tumour of the hand. J Hand Surg Br. 2002;27(3):229-231.

15.  Rettig AC, Strickland JW. Glomus tumor of the digits. J Hand Surg Am. 1977;2(4):261-265.

16.  Beham A, Fletcher CD. Intravascular glomus tumour: a previously undescribed phenomenon. Virchows Arch A Pathol Anat Histopathol. 1991;418(2):175-177.

17.  Googe PB, Griffin WC. Intravenous glomus tumor of the forearm. J Cutan Pathol. 1993;20(4):359-363.

18.   Koibuchi H, Fujii Y, Taniguchi N. An unusual case of a glomus tumor developing in a subcutaneous vein of the wrist. J Clin Ultrasound. 2008;36(6):369-370.

19.  Acebo E, Val-Bernal JF, Arce F. Giant intravenous glomus tumor. J Cutan Pathol. 1997;24(6):384-389.

20.  Ghaly RF, Ring AM. Supraclavicular glomus tumor, 20 year history of undiagnosed shoulder pain: a case report. Pain. 1999;83(2):379-382.

21.  Joseph FR, Posner MA. Glomus tumors of the wrist. J Hand Surg Am. 1983;8(6):918-920.

22.  Abou Jaoude JF, Roula Farah A, Sargi Z, Khairallah S, Fakih C. Glomus tumors: report on eleven cases and a review of the literature. Chir Main. 2000;19(4):243-252.

23.  Jablon M, Horowitz A, Bernstein DA. Magnetic resonance imaging of a glomus tumor of the fingertip. J Hand Surg Am. 1990;15(3):507-509.

24.  Theumann NH, Goettmann S, Le Viet D, et al. Recurrent glomus tumors of fingertips: MR imaging evaluation. Radiology. 2002;223(1):143-151.

25.  Boudghene FP, Gouny P, Tassart M, Callard P, Le Breton C, Vayssairat M. Subungual glomus tumor: combined use of MRI and three-dimensional contrast MR angiography. J Magn Reson Imaging. 1998;8(6):1326-1328.

26.  Van Ruyssevelt CE, Vranckx P. Subungual glomus tumor: emphasis on MR angiography. AJR Am J Roentgenol. 2004;182(1):263-264.

27.  Connell DA, Koulouris G, Thorn DA, Potter HG. Contrast-enhanced MR angiography of the hand. Radiographics. 2002;22(3):583-599.

28.  Varian JP, Cleak DK. Glomus tumours in the hand. Hand. 1980;12(3):293-299.

29.  Robert G, Sawaya E, Pelissier P. Glomus tumor of the dorsal aspect of the wrist: a case report [in French]. Chir Main. 2012;31(4):214-216.

30.   Chim H, Lahiri A, Chew WY. Atypical glomus tumour of the wrist: a case report. Hand Surg. 2009;14(2-3):121-123.

Issue
The American Journal of Orthopedics - 43(12)
Issue
The American Journal of Orthopedics - 43(12)
Page Number
567-570
Page Number
567-570
Publications
Publications
Topics
Article Type
Display Headline
Large Solitary Glomus Tumor of the Wrist Involving the Radial Artery
Display Headline
Large Solitary Glomus Tumor of the Wrist Involving the Radial Artery
Legacy Keywords
american journal of orthopedics, AJO, case report and literature review, case report, oncology, glomus tumor, tumor, wrist, radial artery, artery, lesions, soft-tissue, hsu, balaram, rapp, mehta, bindra
Legacy Keywords
american journal of orthopedics, AJO, case report and literature review, case report, oncology, glomus tumor, tumor, wrist, radial artery, artery, lesions, soft-tissue, hsu, balaram, rapp, mehta, bindra
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma

Article Type
Changed
Display Headline
Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma

Superior vena cava (SVC) syndrome refers to a constellation of symptoms produced by the obstruction of blood flow through the SVC, resulting in symptoms of dyspnea, facial and upper-extremity edema, cough, chest pain, and dysphagia.1 Malignancies represent 60%-85% of the etiologies of SVC syndrome. Cumulatively, lymphoma and lung cancer represent 95% of malignancy-related SVC syndrome etiologies, with non-small-cell lung cancer (NSCLC) reported in about 50% of cases, small-cell lung cancer (SCLC) in about 25%, and non-Hodgkin lymphoma (NHL) in 10 % of all cases.1,2

 

Click on the PDF icon at the top of this introduction to read the full article.

 

Article PDF
Issue
The Journal of Community and Supportive Oncology - 12(11)
Publications
Topics
Page Number
415-417
Legacy Keywords
superior vena cava syndrome, SCV, follicular lymphoma, FL
Sections
Article PDF
Article PDF

Superior vena cava (SVC) syndrome refers to a constellation of symptoms produced by the obstruction of blood flow through the SVC, resulting in symptoms of dyspnea, facial and upper-extremity edema, cough, chest pain, and dysphagia.1 Malignancies represent 60%-85% of the etiologies of SVC syndrome. Cumulatively, lymphoma and lung cancer represent 95% of malignancy-related SVC syndrome etiologies, with non-small-cell lung cancer (NSCLC) reported in about 50% of cases, small-cell lung cancer (SCLC) in about 25%, and non-Hodgkin lymphoma (NHL) in 10 % of all cases.1,2

 

Click on the PDF icon at the top of this introduction to read the full article.

 

Superior vena cava (SVC) syndrome refers to a constellation of symptoms produced by the obstruction of blood flow through the SVC, resulting in symptoms of dyspnea, facial and upper-extremity edema, cough, chest pain, and dysphagia.1 Malignancies represent 60%-85% of the etiologies of SVC syndrome. Cumulatively, lymphoma and lung cancer represent 95% of malignancy-related SVC syndrome etiologies, with non-small-cell lung cancer (NSCLC) reported in about 50% of cases, small-cell lung cancer (SCLC) in about 25%, and non-Hodgkin lymphoma (NHL) in 10 % of all cases.1,2

 

Click on the PDF icon at the top of this introduction to read the full article.

 

Issue
The Journal of Community and Supportive Oncology - 12(11)
Issue
The Journal of Community and Supportive Oncology - 12(11)
Page Number
415-417
Page Number
415-417
Publications
Publications
Topics
Article Type
Display Headline
Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma
Display Headline
Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma
Legacy Keywords
superior vena cava syndrome, SCV, follicular lymphoma, FL
Legacy Keywords
superior vena cava syndrome, SCV, follicular lymphoma, FL
Sections
Citation Override
JCSO 2014;12(11):415-417
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Radioactive Iodine Scintiphotos of a Man With Thyroid Cancer

Article Type
Changed
Images of a man with thyroid cancer indicated abnormal iodine localization. Can you guess the cause?

The contemporary management of differentiated thyroid cancer includes posttreatment monitoring for recurrence or metastasis.1 This monitoring includes clinical, biochemical, and imaging evaluation. Follow-up treatment can then be tailored based on the results of this monitoring.

Our patient was a 61-year-old man with a history of papillary thyroid carcinoma, including lymph node involvement and an extension of the primary focus into skeletal muscle (pT3N1bMX, stage IVa). The patient’s status was posttotal thyroidectomy and radioiodine ablation therapy (196.2 mCi iodine-131) in April 2009. The patient underwent follow-up thyrotropin alpha stimulated whole-body radioiodine surveillance scanning in May 2010.

Images demonstrated residual thyroid tissue/carcinoma regional to the thyroid bed, corresponding to prior posttherapy images. Whole body scintiphotos also demonstrated abnormal iodine localization that raised the possibility of distant bony metastasis in the region of the right hip (see Figures 1A and 1B). Current treatment standards for isolated bony metastases recommend repeated radioactive iodine therapy and potential external beam radiation. Imaging is required for accurate verification.1 This abnormal osseous finding was questionable on initial review, as it was present on the posterior, not anterior, view. The patient was instructed to continue hydration and return for additional delayed scintiphotos for further evaluation.

The patient returned 4 days later for delayed scintiphotos, which again demonstrated abnormal iodine localization near the right hip. However, iodine distribution was different, including now being visible on both the anterior and posterior views (see Figures 2A and 2B on the next page).

 

 

  • What is your diagnosis?
  • How would you treat this patient? 

[Click through to the next page to see the answer.]

 

 

 

 

 

Our Treatment

The patient had no pain in the area and, upon further questioning, reported that he returned wearing the same athletic shorts. Given that radioiodine is excreted in the urine, this atypical distribution was thought to reflect urinary contamination. When images were taken again with the shorts removed, no abnormal radioiodine activity was present (see Figures 2C and 2D). Additional findings with thyrotropin alfa stimulation included increased quantitative thyroglobulin values of 20.2 ng/mL with antithyroglobulin antibody < 20.0 U/mL. Radioiodine ablation therapy using thyrotropin alfa was repeated. Iodine localization also was not present in the hip on posttherapy imaging (not shown).

Despite advances in imaging techniques, radioiodine scanning remains an imperfect science. Artifacts and pitfalls have been identified; in part, these are related to the accumulation of iodide in organs other than the thyroid, such as the nasopharynx and stomach, as well as the apparent accumulation due to excretion in the gut and bladder.2-4 These variations can be divided into ectopic normal thyroid tissue, physiologic accumulation in nonthyroidal tissue, and contamination by physiologic secretions. Recent case reports have confirmed this classification. Abnormal radioiodine uptake has been described in vertebral hemangioma,5 liver abscess6 and hydatid cyst,7 bronchiectasis,8 bronchogenic cyst and mucinous cystadenoma (2 fluid-filled cavities),9 chronic submandibular sialadenitis,10 esophageal diverticulum,11 hiatal hernia,12 appendix,13 indwelling Hickman catheter,14 renal cyst,15 and, similar to this case, contamination of the hair.16

Contaminated clothing is not uncommon; however, a persistent abnormality from contaminated clothing on repeat follow-up is unusual and could easily be misinterpreted.2 It would be valuable for all providers to be aware of the pitfalls of imaging before embarking on an unnecessary and potentially hazardous—not to mention costly—treatment course.

Acknowledgments
The authors acknowledge the assistance of Richard Cacciato, MLIS, Medical Librarian, who assisted in the literature review.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

 

 

References

1. Cooper, DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.

2. Carlisle MR, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun. 2003;24(6):715-735.

3. Shapiro B, Rufini V, Jarwan A, et al. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med. 2000;30(2):115-132.

4. Mitchell G, Pratt BE, Vini L, McCready VR, Harmer CL. False positive 131I whole body scans in thyroid cancer. Br J Radiol. 2000;73(870):627-635.

5. Khan S, Dunn J, Strickland N, Al-Nahhas A. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma. Nucl Med Rev Cent East Eur. 2008;11(1):30-33.

6. Pena Pardo FJ, Crespo de la Jara A, Fernández Morejón FJ, Sureda González M, Forteza Vila J, Brugarolas Masllorens A. Solitary focus in the liver in a thyroid cancer patient after a whole body scan with 131 iodine. Rev Esp Med Nucl. 2007;26(5):294-296.

7. Omür O, Ozbek SS, Akgün A, Yazici B, Mutlukoca N, Ozcan Z. False-positive I-131 accumulation in a hepatic hydatid cyst. Clin Nucl Med. 2007;32(12):930-932.

8. Jong I, Taubman K, Schlicht S. Bronchiectasis simulating pulmonary metastases on iodine-131 scintigraphy in well-differentiated thyroid carcinoma. Clin Nucl Med. 2005;30(10):688-689.

9. Agriantonis DJ, Hall L, Wilson MA. Pitfalls of I-131 whole body scan interpretation: Bronchogenic cyst and mucinous cystadenoma. Clin Nucl Med. 2008;33(5):325-327.

10. Ozguven M, Ilgan S, Karacalioglu AO, Arslan N, Ozturk E. Unusual patterns of I-131 accumulation. Clin Nucl Med. 2004;29(11):738-740.

11. Rashid K, Johns W, Chasse K, Walker M, Gupta SM. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy. Clin Nucl Med. 2006;31(7):405-408.

12. Ceylan Gunay E, Erdogan A. Mediastinal radioiodine uptake due to hiatal hernia: A false-positive reaction in 131I scan. Rev Esp Med Nucl. 2010;29(2):95.

13. Borkar S, Grewal R, Schoder H. I-131 uptake demonstrated in the appendix on a posttreatment scan in a patient with thyroid cancer. Clin Nucl Med. 2008;33(8):551-552.

14. Groskin SA, McCrohan G. Pseudometastasis of the chest wall resulting from a Hickman catheter. J Thorac Imaging. 1994;9(3):169-171.

15. Thust S, Fernando R, Barwick T, Mohan H, Clarke SE. SPECT/CT identification of post-radioactive iodine treatment false-positive uptake in a simple renal cyst. Thyroid. 2009;19(1):75-76.

16. Sinha A, Bradley KM, Steatham J, Weaver A. Asymmetric breast uptake of radioiodine in a patient with thyroid malignancy: Metastases or not? J R Soc Med. 2008;101(6):319-320.

Article PDF
Author and Disclosure Information

Dr. Swislocki is chief of the Endocrine Section and assistant chief of the Medical Service, and Dr. Falk is a staff physician in Nuclear Medicine at the VA Northern California Health Care System. Dr. Swislocki is also a professor of medicine in the Department of Internal Medicine at the University of California Davis School of Medicine.

Issue
Federal Practitioner - 31(11)
Publications
Topics
Page Number
40-42
Legacy Keywords
thyroid cancer, abnormal iodine localization, lymph node involvement, pT3N1bMX stage IVa, whole body scintiphotos, thyrotropin alpha stimulated whole-body radioiodine surveillance scan, residual thyroid tissue/carcinoma, radioactive iodine therapy, potential external beam radiation, urinary contamination, Arthur L M Swislocki, Matthew Falk, What's Your Diagnosis?
Sections
Author and Disclosure Information

Dr. Swislocki is chief of the Endocrine Section and assistant chief of the Medical Service, and Dr. Falk is a staff physician in Nuclear Medicine at the VA Northern California Health Care System. Dr. Swislocki is also a professor of medicine in the Department of Internal Medicine at the University of California Davis School of Medicine.

Author and Disclosure Information

Dr. Swislocki is chief of the Endocrine Section and assistant chief of the Medical Service, and Dr. Falk is a staff physician in Nuclear Medicine at the VA Northern California Health Care System. Dr. Swislocki is also a professor of medicine in the Department of Internal Medicine at the University of California Davis School of Medicine.

Article PDF
Article PDF
Related Articles
Images of a man with thyroid cancer indicated abnormal iodine localization. Can you guess the cause?
Images of a man with thyroid cancer indicated abnormal iodine localization. Can you guess the cause?

The contemporary management of differentiated thyroid cancer includes posttreatment monitoring for recurrence or metastasis.1 This monitoring includes clinical, biochemical, and imaging evaluation. Follow-up treatment can then be tailored based on the results of this monitoring.

Our patient was a 61-year-old man with a history of papillary thyroid carcinoma, including lymph node involvement and an extension of the primary focus into skeletal muscle (pT3N1bMX, stage IVa). The patient’s status was posttotal thyroidectomy and radioiodine ablation therapy (196.2 mCi iodine-131) in April 2009. The patient underwent follow-up thyrotropin alpha stimulated whole-body radioiodine surveillance scanning in May 2010.

Images demonstrated residual thyroid tissue/carcinoma regional to the thyroid bed, corresponding to prior posttherapy images. Whole body scintiphotos also demonstrated abnormal iodine localization that raised the possibility of distant bony metastasis in the region of the right hip (see Figures 1A and 1B). Current treatment standards for isolated bony metastases recommend repeated radioactive iodine therapy and potential external beam radiation. Imaging is required for accurate verification.1 This abnormal osseous finding was questionable on initial review, as it was present on the posterior, not anterior, view. The patient was instructed to continue hydration and return for additional delayed scintiphotos for further evaluation.

The patient returned 4 days later for delayed scintiphotos, which again demonstrated abnormal iodine localization near the right hip. However, iodine distribution was different, including now being visible on both the anterior and posterior views (see Figures 2A and 2B on the next page).

 

 

  • What is your diagnosis?
  • How would you treat this patient? 

[Click through to the next page to see the answer.]

 

 

 

 

 

Our Treatment

The patient had no pain in the area and, upon further questioning, reported that he returned wearing the same athletic shorts. Given that radioiodine is excreted in the urine, this atypical distribution was thought to reflect urinary contamination. When images were taken again with the shorts removed, no abnormal radioiodine activity was present (see Figures 2C and 2D). Additional findings with thyrotropin alfa stimulation included increased quantitative thyroglobulin values of 20.2 ng/mL with antithyroglobulin antibody < 20.0 U/mL. Radioiodine ablation therapy using thyrotropin alfa was repeated. Iodine localization also was not present in the hip on posttherapy imaging (not shown).

Despite advances in imaging techniques, radioiodine scanning remains an imperfect science. Artifacts and pitfalls have been identified; in part, these are related to the accumulation of iodide in organs other than the thyroid, such as the nasopharynx and stomach, as well as the apparent accumulation due to excretion in the gut and bladder.2-4 These variations can be divided into ectopic normal thyroid tissue, physiologic accumulation in nonthyroidal tissue, and contamination by physiologic secretions. Recent case reports have confirmed this classification. Abnormal radioiodine uptake has been described in vertebral hemangioma,5 liver abscess6 and hydatid cyst,7 bronchiectasis,8 bronchogenic cyst and mucinous cystadenoma (2 fluid-filled cavities),9 chronic submandibular sialadenitis,10 esophageal diverticulum,11 hiatal hernia,12 appendix,13 indwelling Hickman catheter,14 renal cyst,15 and, similar to this case, contamination of the hair.16

Contaminated clothing is not uncommon; however, a persistent abnormality from contaminated clothing on repeat follow-up is unusual and could easily be misinterpreted.2 It would be valuable for all providers to be aware of the pitfalls of imaging before embarking on an unnecessary and potentially hazardous—not to mention costly—treatment course.

Acknowledgments
The authors acknowledge the assistance of Richard Cacciato, MLIS, Medical Librarian, who assisted in the literature review.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

 

 

The contemporary management of differentiated thyroid cancer includes posttreatment monitoring for recurrence or metastasis.1 This monitoring includes clinical, biochemical, and imaging evaluation. Follow-up treatment can then be tailored based on the results of this monitoring.

Our patient was a 61-year-old man with a history of papillary thyroid carcinoma, including lymph node involvement and an extension of the primary focus into skeletal muscle (pT3N1bMX, stage IVa). The patient’s status was posttotal thyroidectomy and radioiodine ablation therapy (196.2 mCi iodine-131) in April 2009. The patient underwent follow-up thyrotropin alpha stimulated whole-body radioiodine surveillance scanning in May 2010.

Images demonstrated residual thyroid tissue/carcinoma regional to the thyroid bed, corresponding to prior posttherapy images. Whole body scintiphotos also demonstrated abnormal iodine localization that raised the possibility of distant bony metastasis in the region of the right hip (see Figures 1A and 1B). Current treatment standards for isolated bony metastases recommend repeated radioactive iodine therapy and potential external beam radiation. Imaging is required for accurate verification.1 This abnormal osseous finding was questionable on initial review, as it was present on the posterior, not anterior, view. The patient was instructed to continue hydration and return for additional delayed scintiphotos for further evaluation.

The patient returned 4 days later for delayed scintiphotos, which again demonstrated abnormal iodine localization near the right hip. However, iodine distribution was different, including now being visible on both the anterior and posterior views (see Figures 2A and 2B on the next page).

 

 

  • What is your diagnosis?
  • How would you treat this patient? 

[Click through to the next page to see the answer.]

 

 

 

 

 

Our Treatment

The patient had no pain in the area and, upon further questioning, reported that he returned wearing the same athletic shorts. Given that radioiodine is excreted in the urine, this atypical distribution was thought to reflect urinary contamination. When images were taken again with the shorts removed, no abnormal radioiodine activity was present (see Figures 2C and 2D). Additional findings with thyrotropin alfa stimulation included increased quantitative thyroglobulin values of 20.2 ng/mL with antithyroglobulin antibody < 20.0 U/mL. Radioiodine ablation therapy using thyrotropin alfa was repeated. Iodine localization also was not present in the hip on posttherapy imaging (not shown).

Despite advances in imaging techniques, radioiodine scanning remains an imperfect science. Artifacts and pitfalls have been identified; in part, these are related to the accumulation of iodide in organs other than the thyroid, such as the nasopharynx and stomach, as well as the apparent accumulation due to excretion in the gut and bladder.2-4 These variations can be divided into ectopic normal thyroid tissue, physiologic accumulation in nonthyroidal tissue, and contamination by physiologic secretions. Recent case reports have confirmed this classification. Abnormal radioiodine uptake has been described in vertebral hemangioma,5 liver abscess6 and hydatid cyst,7 bronchiectasis,8 bronchogenic cyst and mucinous cystadenoma (2 fluid-filled cavities),9 chronic submandibular sialadenitis,10 esophageal diverticulum,11 hiatal hernia,12 appendix,13 indwelling Hickman catheter,14 renal cyst,15 and, similar to this case, contamination of the hair.16

Contaminated clothing is not uncommon; however, a persistent abnormality from contaminated clothing on repeat follow-up is unusual and could easily be misinterpreted.2 It would be valuable for all providers to be aware of the pitfalls of imaging before embarking on an unnecessary and potentially hazardous—not to mention costly—treatment course.

Acknowledgments
The authors acknowledge the assistance of Richard Cacciato, MLIS, Medical Librarian, who assisted in the literature review.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

 

 

References

1. Cooper, DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.

2. Carlisle MR, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun. 2003;24(6):715-735.

3. Shapiro B, Rufini V, Jarwan A, et al. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med. 2000;30(2):115-132.

4. Mitchell G, Pratt BE, Vini L, McCready VR, Harmer CL. False positive 131I whole body scans in thyroid cancer. Br J Radiol. 2000;73(870):627-635.

5. Khan S, Dunn J, Strickland N, Al-Nahhas A. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma. Nucl Med Rev Cent East Eur. 2008;11(1):30-33.

6. Pena Pardo FJ, Crespo de la Jara A, Fernández Morejón FJ, Sureda González M, Forteza Vila J, Brugarolas Masllorens A. Solitary focus in the liver in a thyroid cancer patient after a whole body scan with 131 iodine. Rev Esp Med Nucl. 2007;26(5):294-296.

7. Omür O, Ozbek SS, Akgün A, Yazici B, Mutlukoca N, Ozcan Z. False-positive I-131 accumulation in a hepatic hydatid cyst. Clin Nucl Med. 2007;32(12):930-932.

8. Jong I, Taubman K, Schlicht S. Bronchiectasis simulating pulmonary metastases on iodine-131 scintigraphy in well-differentiated thyroid carcinoma. Clin Nucl Med. 2005;30(10):688-689.

9. Agriantonis DJ, Hall L, Wilson MA. Pitfalls of I-131 whole body scan interpretation: Bronchogenic cyst and mucinous cystadenoma. Clin Nucl Med. 2008;33(5):325-327.

10. Ozguven M, Ilgan S, Karacalioglu AO, Arslan N, Ozturk E. Unusual patterns of I-131 accumulation. Clin Nucl Med. 2004;29(11):738-740.

11. Rashid K, Johns W, Chasse K, Walker M, Gupta SM. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy. Clin Nucl Med. 2006;31(7):405-408.

12. Ceylan Gunay E, Erdogan A. Mediastinal radioiodine uptake due to hiatal hernia: A false-positive reaction in 131I scan. Rev Esp Med Nucl. 2010;29(2):95.

13. Borkar S, Grewal R, Schoder H. I-131 uptake demonstrated in the appendix on a posttreatment scan in a patient with thyroid cancer. Clin Nucl Med. 2008;33(8):551-552.

14. Groskin SA, McCrohan G. Pseudometastasis of the chest wall resulting from a Hickman catheter. J Thorac Imaging. 1994;9(3):169-171.

15. Thust S, Fernando R, Barwick T, Mohan H, Clarke SE. SPECT/CT identification of post-radioactive iodine treatment false-positive uptake in a simple renal cyst. Thyroid. 2009;19(1):75-76.

16. Sinha A, Bradley KM, Steatham J, Weaver A. Asymmetric breast uptake of radioiodine in a patient with thyroid malignancy: Metastases or not? J R Soc Med. 2008;101(6):319-320.

References

1. Cooper, DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.

2. Carlisle MR, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun. 2003;24(6):715-735.

3. Shapiro B, Rufini V, Jarwan A, et al. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med. 2000;30(2):115-132.

4. Mitchell G, Pratt BE, Vini L, McCready VR, Harmer CL. False positive 131I whole body scans in thyroid cancer. Br J Radiol. 2000;73(870):627-635.

5. Khan S, Dunn J, Strickland N, Al-Nahhas A. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma. Nucl Med Rev Cent East Eur. 2008;11(1):30-33.

6. Pena Pardo FJ, Crespo de la Jara A, Fernández Morejón FJ, Sureda González M, Forteza Vila J, Brugarolas Masllorens A. Solitary focus in the liver in a thyroid cancer patient after a whole body scan with 131 iodine. Rev Esp Med Nucl. 2007;26(5):294-296.

7. Omür O, Ozbek SS, Akgün A, Yazici B, Mutlukoca N, Ozcan Z. False-positive I-131 accumulation in a hepatic hydatid cyst. Clin Nucl Med. 2007;32(12):930-932.

8. Jong I, Taubman K, Schlicht S. Bronchiectasis simulating pulmonary metastases on iodine-131 scintigraphy in well-differentiated thyroid carcinoma. Clin Nucl Med. 2005;30(10):688-689.

9. Agriantonis DJ, Hall L, Wilson MA. Pitfalls of I-131 whole body scan interpretation: Bronchogenic cyst and mucinous cystadenoma. Clin Nucl Med. 2008;33(5):325-327.

10. Ozguven M, Ilgan S, Karacalioglu AO, Arslan N, Ozturk E. Unusual patterns of I-131 accumulation. Clin Nucl Med. 2004;29(11):738-740.

11. Rashid K, Johns W, Chasse K, Walker M, Gupta SM. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy. Clin Nucl Med. 2006;31(7):405-408.

12. Ceylan Gunay E, Erdogan A. Mediastinal radioiodine uptake due to hiatal hernia: A false-positive reaction in 131I scan. Rev Esp Med Nucl. 2010;29(2):95.

13. Borkar S, Grewal R, Schoder H. I-131 uptake demonstrated in the appendix on a posttreatment scan in a patient with thyroid cancer. Clin Nucl Med. 2008;33(8):551-552.

14. Groskin SA, McCrohan G. Pseudometastasis of the chest wall resulting from a Hickman catheter. J Thorac Imaging. 1994;9(3):169-171.

15. Thust S, Fernando R, Barwick T, Mohan H, Clarke SE. SPECT/CT identification of post-radioactive iodine treatment false-positive uptake in a simple renal cyst. Thyroid. 2009;19(1):75-76.

16. Sinha A, Bradley KM, Steatham J, Weaver A. Asymmetric breast uptake of radioiodine in a patient with thyroid malignancy: Metastases or not? J R Soc Med. 2008;101(6):319-320.

Issue
Federal Practitioner - 31(11)
Issue
Federal Practitioner - 31(11)
Page Number
40-42
Page Number
40-42
Publications
Publications
Topics
Article Type
Legacy Keywords
thyroid cancer, abnormal iodine localization, lymph node involvement, pT3N1bMX stage IVa, whole body scintiphotos, thyrotropin alpha stimulated whole-body radioiodine surveillance scan, residual thyroid tissue/carcinoma, radioactive iodine therapy, potential external beam radiation, urinary contamination, Arthur L M Swislocki, Matthew Falk, What's Your Diagnosis?
Legacy Keywords
thyroid cancer, abnormal iodine localization, lymph node involvement, pT3N1bMX stage IVa, whole body scintiphotos, thyrotropin alpha stimulated whole-body radioiodine surveillance scan, residual thyroid tissue/carcinoma, radioactive iodine therapy, potential external beam radiation, urinary contamination, Arthur L M Swislocki, Matthew Falk, What's Your Diagnosis?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

My Most Unusual Case: Painful Blistering on the Dorsal Hands

Article Type
Changed
Display Headline
My Most Unusual Case: Painful Blistering on the Dorsal Hands
As the onset of pseudoporphyria may be acute, patients often initially present to the ED with this uncommon condition.

Patients with pseudoporphyria, an uncommon blistering skin disease, may initially present in the ED as the onset of this photosensitive condition can be acute—inciting patients to seek care urgently. The causes of pseudoporphyria may be drug-induced or related to hemodialysis, and it can develop even months to years after a patient with end-stage renal disease (ESRD) has been undergoing hemodialysis.1 Alternatively, patients can develop the condition weeks to months after starting certain medications (eg, nonsteroidal anti-inflammatory drugs [NSAIDs], tyrosine kinase receptor inhibitors, hormonal contraceptives, diuretics, antiandrogens, 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors). Recent case reports associate finasteride, torsemide, and β-lactam antibiotics with pseudoporphyria.2,3

With the increasing number of older Americans, as well as approximately one-third of seniors taking more than 5 drugs, the incidence of drug-induced pseudoporphyria is likely to increase in the near future.4 Additionally, ESRD is more common in patients older than age 70 years,5 increasing the risk of hemodialysis-related pseudoporphyria in this population.

Case

A 58-year-old black man presented to the ED with an 8-month history of nail changes and painful blisters on the dorsal hands. He stated that he initially noticed these findings after doing yardwork. Regarding history, he further noted that he smokes 3 cigarette packs daily and receives hemodialysis three times weekly for ESRD secondary to polycystic kidney disease. His medications included simvastatin, omeprazole, minoxidil, calcium, and a vitamin B complex.

On physical examination, the patient was well-appearing and in no acute distress with stable vital signs. His dermatologic examination revealed shallow, well-defined erosions, some with central crusting; and adjacent 1- to 2-mm scattered white papules on the dorsum of his hands bilaterally, with more appearing on his left hand than his right hand. The patient’s digits were tender to palpation, and symmetric tapering of the digits was present. Onycholysis and onychodystrophy were present in the majority of his nails.

The laboratory workup included a complete blood count and differential, which demonstrated a stable anemia of chronic disease when compared to prior labwork; a complete metabolic panel revealed expected elevated blood urea nitrogen and creatinine. Liver function and iron studies were normal.

Punch biopsies were performed on perilesional skin with direct immunofluorescence revealing linear granular deposits of immune complexes (IgG and C3), and direct microscopy noting fibrin at the dermoepidermal junction and perivascular location. These clinical and laboratory findings are consistent with porphyria cutanea tarda (PCT), pseudoporphyria, or variegate porphyria. However, his serum porphyrin studies were normal, thus supporting the diagnosis of pseudoporphyria.

Porphyria Cutanea Tarda

Porphyria cutanea tarda is the most common disorder of heme biosynthesis. In this condition, hepatic uroporphyrinogen decarboxylase is deficient, leading to the accumulation of porphyrins in the serum and blood.6 Patients typically present in adulthood complaining of painful blisters and milia on the dorsal hands, and usually do not recognize the component of sunlight exposure in the subsequent appearance of lesions.7 Genetic, environmental, and infectious etiologies contribute to its onset, acting singly or in concert.8-10 Up to half of patients with PCT are infected with hepatitis C; other associations include tobacco smoking, alcoholism, HIV infection, and hereditary hemochromatosis.10-12

As seen in this patient, no accumulation of photosensitive porphyrins is evident in pseudoporphyria through current laboratory testing. While the pathogenesis of pseudoporphyria is unknown, it may be linked to the generation of free radicals.

It is estimated that pseudoporphyria occurs in about 1.2% to 18% of patients undergoing hemodialysis treatment secondary to ESRD.13,14 Massone et al13 demonstrated that dialysis patients with ESRD are more susceptible to free-radical injury due to a reduction of the antioxidant glutathione in both plasma and erythrocytes. Additionally, ultraviolet (UV)-induced free radical formation in the skin has been well documented in the literature.15 This is further supported by a number of pseudoporphyria cases successfully treated with N-acetylcysteine, which replenishes glutathione. However, use of this medication in the treatment of pseudoporphyria is not common.

Treatment

Treatment of patients with pseudoporphyria requires a multifaceted approach. Removing the causative medication when possible may resolve the eruption. Unfortunately in our patient’s case, simvastatin, a possible cause of pseudoporphyria, was withdrawn for several months without improvement. This implicates hemodialysis as the probable cause of his pseudoporphyria. In a case of hemodialysis-induced pseudoporphyria, hemodialysis is life-saving and unable to be discontinued.

It is also important to counsel patients extensively on the importance of UV avoidance, including the use of photoprotective clothing, mineral-based sunscreen creams, and avoiding outside activity during peak daylight hours (ie, between 10:00 AM and 4:00 PM). A short course (2-4 weeks) of potent topical corticosteroids such as clobetasol 0.05% ointment can be prescribed for twice daily application to active lesions on the hands. Patients should also avoid any photosensitizing medications such as NSAIDs and tetracyclines.

 

 

Case Conclusion

On follow-up visits to the dermatology clinic, this patient continued to report improvement when compliant with the prescribed treatment plan, which included avoidance of direct sunlight, use of photoprotective clothing, and avoidance of photosensitizing medications, as well as daily use of clobetasol to lesions as needed. He noted skin flares with unprotected UV exposure.

Do you have an unusual case that you would like to share with your EM colleagues? Submissions should be cases that presented at and were managed within your ED. Please limit case reports to 1,000 words with a title of no more than 100 characters. Include a brief summary or unstructured abstract before you present the case details and include no more than two tables or figures, which should be submitted as separate, high-resolution files. Please de-identify all patient information. For full author guidelines please go to “author guidelines” at emed-journal.com. You can submit your case at editorialmanager.com/emedjournal or mdales@frontlinemedcom.com.

References

  1. Cordova KB, Oberg TJ, Malik M, Robinson-Bostom L. Dermatologic conditions seen in end-stage renal disease. Semin Dial. 2009;22(1):45-55.
  2. Santo Domingo D, Stevenson ML, Auerbach J, Lerman J. Finasteride-induced pseudoporphyria. Arch Dermatol. 2011;147(6):747-748.
  3. Pérez-Bustillo A, Sánchez-Sambucety P, Suárez-Amor O, Rodríiguez-Prieto MA. Torsemide-induced pseudoporphyria. Arch Dermatol. 2008;144(6):812-813.
  4. Scott IA, Gray LC, Martin JH, Mitchell CA. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125(6):529-537.
  5. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet, 2014. http://www.cdc.gov/diabetes/pubs/pdf/kidney_Factsheet.pdf. Accessed October 24, 2014.
  6. Frank J, Poblete-Gutiérrez P. Porphyria cutanea tarda—when skin meets liver.  Best Pract Res Clin Gastroenterol. 2010;24(5):735-745.
  7. Poh-Fitzpatrick MB. Porphyria cutanea tarda clinical presentation. Medscape Web site. http://emedicine.medscape.com/article/1103643-clinical#a0216. Updated February 24, 2014. Accessed October 24, 2014.
  8. Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci. 2002;47(2):419-426.
  9. Cruz-Rojo J, Fontanellas A, Morán-Jiménez MJ. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol (Noisy-le-grand). 2002;48(8):845-852.
  10. Jalil S, Grady JJ, Lee C, Anderson KE. Associations among behavior-related susceptibility factors in porphyria cutanea tarda. Clin Gastroenterol Hepatol. 2010;8(3):297-302.
  11. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol. 1999;17(4):431-436.
  12. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology. 1998;27(6):1661-1669.
  13. Massone C, Ambros-Rudolph CM, et al: Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis. Acta Derm Venereol. 2006;86(6):538-540.
  14. Cooke NS, McKenna K. A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine. Clin Exp Dermatol. 2007;32(1):64-66.
  15. Jurkiewicz BA, Buettner GR. Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study.
Author and Disclosure Information

Issue
Emergency Medicine - 46(11)
Publications
Topics
Page Number
513-516
Legacy Keywords
pseudoporphyria, blisters, end-stage renal disease, unusual case, Porphyria Cutanea Tarda
Sections
Author and Disclosure Information

Author and Disclosure Information

As the onset of pseudoporphyria may be acute, patients often initially present to the ED with this uncommon condition.
As the onset of pseudoporphyria may be acute, patients often initially present to the ED with this uncommon condition.

Patients with pseudoporphyria, an uncommon blistering skin disease, may initially present in the ED as the onset of this photosensitive condition can be acute—inciting patients to seek care urgently. The causes of pseudoporphyria may be drug-induced or related to hemodialysis, and it can develop even months to years after a patient with end-stage renal disease (ESRD) has been undergoing hemodialysis.1 Alternatively, patients can develop the condition weeks to months after starting certain medications (eg, nonsteroidal anti-inflammatory drugs [NSAIDs], tyrosine kinase receptor inhibitors, hormonal contraceptives, diuretics, antiandrogens, 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors). Recent case reports associate finasteride, torsemide, and β-lactam antibiotics with pseudoporphyria.2,3

With the increasing number of older Americans, as well as approximately one-third of seniors taking more than 5 drugs, the incidence of drug-induced pseudoporphyria is likely to increase in the near future.4 Additionally, ESRD is more common in patients older than age 70 years,5 increasing the risk of hemodialysis-related pseudoporphyria in this population.

Case

A 58-year-old black man presented to the ED with an 8-month history of nail changes and painful blisters on the dorsal hands. He stated that he initially noticed these findings after doing yardwork. Regarding history, he further noted that he smokes 3 cigarette packs daily and receives hemodialysis three times weekly for ESRD secondary to polycystic kidney disease. His medications included simvastatin, omeprazole, minoxidil, calcium, and a vitamin B complex.

On physical examination, the patient was well-appearing and in no acute distress with stable vital signs. His dermatologic examination revealed shallow, well-defined erosions, some with central crusting; and adjacent 1- to 2-mm scattered white papules on the dorsum of his hands bilaterally, with more appearing on his left hand than his right hand. The patient’s digits were tender to palpation, and symmetric tapering of the digits was present. Onycholysis and onychodystrophy were present in the majority of his nails.

The laboratory workup included a complete blood count and differential, which demonstrated a stable anemia of chronic disease when compared to prior labwork; a complete metabolic panel revealed expected elevated blood urea nitrogen and creatinine. Liver function and iron studies were normal.

Punch biopsies were performed on perilesional skin with direct immunofluorescence revealing linear granular deposits of immune complexes (IgG and C3), and direct microscopy noting fibrin at the dermoepidermal junction and perivascular location. These clinical and laboratory findings are consistent with porphyria cutanea tarda (PCT), pseudoporphyria, or variegate porphyria. However, his serum porphyrin studies were normal, thus supporting the diagnosis of pseudoporphyria.

Porphyria Cutanea Tarda

Porphyria cutanea tarda is the most common disorder of heme biosynthesis. In this condition, hepatic uroporphyrinogen decarboxylase is deficient, leading to the accumulation of porphyrins in the serum and blood.6 Patients typically present in adulthood complaining of painful blisters and milia on the dorsal hands, and usually do not recognize the component of sunlight exposure in the subsequent appearance of lesions.7 Genetic, environmental, and infectious etiologies contribute to its onset, acting singly or in concert.8-10 Up to half of patients with PCT are infected with hepatitis C; other associations include tobacco smoking, alcoholism, HIV infection, and hereditary hemochromatosis.10-12

As seen in this patient, no accumulation of photosensitive porphyrins is evident in pseudoporphyria through current laboratory testing. While the pathogenesis of pseudoporphyria is unknown, it may be linked to the generation of free radicals.

It is estimated that pseudoporphyria occurs in about 1.2% to 18% of patients undergoing hemodialysis treatment secondary to ESRD.13,14 Massone et al13 demonstrated that dialysis patients with ESRD are more susceptible to free-radical injury due to a reduction of the antioxidant glutathione in both plasma and erythrocytes. Additionally, ultraviolet (UV)-induced free radical formation in the skin has been well documented in the literature.15 This is further supported by a number of pseudoporphyria cases successfully treated with N-acetylcysteine, which replenishes glutathione. However, use of this medication in the treatment of pseudoporphyria is not common.

Treatment

Treatment of patients with pseudoporphyria requires a multifaceted approach. Removing the causative medication when possible may resolve the eruption. Unfortunately in our patient’s case, simvastatin, a possible cause of pseudoporphyria, was withdrawn for several months without improvement. This implicates hemodialysis as the probable cause of his pseudoporphyria. In a case of hemodialysis-induced pseudoporphyria, hemodialysis is life-saving and unable to be discontinued.

It is also important to counsel patients extensively on the importance of UV avoidance, including the use of photoprotective clothing, mineral-based sunscreen creams, and avoiding outside activity during peak daylight hours (ie, between 10:00 AM and 4:00 PM). A short course (2-4 weeks) of potent topical corticosteroids such as clobetasol 0.05% ointment can be prescribed for twice daily application to active lesions on the hands. Patients should also avoid any photosensitizing medications such as NSAIDs and tetracyclines.

 

 

Case Conclusion

On follow-up visits to the dermatology clinic, this patient continued to report improvement when compliant with the prescribed treatment plan, which included avoidance of direct sunlight, use of photoprotective clothing, and avoidance of photosensitizing medications, as well as daily use of clobetasol to lesions as needed. He noted skin flares with unprotected UV exposure.

Do you have an unusual case that you would like to share with your EM colleagues? Submissions should be cases that presented at and were managed within your ED. Please limit case reports to 1,000 words with a title of no more than 100 characters. Include a brief summary or unstructured abstract before you present the case details and include no more than two tables or figures, which should be submitted as separate, high-resolution files. Please de-identify all patient information. For full author guidelines please go to “author guidelines” at emed-journal.com. You can submit your case at editorialmanager.com/emedjournal or mdales@frontlinemedcom.com.

Patients with pseudoporphyria, an uncommon blistering skin disease, may initially present in the ED as the onset of this photosensitive condition can be acute—inciting patients to seek care urgently. The causes of pseudoporphyria may be drug-induced or related to hemodialysis, and it can develop even months to years after a patient with end-stage renal disease (ESRD) has been undergoing hemodialysis.1 Alternatively, patients can develop the condition weeks to months after starting certain medications (eg, nonsteroidal anti-inflammatory drugs [NSAIDs], tyrosine kinase receptor inhibitors, hormonal contraceptives, diuretics, antiandrogens, 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors). Recent case reports associate finasteride, torsemide, and β-lactam antibiotics with pseudoporphyria.2,3

With the increasing number of older Americans, as well as approximately one-third of seniors taking more than 5 drugs, the incidence of drug-induced pseudoporphyria is likely to increase in the near future.4 Additionally, ESRD is more common in patients older than age 70 years,5 increasing the risk of hemodialysis-related pseudoporphyria in this population.

Case

A 58-year-old black man presented to the ED with an 8-month history of nail changes and painful blisters on the dorsal hands. He stated that he initially noticed these findings after doing yardwork. Regarding history, he further noted that he smokes 3 cigarette packs daily and receives hemodialysis three times weekly for ESRD secondary to polycystic kidney disease. His medications included simvastatin, omeprazole, minoxidil, calcium, and a vitamin B complex.

On physical examination, the patient was well-appearing and in no acute distress with stable vital signs. His dermatologic examination revealed shallow, well-defined erosions, some with central crusting; and adjacent 1- to 2-mm scattered white papules on the dorsum of his hands bilaterally, with more appearing on his left hand than his right hand. The patient’s digits were tender to palpation, and symmetric tapering of the digits was present. Onycholysis and onychodystrophy were present in the majority of his nails.

The laboratory workup included a complete blood count and differential, which demonstrated a stable anemia of chronic disease when compared to prior labwork; a complete metabolic panel revealed expected elevated blood urea nitrogen and creatinine. Liver function and iron studies were normal.

Punch biopsies were performed on perilesional skin with direct immunofluorescence revealing linear granular deposits of immune complexes (IgG and C3), and direct microscopy noting fibrin at the dermoepidermal junction and perivascular location. These clinical and laboratory findings are consistent with porphyria cutanea tarda (PCT), pseudoporphyria, or variegate porphyria. However, his serum porphyrin studies were normal, thus supporting the diagnosis of pseudoporphyria.

Porphyria Cutanea Tarda

Porphyria cutanea tarda is the most common disorder of heme biosynthesis. In this condition, hepatic uroporphyrinogen decarboxylase is deficient, leading to the accumulation of porphyrins in the serum and blood.6 Patients typically present in adulthood complaining of painful blisters and milia on the dorsal hands, and usually do not recognize the component of sunlight exposure in the subsequent appearance of lesions.7 Genetic, environmental, and infectious etiologies contribute to its onset, acting singly or in concert.8-10 Up to half of patients with PCT are infected with hepatitis C; other associations include tobacco smoking, alcoholism, HIV infection, and hereditary hemochromatosis.10-12

As seen in this patient, no accumulation of photosensitive porphyrins is evident in pseudoporphyria through current laboratory testing. While the pathogenesis of pseudoporphyria is unknown, it may be linked to the generation of free radicals.

It is estimated that pseudoporphyria occurs in about 1.2% to 18% of patients undergoing hemodialysis treatment secondary to ESRD.13,14 Massone et al13 demonstrated that dialysis patients with ESRD are more susceptible to free-radical injury due to a reduction of the antioxidant glutathione in both plasma and erythrocytes. Additionally, ultraviolet (UV)-induced free radical formation in the skin has been well documented in the literature.15 This is further supported by a number of pseudoporphyria cases successfully treated with N-acetylcysteine, which replenishes glutathione. However, use of this medication in the treatment of pseudoporphyria is not common.

Treatment

Treatment of patients with pseudoporphyria requires a multifaceted approach. Removing the causative medication when possible may resolve the eruption. Unfortunately in our patient’s case, simvastatin, a possible cause of pseudoporphyria, was withdrawn for several months without improvement. This implicates hemodialysis as the probable cause of his pseudoporphyria. In a case of hemodialysis-induced pseudoporphyria, hemodialysis is life-saving and unable to be discontinued.

It is also important to counsel patients extensively on the importance of UV avoidance, including the use of photoprotective clothing, mineral-based sunscreen creams, and avoiding outside activity during peak daylight hours (ie, between 10:00 AM and 4:00 PM). A short course (2-4 weeks) of potent topical corticosteroids such as clobetasol 0.05% ointment can be prescribed for twice daily application to active lesions on the hands. Patients should also avoid any photosensitizing medications such as NSAIDs and tetracyclines.

 

 

Case Conclusion

On follow-up visits to the dermatology clinic, this patient continued to report improvement when compliant with the prescribed treatment plan, which included avoidance of direct sunlight, use of photoprotective clothing, and avoidance of photosensitizing medications, as well as daily use of clobetasol to lesions as needed. He noted skin flares with unprotected UV exposure.

Do you have an unusual case that you would like to share with your EM colleagues? Submissions should be cases that presented at and were managed within your ED. Please limit case reports to 1,000 words with a title of no more than 100 characters. Include a brief summary or unstructured abstract before you present the case details and include no more than two tables or figures, which should be submitted as separate, high-resolution files. Please de-identify all patient information. For full author guidelines please go to “author guidelines” at emed-journal.com. You can submit your case at editorialmanager.com/emedjournal or mdales@frontlinemedcom.com.

References

  1. Cordova KB, Oberg TJ, Malik M, Robinson-Bostom L. Dermatologic conditions seen in end-stage renal disease. Semin Dial. 2009;22(1):45-55.
  2. Santo Domingo D, Stevenson ML, Auerbach J, Lerman J. Finasteride-induced pseudoporphyria. Arch Dermatol. 2011;147(6):747-748.
  3. Pérez-Bustillo A, Sánchez-Sambucety P, Suárez-Amor O, Rodríiguez-Prieto MA. Torsemide-induced pseudoporphyria. Arch Dermatol. 2008;144(6):812-813.
  4. Scott IA, Gray LC, Martin JH, Mitchell CA. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125(6):529-537.
  5. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet, 2014. http://www.cdc.gov/diabetes/pubs/pdf/kidney_Factsheet.pdf. Accessed October 24, 2014.
  6. Frank J, Poblete-Gutiérrez P. Porphyria cutanea tarda—when skin meets liver.  Best Pract Res Clin Gastroenterol. 2010;24(5):735-745.
  7. Poh-Fitzpatrick MB. Porphyria cutanea tarda clinical presentation. Medscape Web site. http://emedicine.medscape.com/article/1103643-clinical#a0216. Updated February 24, 2014. Accessed October 24, 2014.
  8. Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci. 2002;47(2):419-426.
  9. Cruz-Rojo J, Fontanellas A, Morán-Jiménez MJ. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol (Noisy-le-grand). 2002;48(8):845-852.
  10. Jalil S, Grady JJ, Lee C, Anderson KE. Associations among behavior-related susceptibility factors in porphyria cutanea tarda. Clin Gastroenterol Hepatol. 2010;8(3):297-302.
  11. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol. 1999;17(4):431-436.
  12. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology. 1998;27(6):1661-1669.
  13. Massone C, Ambros-Rudolph CM, et al: Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis. Acta Derm Venereol. 2006;86(6):538-540.
  14. Cooke NS, McKenna K. A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine. Clin Exp Dermatol. 2007;32(1):64-66.
  15. Jurkiewicz BA, Buettner GR. Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study.
References

  1. Cordova KB, Oberg TJ, Malik M, Robinson-Bostom L. Dermatologic conditions seen in end-stage renal disease. Semin Dial. 2009;22(1):45-55.
  2. Santo Domingo D, Stevenson ML, Auerbach J, Lerman J. Finasteride-induced pseudoporphyria. Arch Dermatol. 2011;147(6):747-748.
  3. Pérez-Bustillo A, Sánchez-Sambucety P, Suárez-Amor O, Rodríiguez-Prieto MA. Torsemide-induced pseudoporphyria. Arch Dermatol. 2008;144(6):812-813.
  4. Scott IA, Gray LC, Martin JH, Mitchell CA. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125(6):529-537.
  5. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet, 2014. http://www.cdc.gov/diabetes/pubs/pdf/kidney_Factsheet.pdf. Accessed October 24, 2014.
  6. Frank J, Poblete-Gutiérrez P. Porphyria cutanea tarda—when skin meets liver.  Best Pract Res Clin Gastroenterol. 2010;24(5):735-745.
  7. Poh-Fitzpatrick MB. Porphyria cutanea tarda clinical presentation. Medscape Web site. http://emedicine.medscape.com/article/1103643-clinical#a0216. Updated February 24, 2014. Accessed October 24, 2014.
  8. Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci. 2002;47(2):419-426.
  9. Cruz-Rojo J, Fontanellas A, Morán-Jiménez MJ. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol (Noisy-le-grand). 2002;48(8):845-852.
  10. Jalil S, Grady JJ, Lee C, Anderson KE. Associations among behavior-related susceptibility factors in porphyria cutanea tarda. Clin Gastroenterol Hepatol. 2010;8(3):297-302.
  11. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol. 1999;17(4):431-436.
  12. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology. 1998;27(6):1661-1669.
  13. Massone C, Ambros-Rudolph CM, et al: Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis. Acta Derm Venereol. 2006;86(6):538-540.
  14. Cooke NS, McKenna K. A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine. Clin Exp Dermatol. 2007;32(1):64-66.
  15. Jurkiewicz BA, Buettner GR. Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study.
Issue
Emergency Medicine - 46(11)
Issue
Emergency Medicine - 46(11)
Page Number
513-516
Page Number
513-516
Publications
Publications
Topics
Article Type
Display Headline
My Most Unusual Case: Painful Blistering on the Dorsal Hands
Display Headline
My Most Unusual Case: Painful Blistering on the Dorsal Hands
Legacy Keywords
pseudoporphyria, blisters, end-stage renal disease, unusual case, Porphyria Cutanea Tarda
Legacy Keywords
pseudoporphyria, blisters, end-stage renal disease, unusual case, Porphyria Cutanea Tarda
Sections
Article Source

PURLs Copyright

Inside the Article

Aortic Dissection

Article Type
Changed
Display Headline
Aortic Dissection
Use of this imaging modality at bedside provides a rapid and noninvasive study with a high specificity for detection of aortic dissection as well as other potential life-threatening emergencies.

Case

A 72-year-old man with a past medical history of hypertension and social history of tobacco use presented to the ED with chest pain and abdominal pain. His vital signs at presentation were: heart rate, 110 beats/minute; blood pressure, 80/40 mm Hg; respiratory rate, 22 breaths/minute; temperature, afebrile. His oxygen saturation was 98% on room air. The patient was alert and oriented; his abdomen was soft with no reproducible tenderness to palpation and without a palpable mass. The remainder of the physical examination was otherwise unremarkable. An electrocardiogram revealed sinus tachycardia with left ventricular hypertrophy, and a chest X-ray was read as no acute process by radiology services. Since the patient’s creatinine level was elevated at 3.5 mg/dL, the use of radiocontrast media relatively contraindicated.

To quickly assess the patient, the treating emergency physician (EP) performed a limited transabdominal ultrasound at the bedside, which revealed an intimal flap in the abdominal aorta in the transverse plane visible at the subcostal margin (Figure 1). The longitudinal view demonstrated the intimal flap clearly, but with no clear point of origin in the abdominal portion of the aorta (Figure 2).

The subcostal cardiac view also revealed the cause for the patient’s hemodynamic instability: a large pericardial effusion with evidence of early acute pericardial tamponade via right atrial collapse (Figure 3).

The patient was taken to the operating room within 20 minutes of arrival to the ED. Expedient diagnosis of both the presence and extent of his aortic dissection and its complications by bedside ultrasound facilitated early and aggressive management of this life-threatening disease process.

Imaging Techniques

Abdominal Aorta
Ultrasound of the abdominal aorta begins with the use of a curvilinear probe, starting in the transverse plane with the probe marker pointing toward the patient’s right side (ie, the 9-o’clock position). The probe should scan the epigastrium, which is located just below the xiphoid process (Figure 4).

For orientation, the clinician should identify the vertebral body, which will appear as a dark and rounded object at the bottom center of the screen with a dark shadow behind it. Both the aorta and inferior vena cava (IVC) will be visualized just superficial to the vertebral body; the aorta typically appears anterior to the vertebral body, with the IVC slightly to the right of it. The amount of pressure applied for visualization of these structures will vary depending on the patient’s body habitus and volume status (Figure 5).

Once orientation is established and there is a clear transverse view of the aorta, calipers are used to measure the diameter of the aorta from superficial to deep, measuring from outer wall to outer wall (Figure 6).

Next, the clinician should scan the probe caudally as he or she follows the aorta down to the level of the bifurcation into the iliac vessels, near the level of the umbilicus (Figure 7).

Then, rotating the probe clockwise 90˚ to place the probe marker in the 12-o’clock position, the abdominal aorta can be measured in the long axis, giving a broad overview of the entire structure (Figure 8).

Identification of an undulating intimal flap is highly specific for the diagnosis of aortic dissection.

Thoracic Aorta
After imaging of the abdominal aorta is complete, a phased array probe is used to scan the thoracic aorta, beginning with a subxiphoid view of the heart. The probe should be placed in the transverse plane, just inferior to the xiphoid process and with the probe marker aimed toward the patient’s right side (ie, the 9-o’clock position). Next, the probe is angled cephalad and slightly toward the patient’s left shoulder, nearly laying it flat on the abdomen, using the liver as the acoustic window. As with abdominal ultrasound, depending on the patient’s body habitus and anatomy, the depth may need to be adjusted for optimal view. This is one of the best views when evaluating for pericardial effusion, which will appear as a dark or anechoic stripe surrounding the heart (Figure 3).

After this view is complete, the clinician should proceed to scan the parasternal long axis view to evaluate the aortic outflow track and descending aorta. The cardiac probe should be placed in the left third or fourth intercostal space with the probe marker angled toward the patient’s right shoulder (ie, the 10- to 11-o’clock position). Proceeding from superficial to deep on the screen, the right ventricle, left ventricle and aortic outflow tract, left atrium, and then the descending aorta (Figure 9) will be visualized.

The two main areas to assess closely are the aortic outflow tract and the descending aorta. While looking at the aortic outflow tract, evidence of aortic regurgitation or a linear echodensity within the aortic root may be seen, suggestive of the intimal flap occurring in aortic dissection. Focusing on the descending aorta, the clinician should again look for a linear echodensity across the aorta, which represents the intimal flap (red highlighted area, Figure 9).

 

 

Discussion

Acute aortic dissection is an emergent, life-threatening condition with a high morbidity and mortality rate and a wide range of clinical manifestations and atypical presentations—all of which benefit from rapid identification. The combination of these factors makes diagnosis difficult, but all the more essential, especially considering the time-sensitivity of initiating treatment with intravenous antihypertensive agents and operative intervention.1

Bedside ultrasound provides a rapid and reliable method of making the diagnosis at the point of care, thus positively affecting patient care and outcome. Although existing research is limited, available data indicate that the EP can accurately diagnose acute aortic dissection and its complications using this modality.

Rapid diagnosis of aortic catastrophes at the bedside is not a novel concept. Shuman et al2 studied bedside transabdominal ultrasound on initial presentation of patients with severe abdominal or back pain, suspicious for abdominal aortic aneurysm (AAA). In this study of 60 patients, 31 of 32 AAAs were identified; these diagnoses were made prior to a surgeon’s evaluation.

More recently, Kuhn et al3 completed a similar study of EP use of beside ultrasound in the ED. Although their study lacked strength secondary to small sample size, it did indicate the ability to accurately determine the presence of an AAA with minimal training and experience.

Bedside Ultrasound Versus Other Imaging Modalities

There are multiple imaging modalities to consider when evaluating a patient with a possible aortic dissection, the decision of which should also take into account the ability to determine alternative diagnoses.

Bedside Ultrasound. This modality provides the EP with a quick, easy tool to evaluate multiple, potential life-threatening emergencies immediately at the bedside in a patient with suspected aortic dissection.4 Numerous studies have documented a sensitivity of 78% to 87% and a specificity of 99% to 100% for the diagnosis of aortic dissection by transthoracic and transabdominal ultrasound when an undulating intimal flap is visualized.5

Computed Tomography Angiography. In comparison to beside ultrasound, computed tomography angiography (CTA) has a sensitivity of 96% to 100% and a specificity of 96% to 100%.6,7 However, since CTA requires the use of iodinated contrast material, it is relatively contraindicated in the setting of acute kidney injury, a condition not uncommon in patients with acute aortic dissection.

Magnetic Resonance Imaging. Currently the gold standard for the identification of aortic dissection, magnetic resonance imaging has both a sensitivity and specificity of 98%.7,8 The major disadvantages of this test are the lack of availability and the length of the study itself.

Chest X-ray. A chest X-ray is commonly used as a screening test for aortic dissection, despite 12% to 20% of patients with aortic dissection having a “normal” X-ray.6

Transesophageal echocardiography. Another good modality for diagnosing aortic dissection is transesophageal echocardiography (TEE), which has a sensitivity of up to 98% and a specificity of up to 97%.8 This test, however, requires an experienced operator at the bedside, typically a cardiologist, and is an invasive study that requires the use of sedation and occasionally general anesthesia. A TEE is limited by its inability to visualize the descending aorta below the stomach.6-8

Conclusion

There are several benefits to using bedside ultrasound at the point of care to diagnose aortic dissection. This modality provides not only a rapid, noninvasive, and painless study requiring no radiocontrast media, but also has a high specificity for detection of aortic dissection. Moreover, it also allows the provider to evaluate for other potential life-threatening emergencies such as concomitant abdominal aortic aneurysm, intraperitoneal hemorrhage, pericardial effusion, and cardiac tamponade.9,10

Dr Venezia is a resident in the department of emergency medicine, Eastern Virginia Medical School, Norfolk. Dr Sawyer is a clinical instructor in the department of emergency medicine, Eastern Virginia Medical School, Norfolk. Dr Byars is an associate professor in the department of emergency medicine, Eastern Virginia Medical School, Norfolk.

For a video clip showing a transverse view of the abdominal aorta with the dissection flap clearly visible mid-lumen of the proximal aorta, visit https://vimeo.com/111462170.

For a video clip showing a longitudinal view of the abdominal aorta with the dissection flap clearly visible in the mid-lumen of the aorta, visit https://vimeo.com/111462168.

For a video clip of a cardiac view demonstrating large pericardial effusion in the patient with aortic dissection, visit https://vimeo.com/111462169.

For a video clip demonstrating ultrasound of the parasternal long axis view with a phased array probe, visit https://vimeo.com/111462167.

References

  1. Lo, BM. An evidence-based approach to acute aortic syndromes. Emerg Med Pract. 2013;15(12):1-23.
  2. Shuman WP, Hastrup W Jr, Kohler TR, et al. Suspected leaking abdominal aortic aneurysm: use of sonography in the emergency room. Radiology. 1988;168(1):117-119.
  3. Kuhn M, Bonnin RL, Davey MJ, Rowland JL, Langlois SL. Emergency department ultrasound scanning for abdominal aortic aneurysm: accessible, accurate, and advantageous. Ann Emerg Med. 2000;36(3):219-223.
  4. Fojtik JP, Costantino TG, Dean AJ. The diagnosis of aortic dissection by emergency medicine ultrasound. J Emerg Med. 2007;32(2):191-196.
  5. Brunson JM, Fine RL, Schussler JM. Acute ascending aortic dissection diagnosed with transthoracic echocardiography. J Am Soc Echo. 2009;22(9):1086.e5–1086.e7.
  6. Erbel R, Alfonso F, Boileau C, et al; Task Force on Aortic Dissection, European Society of Cardiology. Diagnosis and management of aortic dissection. Eur Heart J. 2001;22(18):1642-1681.
  7. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328(1):1-
  8. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation. 2003;108(5):628-635.
  9. Goodman A, Perera P, Mailhot T, Mandavia D. The role of bedside ultrasound in the diagnosis of pericardial effusion and cardiac tamponade. J Emerg Trauma Shock. 2012;5(1):72-75.
  10. Perera P, Mailhot T, Riley D, Mandavia D. The RUSH exam: Rapid ultrasound in shock in the evaluation of the critically ill. Emerg Med Clin North Am. 2010;28(1):29-56.
Author and Disclosure Information

Issue
Emergency Medicine - 46(11)
Publications
Topics
Page Number
506-511
Legacy Keywords
aortic dissection, hypertension, electrocardiogram, sinus tachycardia, X-ray, imaging, ultrasound
Sections
Author and Disclosure Information

Author and Disclosure Information

Use of this imaging modality at bedside provides a rapid and noninvasive study with a high specificity for detection of aortic dissection as well as other potential life-threatening emergencies.
Use of this imaging modality at bedside provides a rapid and noninvasive study with a high specificity for detection of aortic dissection as well as other potential life-threatening emergencies.

Case

A 72-year-old man with a past medical history of hypertension and social history of tobacco use presented to the ED with chest pain and abdominal pain. His vital signs at presentation were: heart rate, 110 beats/minute; blood pressure, 80/40 mm Hg; respiratory rate, 22 breaths/minute; temperature, afebrile. His oxygen saturation was 98% on room air. The patient was alert and oriented; his abdomen was soft with no reproducible tenderness to palpation and without a palpable mass. The remainder of the physical examination was otherwise unremarkable. An electrocardiogram revealed sinus tachycardia with left ventricular hypertrophy, and a chest X-ray was read as no acute process by radiology services. Since the patient’s creatinine level was elevated at 3.5 mg/dL, the use of radiocontrast media relatively contraindicated.

To quickly assess the patient, the treating emergency physician (EP) performed a limited transabdominal ultrasound at the bedside, which revealed an intimal flap in the abdominal aorta in the transverse plane visible at the subcostal margin (Figure 1). The longitudinal view demonstrated the intimal flap clearly, but with no clear point of origin in the abdominal portion of the aorta (Figure 2).

The subcostal cardiac view also revealed the cause for the patient’s hemodynamic instability: a large pericardial effusion with evidence of early acute pericardial tamponade via right atrial collapse (Figure 3).

The patient was taken to the operating room within 20 minutes of arrival to the ED. Expedient diagnosis of both the presence and extent of his aortic dissection and its complications by bedside ultrasound facilitated early and aggressive management of this life-threatening disease process.

Imaging Techniques

Abdominal Aorta
Ultrasound of the abdominal aorta begins with the use of a curvilinear probe, starting in the transverse plane with the probe marker pointing toward the patient’s right side (ie, the 9-o’clock position). The probe should scan the epigastrium, which is located just below the xiphoid process (Figure 4).

For orientation, the clinician should identify the vertebral body, which will appear as a dark and rounded object at the bottom center of the screen with a dark shadow behind it. Both the aorta and inferior vena cava (IVC) will be visualized just superficial to the vertebral body; the aorta typically appears anterior to the vertebral body, with the IVC slightly to the right of it. The amount of pressure applied for visualization of these structures will vary depending on the patient’s body habitus and volume status (Figure 5).

Once orientation is established and there is a clear transverse view of the aorta, calipers are used to measure the diameter of the aorta from superficial to deep, measuring from outer wall to outer wall (Figure 6).

Next, the clinician should scan the probe caudally as he or she follows the aorta down to the level of the bifurcation into the iliac vessels, near the level of the umbilicus (Figure 7).

Then, rotating the probe clockwise 90˚ to place the probe marker in the 12-o’clock position, the abdominal aorta can be measured in the long axis, giving a broad overview of the entire structure (Figure 8).

Identification of an undulating intimal flap is highly specific for the diagnosis of aortic dissection.

Thoracic Aorta
After imaging of the abdominal aorta is complete, a phased array probe is used to scan the thoracic aorta, beginning with a subxiphoid view of the heart. The probe should be placed in the transverse plane, just inferior to the xiphoid process and with the probe marker aimed toward the patient’s right side (ie, the 9-o’clock position). Next, the probe is angled cephalad and slightly toward the patient’s left shoulder, nearly laying it flat on the abdomen, using the liver as the acoustic window. As with abdominal ultrasound, depending on the patient’s body habitus and anatomy, the depth may need to be adjusted for optimal view. This is one of the best views when evaluating for pericardial effusion, which will appear as a dark or anechoic stripe surrounding the heart (Figure 3).

After this view is complete, the clinician should proceed to scan the parasternal long axis view to evaluate the aortic outflow track and descending aorta. The cardiac probe should be placed in the left third or fourth intercostal space with the probe marker angled toward the patient’s right shoulder (ie, the 10- to 11-o’clock position). Proceeding from superficial to deep on the screen, the right ventricle, left ventricle and aortic outflow tract, left atrium, and then the descending aorta (Figure 9) will be visualized.

The two main areas to assess closely are the aortic outflow tract and the descending aorta. While looking at the aortic outflow tract, evidence of aortic regurgitation or a linear echodensity within the aortic root may be seen, suggestive of the intimal flap occurring in aortic dissection. Focusing on the descending aorta, the clinician should again look for a linear echodensity across the aorta, which represents the intimal flap (red highlighted area, Figure 9).

 

 

Discussion

Acute aortic dissection is an emergent, life-threatening condition with a high morbidity and mortality rate and a wide range of clinical manifestations and atypical presentations—all of which benefit from rapid identification. The combination of these factors makes diagnosis difficult, but all the more essential, especially considering the time-sensitivity of initiating treatment with intravenous antihypertensive agents and operative intervention.1

Bedside ultrasound provides a rapid and reliable method of making the diagnosis at the point of care, thus positively affecting patient care and outcome. Although existing research is limited, available data indicate that the EP can accurately diagnose acute aortic dissection and its complications using this modality.

Rapid diagnosis of aortic catastrophes at the bedside is not a novel concept. Shuman et al2 studied bedside transabdominal ultrasound on initial presentation of patients with severe abdominal or back pain, suspicious for abdominal aortic aneurysm (AAA). In this study of 60 patients, 31 of 32 AAAs were identified; these diagnoses were made prior to a surgeon’s evaluation.

More recently, Kuhn et al3 completed a similar study of EP use of beside ultrasound in the ED. Although their study lacked strength secondary to small sample size, it did indicate the ability to accurately determine the presence of an AAA with minimal training and experience.

Bedside Ultrasound Versus Other Imaging Modalities

There are multiple imaging modalities to consider when evaluating a patient with a possible aortic dissection, the decision of which should also take into account the ability to determine alternative diagnoses.

Bedside Ultrasound. This modality provides the EP with a quick, easy tool to evaluate multiple, potential life-threatening emergencies immediately at the bedside in a patient with suspected aortic dissection.4 Numerous studies have documented a sensitivity of 78% to 87% and a specificity of 99% to 100% for the diagnosis of aortic dissection by transthoracic and transabdominal ultrasound when an undulating intimal flap is visualized.5

Computed Tomography Angiography. In comparison to beside ultrasound, computed tomography angiography (CTA) has a sensitivity of 96% to 100% and a specificity of 96% to 100%.6,7 However, since CTA requires the use of iodinated contrast material, it is relatively contraindicated in the setting of acute kidney injury, a condition not uncommon in patients with acute aortic dissection.

Magnetic Resonance Imaging. Currently the gold standard for the identification of aortic dissection, magnetic resonance imaging has both a sensitivity and specificity of 98%.7,8 The major disadvantages of this test are the lack of availability and the length of the study itself.

Chest X-ray. A chest X-ray is commonly used as a screening test for aortic dissection, despite 12% to 20% of patients with aortic dissection having a “normal” X-ray.6

Transesophageal echocardiography. Another good modality for diagnosing aortic dissection is transesophageal echocardiography (TEE), which has a sensitivity of up to 98% and a specificity of up to 97%.8 This test, however, requires an experienced operator at the bedside, typically a cardiologist, and is an invasive study that requires the use of sedation and occasionally general anesthesia. A TEE is limited by its inability to visualize the descending aorta below the stomach.6-8

Conclusion

There are several benefits to using bedside ultrasound at the point of care to diagnose aortic dissection. This modality provides not only a rapid, noninvasive, and painless study requiring no radiocontrast media, but also has a high specificity for detection of aortic dissection. Moreover, it also allows the provider to evaluate for other potential life-threatening emergencies such as concomitant abdominal aortic aneurysm, intraperitoneal hemorrhage, pericardial effusion, and cardiac tamponade.9,10

Dr Venezia is a resident in the department of emergency medicine, Eastern Virginia Medical School, Norfolk. Dr Sawyer is a clinical instructor in the department of emergency medicine, Eastern Virginia Medical School, Norfolk. Dr Byars is an associate professor in the department of emergency medicine, Eastern Virginia Medical School, Norfolk.

For a video clip showing a transverse view of the abdominal aorta with the dissection flap clearly visible mid-lumen of the proximal aorta, visit https://vimeo.com/111462170.

For a video clip showing a longitudinal view of the abdominal aorta with the dissection flap clearly visible in the mid-lumen of the aorta, visit https://vimeo.com/111462168.

For a video clip of a cardiac view demonstrating large pericardial effusion in the patient with aortic dissection, visit https://vimeo.com/111462169.

For a video clip demonstrating ultrasound of the parasternal long axis view with a phased array probe, visit https://vimeo.com/111462167.

Case

A 72-year-old man with a past medical history of hypertension and social history of tobacco use presented to the ED with chest pain and abdominal pain. His vital signs at presentation were: heart rate, 110 beats/minute; blood pressure, 80/40 mm Hg; respiratory rate, 22 breaths/minute; temperature, afebrile. His oxygen saturation was 98% on room air. The patient was alert and oriented; his abdomen was soft with no reproducible tenderness to palpation and without a palpable mass. The remainder of the physical examination was otherwise unremarkable. An electrocardiogram revealed sinus tachycardia with left ventricular hypertrophy, and a chest X-ray was read as no acute process by radiology services. Since the patient’s creatinine level was elevated at 3.5 mg/dL, the use of radiocontrast media relatively contraindicated.

To quickly assess the patient, the treating emergency physician (EP) performed a limited transabdominal ultrasound at the bedside, which revealed an intimal flap in the abdominal aorta in the transverse plane visible at the subcostal margin (Figure 1). The longitudinal view demonstrated the intimal flap clearly, but with no clear point of origin in the abdominal portion of the aorta (Figure 2).

The subcostal cardiac view also revealed the cause for the patient’s hemodynamic instability: a large pericardial effusion with evidence of early acute pericardial tamponade via right atrial collapse (Figure 3).

The patient was taken to the operating room within 20 minutes of arrival to the ED. Expedient diagnosis of both the presence and extent of his aortic dissection and its complications by bedside ultrasound facilitated early and aggressive management of this life-threatening disease process.

Imaging Techniques

Abdominal Aorta
Ultrasound of the abdominal aorta begins with the use of a curvilinear probe, starting in the transverse plane with the probe marker pointing toward the patient’s right side (ie, the 9-o’clock position). The probe should scan the epigastrium, which is located just below the xiphoid process (Figure 4).

For orientation, the clinician should identify the vertebral body, which will appear as a dark and rounded object at the bottom center of the screen with a dark shadow behind it. Both the aorta and inferior vena cava (IVC) will be visualized just superficial to the vertebral body; the aorta typically appears anterior to the vertebral body, with the IVC slightly to the right of it. The amount of pressure applied for visualization of these structures will vary depending on the patient’s body habitus and volume status (Figure 5).

Once orientation is established and there is a clear transverse view of the aorta, calipers are used to measure the diameter of the aorta from superficial to deep, measuring from outer wall to outer wall (Figure 6).

Next, the clinician should scan the probe caudally as he or she follows the aorta down to the level of the bifurcation into the iliac vessels, near the level of the umbilicus (Figure 7).

Then, rotating the probe clockwise 90˚ to place the probe marker in the 12-o’clock position, the abdominal aorta can be measured in the long axis, giving a broad overview of the entire structure (Figure 8).

Identification of an undulating intimal flap is highly specific for the diagnosis of aortic dissection.

Thoracic Aorta
After imaging of the abdominal aorta is complete, a phased array probe is used to scan the thoracic aorta, beginning with a subxiphoid view of the heart. The probe should be placed in the transverse plane, just inferior to the xiphoid process and with the probe marker aimed toward the patient’s right side (ie, the 9-o’clock position). Next, the probe is angled cephalad and slightly toward the patient’s left shoulder, nearly laying it flat on the abdomen, using the liver as the acoustic window. As with abdominal ultrasound, depending on the patient’s body habitus and anatomy, the depth may need to be adjusted for optimal view. This is one of the best views when evaluating for pericardial effusion, which will appear as a dark or anechoic stripe surrounding the heart (Figure 3).

After this view is complete, the clinician should proceed to scan the parasternal long axis view to evaluate the aortic outflow track and descending aorta. The cardiac probe should be placed in the left third or fourth intercostal space with the probe marker angled toward the patient’s right shoulder (ie, the 10- to 11-o’clock position). Proceeding from superficial to deep on the screen, the right ventricle, left ventricle and aortic outflow tract, left atrium, and then the descending aorta (Figure 9) will be visualized.

The two main areas to assess closely are the aortic outflow tract and the descending aorta. While looking at the aortic outflow tract, evidence of aortic regurgitation or a linear echodensity within the aortic root may be seen, suggestive of the intimal flap occurring in aortic dissection. Focusing on the descending aorta, the clinician should again look for a linear echodensity across the aorta, which represents the intimal flap (red highlighted area, Figure 9).

 

 

Discussion

Acute aortic dissection is an emergent, life-threatening condition with a high morbidity and mortality rate and a wide range of clinical manifestations and atypical presentations—all of which benefit from rapid identification. The combination of these factors makes diagnosis difficult, but all the more essential, especially considering the time-sensitivity of initiating treatment with intravenous antihypertensive agents and operative intervention.1

Bedside ultrasound provides a rapid and reliable method of making the diagnosis at the point of care, thus positively affecting patient care and outcome. Although existing research is limited, available data indicate that the EP can accurately diagnose acute aortic dissection and its complications using this modality.

Rapid diagnosis of aortic catastrophes at the bedside is not a novel concept. Shuman et al2 studied bedside transabdominal ultrasound on initial presentation of patients with severe abdominal or back pain, suspicious for abdominal aortic aneurysm (AAA). In this study of 60 patients, 31 of 32 AAAs were identified; these diagnoses were made prior to a surgeon’s evaluation.

More recently, Kuhn et al3 completed a similar study of EP use of beside ultrasound in the ED. Although their study lacked strength secondary to small sample size, it did indicate the ability to accurately determine the presence of an AAA with minimal training and experience.

Bedside Ultrasound Versus Other Imaging Modalities

There are multiple imaging modalities to consider when evaluating a patient with a possible aortic dissection, the decision of which should also take into account the ability to determine alternative diagnoses.

Bedside Ultrasound. This modality provides the EP with a quick, easy tool to evaluate multiple, potential life-threatening emergencies immediately at the bedside in a patient with suspected aortic dissection.4 Numerous studies have documented a sensitivity of 78% to 87% and a specificity of 99% to 100% for the diagnosis of aortic dissection by transthoracic and transabdominal ultrasound when an undulating intimal flap is visualized.5

Computed Tomography Angiography. In comparison to beside ultrasound, computed tomography angiography (CTA) has a sensitivity of 96% to 100% and a specificity of 96% to 100%.6,7 However, since CTA requires the use of iodinated contrast material, it is relatively contraindicated in the setting of acute kidney injury, a condition not uncommon in patients with acute aortic dissection.

Magnetic Resonance Imaging. Currently the gold standard for the identification of aortic dissection, magnetic resonance imaging has both a sensitivity and specificity of 98%.7,8 The major disadvantages of this test are the lack of availability and the length of the study itself.

Chest X-ray. A chest X-ray is commonly used as a screening test for aortic dissection, despite 12% to 20% of patients with aortic dissection having a “normal” X-ray.6

Transesophageal echocardiography. Another good modality for diagnosing aortic dissection is transesophageal echocardiography (TEE), which has a sensitivity of up to 98% and a specificity of up to 97%.8 This test, however, requires an experienced operator at the bedside, typically a cardiologist, and is an invasive study that requires the use of sedation and occasionally general anesthesia. A TEE is limited by its inability to visualize the descending aorta below the stomach.6-8

Conclusion

There are several benefits to using bedside ultrasound at the point of care to diagnose aortic dissection. This modality provides not only a rapid, noninvasive, and painless study requiring no radiocontrast media, but also has a high specificity for detection of aortic dissection. Moreover, it also allows the provider to evaluate for other potential life-threatening emergencies such as concomitant abdominal aortic aneurysm, intraperitoneal hemorrhage, pericardial effusion, and cardiac tamponade.9,10

Dr Venezia is a resident in the department of emergency medicine, Eastern Virginia Medical School, Norfolk. Dr Sawyer is a clinical instructor in the department of emergency medicine, Eastern Virginia Medical School, Norfolk. Dr Byars is an associate professor in the department of emergency medicine, Eastern Virginia Medical School, Norfolk.

For a video clip showing a transverse view of the abdominal aorta with the dissection flap clearly visible mid-lumen of the proximal aorta, visit https://vimeo.com/111462170.

For a video clip showing a longitudinal view of the abdominal aorta with the dissection flap clearly visible in the mid-lumen of the aorta, visit https://vimeo.com/111462168.

For a video clip of a cardiac view demonstrating large pericardial effusion in the patient with aortic dissection, visit https://vimeo.com/111462169.

For a video clip demonstrating ultrasound of the parasternal long axis view with a phased array probe, visit https://vimeo.com/111462167.

References

  1. Lo, BM. An evidence-based approach to acute aortic syndromes. Emerg Med Pract. 2013;15(12):1-23.
  2. Shuman WP, Hastrup W Jr, Kohler TR, et al. Suspected leaking abdominal aortic aneurysm: use of sonography in the emergency room. Radiology. 1988;168(1):117-119.
  3. Kuhn M, Bonnin RL, Davey MJ, Rowland JL, Langlois SL. Emergency department ultrasound scanning for abdominal aortic aneurysm: accessible, accurate, and advantageous. Ann Emerg Med. 2000;36(3):219-223.
  4. Fojtik JP, Costantino TG, Dean AJ. The diagnosis of aortic dissection by emergency medicine ultrasound. J Emerg Med. 2007;32(2):191-196.
  5. Brunson JM, Fine RL, Schussler JM. Acute ascending aortic dissection diagnosed with transthoracic echocardiography. J Am Soc Echo. 2009;22(9):1086.e5–1086.e7.
  6. Erbel R, Alfonso F, Boileau C, et al; Task Force on Aortic Dissection, European Society of Cardiology. Diagnosis and management of aortic dissection. Eur Heart J. 2001;22(18):1642-1681.
  7. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328(1):1-
  8. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation. 2003;108(5):628-635.
  9. Goodman A, Perera P, Mailhot T, Mandavia D. The role of bedside ultrasound in the diagnosis of pericardial effusion and cardiac tamponade. J Emerg Trauma Shock. 2012;5(1):72-75.
  10. Perera P, Mailhot T, Riley D, Mandavia D. The RUSH exam: Rapid ultrasound in shock in the evaluation of the critically ill. Emerg Med Clin North Am. 2010;28(1):29-56.
References

  1. Lo, BM. An evidence-based approach to acute aortic syndromes. Emerg Med Pract. 2013;15(12):1-23.
  2. Shuman WP, Hastrup W Jr, Kohler TR, et al. Suspected leaking abdominal aortic aneurysm: use of sonography in the emergency room. Radiology. 1988;168(1):117-119.
  3. Kuhn M, Bonnin RL, Davey MJ, Rowland JL, Langlois SL. Emergency department ultrasound scanning for abdominal aortic aneurysm: accessible, accurate, and advantageous. Ann Emerg Med. 2000;36(3):219-223.
  4. Fojtik JP, Costantino TG, Dean AJ. The diagnosis of aortic dissection by emergency medicine ultrasound. J Emerg Med. 2007;32(2):191-196.
  5. Brunson JM, Fine RL, Schussler JM. Acute ascending aortic dissection diagnosed with transthoracic echocardiography. J Am Soc Echo. 2009;22(9):1086.e5–1086.e7.
  6. Erbel R, Alfonso F, Boileau C, et al; Task Force on Aortic Dissection, European Society of Cardiology. Diagnosis and management of aortic dissection. Eur Heart J. 2001;22(18):1642-1681.
  7. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328(1):1-
  8. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation. 2003;108(5):628-635.
  9. Goodman A, Perera P, Mailhot T, Mandavia D. The role of bedside ultrasound in the diagnosis of pericardial effusion and cardiac tamponade. J Emerg Trauma Shock. 2012;5(1):72-75.
  10. Perera P, Mailhot T, Riley D, Mandavia D. The RUSH exam: Rapid ultrasound in shock in the evaluation of the critically ill. Emerg Med Clin North Am. 2010;28(1):29-56.
Issue
Emergency Medicine - 46(11)
Issue
Emergency Medicine - 46(11)
Page Number
506-511
Page Number
506-511
Publications
Publications
Topics
Article Type
Display Headline
Aortic Dissection
Display Headline
Aortic Dissection
Legacy Keywords
aortic dissection, hypertension, electrocardiogram, sinus tachycardia, X-ray, imaging, ultrasound
Legacy Keywords
aortic dissection, hypertension, electrocardiogram, sinus tachycardia, X-ray, imaging, ultrasound
Sections
Article Source

PURLs Copyright

Inside the Article

Case Studies in Toxicology: Sippin’ on Some “Sizzurp”

Article Type
Changed
Display Headline
Case Studies in Toxicology: Sippin’ on Some “Sizzurp”
He rolled up, asked him what he was sipping onHe said, “Lean, you want to hit it, dawg?”“That’s the same stuff Weezy’s sipping, huh?And tons of other rappers that be spitting hard?”—Macklemore, Otherside

Case

A 19-year-old man was found unresponsive by his girlfriend. They both attended a party the previous night where a number of people were drinking alcohol and cough syrup to get “high.” When emergency medical technicians arrived at the patient’s house, they administered naloxone, which somewhat improved the patient’s level of consciousness; oxygen was also delivered via facemask.

Upon arrival to the ED, the patient complained of hearing loss and tinnitus. His initial vital signs were: blood pressure, 99/60 mm Hg; heart rate, 110 beats/minute; respiratory rate, 20 breaths/minute; temperature, 96.8°F. Oxygen saturation was 80% on room air. On examination, he was lethargic but responsive to voice and oriented to time, place, and person. His pupils were pinpoint; his hearing was decreased bilaterally; his breathing was shallow, with rales audible at both lung bases; his bowel sounds were hypoactive; and his skin was warm and moist. The rest of the examination was otherwise unremarkable.

What cough and cold products are commonly abused with the intent to get high?

Hundreds of nonprescription pharmaceutical products—each with the potential for misuse or abuse—are available to consumers in retail stores and online. These products can be classified by expected clinical effect, which helps clinicians with the diagnosis and management of these patients (Table).

Dextromethorphan

Of the antitussive products currently available over the counter (OTC), those that contain dextromethorphan have the widest abuse potential. Referred to as “dex,” “DMX,” or “tuss,” this drug is widely abused among adolescents and young adults due to its easy availability. In therapeutic doses, dextromethorphan suppresses cough via the medullary cough center. Ingesting dextromethorphan at higher doses, a practice referred to as “Robo tripping,” can produce hallucinations and a dissociative state marked by alterations in consciousness and impaired motor control. Dextromethorphan is a structural analog of ketamine and phencyclidine, which accounts for their similar clinical effects.

Codeine

Codeine is another drug added to various cough medications for its antitussive properties. An opioid, it acts centrally to suppress cough and has mild analgesic properties. It is available only by prescription in the United States, but can be purchased as an OTC product in other countries. Recently, it has come into the media spotlight as the starting product to make “Krokodil” (see Emerg Med. 2014;46[2]:76-78).

Case Continuation

While undergoing his workup in the ED, the patient became increasingly lethargic with persistent hypoxia. Although initially
responsive to naloxone, his respirations became more labored, requiring intubation. Prior to intubation and while awake, the patient mentioned that he was drinking “sizzurp” the evening prior. He denied the use of other drugs or of having any suicidal intent. A postintubation chest X-ray revealed a left-sided retrocardiac infiltrate consistent with aspiration pneumonitis.

What is sizzurp?

Sizzurp is a slang term used to describe a beverage that is most frequently comprised of fruit-flavored soda, codeine/promethazine hydrochloride cough syrup (CPHCS), and hard candy (classically a Jolly Rancher).1 This combination is ingested by the user with the intent of achieving a unique high—attributable to the combined effects of codeine, an opioid, and promethazine, an antihistamine (with antipsychotic properties). According to user reports, CPHCS induces a deep sense of euphoria, relaxation, and a slowed sense of time.2 Additional slang terms used to describe this product include “lean,” “purple drank,” “purp,” “drank,” “syrup,” “barre,” and “Texas tea.”

According to one source, purple drank originated in Houston, Texas around the 1960s, when blues musicians would combine dextromethorphan with beer.3 Over time, the recipe was modified, and by the 1980s, when purple drank was adopted by hip-hop musicians from the same Houston neighborhoods, the name sizzurp took hold.

In the 1990s, one Houston-based hiphop artist, DJ Screw, developed a genre of music called “chopped and screwed,” inspired by the CPHCS high and notable for its slowed-down tempo that fit the sedation and decreased motor activity induced by the drug. As chopped and screwed music became popularized, so too did the recreational use of CPHCS. In 2000, “Sippin’ on Some Sizzurp,” a hit song by southern hip-hop group Three Six Mafia, introduced CPHCS to more mainstream hip-hop audiences.

Despite the CPHCS-related deaths of a number of hip-hop musicians, including DJ Screw, as well as the arrests of professional
football players linked to abusing the drug, CPHCS continues to be glorified by a number of hip-hop and pop musicians.

Unfortunately, media attention of these events often has the paradoxical effect of promoting use among adolescents and young adults, and CPHCS has become a drug of choice for black adolescents in many Texas communities.4 However, one study attempting to define a purple drank user profile among college students at a large public university in the southeastern United States revealed that use was most prevalent among urban male youth primarily from Hispanic, Native American, and white ethnic backgrounds—challenging the notion that it is confined to the black community.5

 

 

Although CPHCS is only available by prescription in the United States, its widespread abuse suggests easy access to this drug. In April 2014, Actavis, the pharmaceutical company that produces a promethazine/codeine product known as the “champagne of sizzurp,” made a bold decision to cease all production and sales of the product in direct response to the widespread media attention and glamorization of CPHCS. In its announcement, the company cited its “commitment to being a partner in the fight against prescription-drug abuse.”6 Despite Actavis’ cessation of manufacturing CPHC, at least four other companies continue to sell similar formulations.

What are the dangers of CPHCS use?

The effects produced by CPHCS are described as euphoric, which may be attributable to both codeine and promethazine. Codeine, or 3-methyl morphine, is an inactive opioid agonist and prodrug that requires metabolic activation via O-demethylation to morphine by CYP2D6. Onset of action occurs 30 to 45 minutes after ingestion, while peak effects are reached within 1 to 2 hours and last approximately 4 to 6 hours.7 Since approximately 5% to 7% of the white population lack CPY2D6 function, these individuals will experience no analgesic or euphoric effects from codeine.8 However, ultra-rapid CYP2D6 metabolizers can produce significant and potentially life-threatening concentrations of morphine.

Adverse effects of recreational codeine use are similar to that of any opioid and include central nervous system (CNS) depression, miosis, and hypoactive bowel sounds, with severe toxicity marked by coma, respiratory depression, hypotension, bradycardia, and/or death due to respiratory arrest. Aspiration pneumonitis and rhabdomyolysis are complications of impaired airway protection and prolonged immobility. Opioid-induced ototoxicity, resulting in either temporary or permanent hearing loss, is a rare complication, described largely in case reports.9 (See Emerg Med. 2012;44[11]:4-6).

Promethazine hydrochloride contributes to the unique effects experienced by the recreational user and likely acts synergistically with codeine to augment CNS depression. Both a histamine H1-receptor antagonist and the muscarinic dopamine (D2)-receptor antagonist promethazine is included in prescription cough syrups to produce its antihistamine, antiemetic, and sedative properties.7 It is well absorbed from the gastrointestinal (GI) tract with more limited oral bioavailability due to the first-pass effect. Onset of action occurs within 20 minutes of administration, and the duration of effect is approximately 4 to 6 hours. Adverse effects of promethazine include variable CNS effects, from obtundation to agitated delirium, and are often accompanied by anticholinergic effects such as hyperthermia, dry flushed skin, mydriasis, hypoactive bowel sounds, and urinary retention. Neurological manifestations, likely mediated by dopamine blockade, include muscle rigidity, athetosis, hyperreflexia, and other upper motor neuron signs. Severe toxicity can produce coma, respiratory depression, seizure, and/or death.

What are the treatment strategies?

Management of patients with CPHCS toxicity, as with all poisoned patients, begins with rapid evaluation and stabilization of the airway, breathing, and circulation. The benefits of GI decontamination are likely to be outweighed by the risks engendered by CNS depression. While supportive care is the mainstay, targeted therapies may include naloxone for the treatment of opioid-induced respiratory depression and physostigmine, when contraindications have been ruled out, for the reversal of the anticholinergic toxidrome.

Conclusion

The patient was admitted to the intensive care unit where he was treated for aspiration pneumonitis, acute respiratory distress syndrome, rhabdomyolysis, and acute renal failure. His hearing loss and tinnitus resolved. He was extubated on hospital day 9 and discharged from the hospital on day 14.

Dr Laskowski is a medical toxicology fellow in the department of emergency medicine at New York University Langone Medical Center. Dr Nelson, editor of “Case Studies in Toxicology,” is a professor in the department of emergency medicine and director of the medical toxicology fellowship program at the New York University School of Medicine and the New York City Poison Control Center. He is also associate editor, toxicology, of the EMERGENCY MEDICINE editorial board.

References

 

 

 

  1. Sizzurp. Urban Dictionary Web site. http://www.urbandictionary.com/define.php?term=sizzurp. Accessed October 15, 2014.
  2. Jodeine. Sippin’ purple drank: an experience with promethazine with codeine & cannabis. Erowid Web site. https://www.erowid.org/experiences/exp.php?ID=54165. Accessed October 15, 2014.
  3. Fergusen G. Sizzurp. KCRW Radio Web site. http://www.kcrw.com/news-culture/shows/good-food/butter-carving-the-last-supper-sizzurp-cheftestants. March 23, 2013. Accessed October 15, 2014.
  4. Elwood WN. Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. J Psychoactive Drugs. 2001;33(2):121-133.
  5. Agnich LE, Stogner JM, Miller BL, Marcum CD. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict Behav. 2013;38(9):2445-2449.
  6. Hlavaty C. Drug company cites abuse, pop culture hype in ending cough syrup production. Houston Chronicle. April 24, 2014. http://blog.chron.com/thetexican/2014/04/drug-company-cites-abuse-pop-culture-hype-in-ending-cough-syrup-production/. Accessed October 15, 2014.
  7. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013;4:75-82.
  8. Nelson LS, Olsen D. Opioids. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, NY: McGraw Hill; 2011:559-578.
  9. Freeman SR, Bray ME, Amos CS, Gibson WP. The association of codeine, macrocytosis and bilateral sudden or rapidly progressive profound sensorineural deafness. Acta Otolaryngol. 2009;129(1):1061-1066.
Issue
Emergency Medicine - 46(11)
Publications
Topics
Page Number
501-504
Legacy Keywords
Sizzurp, codeine, cough medicine, Dextromethorphan, purple drank, DJ Screw, CPHCS, cough syrup
Sections
He rolled up, asked him what he was sipping onHe said, “Lean, you want to hit it, dawg?”“That’s the same stuff Weezy’s sipping, huh?And tons of other rappers that be spitting hard?”—Macklemore, Otherside
He rolled up, asked him what he was sipping onHe said, “Lean, you want to hit it, dawg?”“That’s the same stuff Weezy’s sipping, huh?And tons of other rappers that be spitting hard?”—Macklemore, Otherside

Case

A 19-year-old man was found unresponsive by his girlfriend. They both attended a party the previous night where a number of people were drinking alcohol and cough syrup to get “high.” When emergency medical technicians arrived at the patient’s house, they administered naloxone, which somewhat improved the patient’s level of consciousness; oxygen was also delivered via facemask.

Upon arrival to the ED, the patient complained of hearing loss and tinnitus. His initial vital signs were: blood pressure, 99/60 mm Hg; heart rate, 110 beats/minute; respiratory rate, 20 breaths/minute; temperature, 96.8°F. Oxygen saturation was 80% on room air. On examination, he was lethargic but responsive to voice and oriented to time, place, and person. His pupils were pinpoint; his hearing was decreased bilaterally; his breathing was shallow, with rales audible at both lung bases; his bowel sounds were hypoactive; and his skin was warm and moist. The rest of the examination was otherwise unremarkable.

What cough and cold products are commonly abused with the intent to get high?

Hundreds of nonprescription pharmaceutical products—each with the potential for misuse or abuse—are available to consumers in retail stores and online. These products can be classified by expected clinical effect, which helps clinicians with the diagnosis and management of these patients (Table).

Dextromethorphan

Of the antitussive products currently available over the counter (OTC), those that contain dextromethorphan have the widest abuse potential. Referred to as “dex,” “DMX,” or “tuss,” this drug is widely abused among adolescents and young adults due to its easy availability. In therapeutic doses, dextromethorphan suppresses cough via the medullary cough center. Ingesting dextromethorphan at higher doses, a practice referred to as “Robo tripping,” can produce hallucinations and a dissociative state marked by alterations in consciousness and impaired motor control. Dextromethorphan is a structural analog of ketamine and phencyclidine, which accounts for their similar clinical effects.

Codeine

Codeine is another drug added to various cough medications for its antitussive properties. An opioid, it acts centrally to suppress cough and has mild analgesic properties. It is available only by prescription in the United States, but can be purchased as an OTC product in other countries. Recently, it has come into the media spotlight as the starting product to make “Krokodil” (see Emerg Med. 2014;46[2]:76-78).

Case Continuation

While undergoing his workup in the ED, the patient became increasingly lethargic with persistent hypoxia. Although initially
responsive to naloxone, his respirations became more labored, requiring intubation. Prior to intubation and while awake, the patient mentioned that he was drinking “sizzurp” the evening prior. He denied the use of other drugs or of having any suicidal intent. A postintubation chest X-ray revealed a left-sided retrocardiac infiltrate consistent with aspiration pneumonitis.

What is sizzurp?

Sizzurp is a slang term used to describe a beverage that is most frequently comprised of fruit-flavored soda, codeine/promethazine hydrochloride cough syrup (CPHCS), and hard candy (classically a Jolly Rancher).1 This combination is ingested by the user with the intent of achieving a unique high—attributable to the combined effects of codeine, an opioid, and promethazine, an antihistamine (with antipsychotic properties). According to user reports, CPHCS induces a deep sense of euphoria, relaxation, and a slowed sense of time.2 Additional slang terms used to describe this product include “lean,” “purple drank,” “purp,” “drank,” “syrup,” “barre,” and “Texas tea.”

According to one source, purple drank originated in Houston, Texas around the 1960s, when blues musicians would combine dextromethorphan with beer.3 Over time, the recipe was modified, and by the 1980s, when purple drank was adopted by hip-hop musicians from the same Houston neighborhoods, the name sizzurp took hold.

In the 1990s, one Houston-based hiphop artist, DJ Screw, developed a genre of music called “chopped and screwed,” inspired by the CPHCS high and notable for its slowed-down tempo that fit the sedation and decreased motor activity induced by the drug. As chopped and screwed music became popularized, so too did the recreational use of CPHCS. In 2000, “Sippin’ on Some Sizzurp,” a hit song by southern hip-hop group Three Six Mafia, introduced CPHCS to more mainstream hip-hop audiences.

Despite the CPHCS-related deaths of a number of hip-hop musicians, including DJ Screw, as well as the arrests of professional
football players linked to abusing the drug, CPHCS continues to be glorified by a number of hip-hop and pop musicians.

Unfortunately, media attention of these events often has the paradoxical effect of promoting use among adolescents and young adults, and CPHCS has become a drug of choice for black adolescents in many Texas communities.4 However, one study attempting to define a purple drank user profile among college students at a large public university in the southeastern United States revealed that use was most prevalent among urban male youth primarily from Hispanic, Native American, and white ethnic backgrounds—challenging the notion that it is confined to the black community.5

 

 

Although CPHCS is only available by prescription in the United States, its widespread abuse suggests easy access to this drug. In April 2014, Actavis, the pharmaceutical company that produces a promethazine/codeine product known as the “champagne of sizzurp,” made a bold decision to cease all production and sales of the product in direct response to the widespread media attention and glamorization of CPHCS. In its announcement, the company cited its “commitment to being a partner in the fight against prescription-drug abuse.”6 Despite Actavis’ cessation of manufacturing CPHC, at least four other companies continue to sell similar formulations.

What are the dangers of CPHCS use?

The effects produced by CPHCS are described as euphoric, which may be attributable to both codeine and promethazine. Codeine, or 3-methyl morphine, is an inactive opioid agonist and prodrug that requires metabolic activation via O-demethylation to morphine by CYP2D6. Onset of action occurs 30 to 45 minutes after ingestion, while peak effects are reached within 1 to 2 hours and last approximately 4 to 6 hours.7 Since approximately 5% to 7% of the white population lack CPY2D6 function, these individuals will experience no analgesic or euphoric effects from codeine.8 However, ultra-rapid CYP2D6 metabolizers can produce significant and potentially life-threatening concentrations of morphine.

Adverse effects of recreational codeine use are similar to that of any opioid and include central nervous system (CNS) depression, miosis, and hypoactive bowel sounds, with severe toxicity marked by coma, respiratory depression, hypotension, bradycardia, and/or death due to respiratory arrest. Aspiration pneumonitis and rhabdomyolysis are complications of impaired airway protection and prolonged immobility. Opioid-induced ototoxicity, resulting in either temporary or permanent hearing loss, is a rare complication, described largely in case reports.9 (See Emerg Med. 2012;44[11]:4-6).

Promethazine hydrochloride contributes to the unique effects experienced by the recreational user and likely acts synergistically with codeine to augment CNS depression. Both a histamine H1-receptor antagonist and the muscarinic dopamine (D2)-receptor antagonist promethazine is included in prescription cough syrups to produce its antihistamine, antiemetic, and sedative properties.7 It is well absorbed from the gastrointestinal (GI) tract with more limited oral bioavailability due to the first-pass effect. Onset of action occurs within 20 minutes of administration, and the duration of effect is approximately 4 to 6 hours. Adverse effects of promethazine include variable CNS effects, from obtundation to agitated delirium, and are often accompanied by anticholinergic effects such as hyperthermia, dry flushed skin, mydriasis, hypoactive bowel sounds, and urinary retention. Neurological manifestations, likely mediated by dopamine blockade, include muscle rigidity, athetosis, hyperreflexia, and other upper motor neuron signs. Severe toxicity can produce coma, respiratory depression, seizure, and/or death.

What are the treatment strategies?

Management of patients with CPHCS toxicity, as with all poisoned patients, begins with rapid evaluation and stabilization of the airway, breathing, and circulation. The benefits of GI decontamination are likely to be outweighed by the risks engendered by CNS depression. While supportive care is the mainstay, targeted therapies may include naloxone for the treatment of opioid-induced respiratory depression and physostigmine, when contraindications have been ruled out, for the reversal of the anticholinergic toxidrome.

Conclusion

The patient was admitted to the intensive care unit where he was treated for aspiration pneumonitis, acute respiratory distress syndrome, rhabdomyolysis, and acute renal failure. His hearing loss and tinnitus resolved. He was extubated on hospital day 9 and discharged from the hospital on day 14.

Dr Laskowski is a medical toxicology fellow in the department of emergency medicine at New York University Langone Medical Center. Dr Nelson, editor of “Case Studies in Toxicology,” is a professor in the department of emergency medicine and director of the medical toxicology fellowship program at the New York University School of Medicine and the New York City Poison Control Center. He is also associate editor, toxicology, of the EMERGENCY MEDICINE editorial board.

Case

A 19-year-old man was found unresponsive by his girlfriend. They both attended a party the previous night where a number of people were drinking alcohol and cough syrup to get “high.” When emergency medical technicians arrived at the patient’s house, they administered naloxone, which somewhat improved the patient’s level of consciousness; oxygen was also delivered via facemask.

Upon arrival to the ED, the patient complained of hearing loss and tinnitus. His initial vital signs were: blood pressure, 99/60 mm Hg; heart rate, 110 beats/minute; respiratory rate, 20 breaths/minute; temperature, 96.8°F. Oxygen saturation was 80% on room air. On examination, he was lethargic but responsive to voice and oriented to time, place, and person. His pupils were pinpoint; his hearing was decreased bilaterally; his breathing was shallow, with rales audible at both lung bases; his bowel sounds were hypoactive; and his skin was warm and moist. The rest of the examination was otherwise unremarkable.

What cough and cold products are commonly abused with the intent to get high?

Hundreds of nonprescription pharmaceutical products—each with the potential for misuse or abuse—are available to consumers in retail stores and online. These products can be classified by expected clinical effect, which helps clinicians with the diagnosis and management of these patients (Table).

Dextromethorphan

Of the antitussive products currently available over the counter (OTC), those that contain dextromethorphan have the widest abuse potential. Referred to as “dex,” “DMX,” or “tuss,” this drug is widely abused among adolescents and young adults due to its easy availability. In therapeutic doses, dextromethorphan suppresses cough via the medullary cough center. Ingesting dextromethorphan at higher doses, a practice referred to as “Robo tripping,” can produce hallucinations and a dissociative state marked by alterations in consciousness and impaired motor control. Dextromethorphan is a structural analog of ketamine and phencyclidine, which accounts for their similar clinical effects.

Codeine

Codeine is another drug added to various cough medications for its antitussive properties. An opioid, it acts centrally to suppress cough and has mild analgesic properties. It is available only by prescription in the United States, but can be purchased as an OTC product in other countries. Recently, it has come into the media spotlight as the starting product to make “Krokodil” (see Emerg Med. 2014;46[2]:76-78).

Case Continuation

While undergoing his workup in the ED, the patient became increasingly lethargic with persistent hypoxia. Although initially
responsive to naloxone, his respirations became more labored, requiring intubation. Prior to intubation and while awake, the patient mentioned that he was drinking “sizzurp” the evening prior. He denied the use of other drugs or of having any suicidal intent. A postintubation chest X-ray revealed a left-sided retrocardiac infiltrate consistent with aspiration pneumonitis.

What is sizzurp?

Sizzurp is a slang term used to describe a beverage that is most frequently comprised of fruit-flavored soda, codeine/promethazine hydrochloride cough syrup (CPHCS), and hard candy (classically a Jolly Rancher).1 This combination is ingested by the user with the intent of achieving a unique high—attributable to the combined effects of codeine, an opioid, and promethazine, an antihistamine (with antipsychotic properties). According to user reports, CPHCS induces a deep sense of euphoria, relaxation, and a slowed sense of time.2 Additional slang terms used to describe this product include “lean,” “purple drank,” “purp,” “drank,” “syrup,” “barre,” and “Texas tea.”

According to one source, purple drank originated in Houston, Texas around the 1960s, when blues musicians would combine dextromethorphan with beer.3 Over time, the recipe was modified, and by the 1980s, when purple drank was adopted by hip-hop musicians from the same Houston neighborhoods, the name sizzurp took hold.

In the 1990s, one Houston-based hiphop artist, DJ Screw, developed a genre of music called “chopped and screwed,” inspired by the CPHCS high and notable for its slowed-down tempo that fit the sedation and decreased motor activity induced by the drug. As chopped and screwed music became popularized, so too did the recreational use of CPHCS. In 2000, “Sippin’ on Some Sizzurp,” a hit song by southern hip-hop group Three Six Mafia, introduced CPHCS to more mainstream hip-hop audiences.

Despite the CPHCS-related deaths of a number of hip-hop musicians, including DJ Screw, as well as the arrests of professional
football players linked to abusing the drug, CPHCS continues to be glorified by a number of hip-hop and pop musicians.

Unfortunately, media attention of these events often has the paradoxical effect of promoting use among adolescents and young adults, and CPHCS has become a drug of choice for black adolescents in many Texas communities.4 However, one study attempting to define a purple drank user profile among college students at a large public university in the southeastern United States revealed that use was most prevalent among urban male youth primarily from Hispanic, Native American, and white ethnic backgrounds—challenging the notion that it is confined to the black community.5

 

 

Although CPHCS is only available by prescription in the United States, its widespread abuse suggests easy access to this drug. In April 2014, Actavis, the pharmaceutical company that produces a promethazine/codeine product known as the “champagne of sizzurp,” made a bold decision to cease all production and sales of the product in direct response to the widespread media attention and glamorization of CPHCS. In its announcement, the company cited its “commitment to being a partner in the fight against prescription-drug abuse.”6 Despite Actavis’ cessation of manufacturing CPHC, at least four other companies continue to sell similar formulations.

What are the dangers of CPHCS use?

The effects produced by CPHCS are described as euphoric, which may be attributable to both codeine and promethazine. Codeine, or 3-methyl morphine, is an inactive opioid agonist and prodrug that requires metabolic activation via O-demethylation to morphine by CYP2D6. Onset of action occurs 30 to 45 minutes after ingestion, while peak effects are reached within 1 to 2 hours and last approximately 4 to 6 hours.7 Since approximately 5% to 7% of the white population lack CPY2D6 function, these individuals will experience no analgesic or euphoric effects from codeine.8 However, ultra-rapid CYP2D6 metabolizers can produce significant and potentially life-threatening concentrations of morphine.

Adverse effects of recreational codeine use are similar to that of any opioid and include central nervous system (CNS) depression, miosis, and hypoactive bowel sounds, with severe toxicity marked by coma, respiratory depression, hypotension, bradycardia, and/or death due to respiratory arrest. Aspiration pneumonitis and rhabdomyolysis are complications of impaired airway protection and prolonged immobility. Opioid-induced ototoxicity, resulting in either temporary or permanent hearing loss, is a rare complication, described largely in case reports.9 (See Emerg Med. 2012;44[11]:4-6).

Promethazine hydrochloride contributes to the unique effects experienced by the recreational user and likely acts synergistically with codeine to augment CNS depression. Both a histamine H1-receptor antagonist and the muscarinic dopamine (D2)-receptor antagonist promethazine is included in prescription cough syrups to produce its antihistamine, antiemetic, and sedative properties.7 It is well absorbed from the gastrointestinal (GI) tract with more limited oral bioavailability due to the first-pass effect. Onset of action occurs within 20 minutes of administration, and the duration of effect is approximately 4 to 6 hours. Adverse effects of promethazine include variable CNS effects, from obtundation to agitated delirium, and are often accompanied by anticholinergic effects such as hyperthermia, dry flushed skin, mydriasis, hypoactive bowel sounds, and urinary retention. Neurological manifestations, likely mediated by dopamine blockade, include muscle rigidity, athetosis, hyperreflexia, and other upper motor neuron signs. Severe toxicity can produce coma, respiratory depression, seizure, and/or death.

What are the treatment strategies?

Management of patients with CPHCS toxicity, as with all poisoned patients, begins with rapid evaluation and stabilization of the airway, breathing, and circulation. The benefits of GI decontamination are likely to be outweighed by the risks engendered by CNS depression. While supportive care is the mainstay, targeted therapies may include naloxone for the treatment of opioid-induced respiratory depression and physostigmine, when contraindications have been ruled out, for the reversal of the anticholinergic toxidrome.

Conclusion

The patient was admitted to the intensive care unit where he was treated for aspiration pneumonitis, acute respiratory distress syndrome, rhabdomyolysis, and acute renal failure. His hearing loss and tinnitus resolved. He was extubated on hospital day 9 and discharged from the hospital on day 14.

Dr Laskowski is a medical toxicology fellow in the department of emergency medicine at New York University Langone Medical Center. Dr Nelson, editor of “Case Studies in Toxicology,” is a professor in the department of emergency medicine and director of the medical toxicology fellowship program at the New York University School of Medicine and the New York City Poison Control Center. He is also associate editor, toxicology, of the EMERGENCY MEDICINE editorial board.

References

 

 

 

  1. Sizzurp. Urban Dictionary Web site. http://www.urbandictionary.com/define.php?term=sizzurp. Accessed October 15, 2014.
  2. Jodeine. Sippin’ purple drank: an experience with promethazine with codeine & cannabis. Erowid Web site. https://www.erowid.org/experiences/exp.php?ID=54165. Accessed October 15, 2014.
  3. Fergusen G. Sizzurp. KCRW Radio Web site. http://www.kcrw.com/news-culture/shows/good-food/butter-carving-the-last-supper-sizzurp-cheftestants. March 23, 2013. Accessed October 15, 2014.
  4. Elwood WN. Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. J Psychoactive Drugs. 2001;33(2):121-133.
  5. Agnich LE, Stogner JM, Miller BL, Marcum CD. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict Behav. 2013;38(9):2445-2449.
  6. Hlavaty C. Drug company cites abuse, pop culture hype in ending cough syrup production. Houston Chronicle. April 24, 2014. http://blog.chron.com/thetexican/2014/04/drug-company-cites-abuse-pop-culture-hype-in-ending-cough-syrup-production/. Accessed October 15, 2014.
  7. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013;4:75-82.
  8. Nelson LS, Olsen D. Opioids. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, NY: McGraw Hill; 2011:559-578.
  9. Freeman SR, Bray ME, Amos CS, Gibson WP. The association of codeine, macrocytosis and bilateral sudden or rapidly progressive profound sensorineural deafness. Acta Otolaryngol. 2009;129(1):1061-1066.
References

 

 

 

  1. Sizzurp. Urban Dictionary Web site. http://www.urbandictionary.com/define.php?term=sizzurp. Accessed October 15, 2014.
  2. Jodeine. Sippin’ purple drank: an experience with promethazine with codeine & cannabis. Erowid Web site. https://www.erowid.org/experiences/exp.php?ID=54165. Accessed October 15, 2014.
  3. Fergusen G. Sizzurp. KCRW Radio Web site. http://www.kcrw.com/news-culture/shows/good-food/butter-carving-the-last-supper-sizzurp-cheftestants. March 23, 2013. Accessed October 15, 2014.
  4. Elwood WN. Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. J Psychoactive Drugs. 2001;33(2):121-133.
  5. Agnich LE, Stogner JM, Miller BL, Marcum CD. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict Behav. 2013;38(9):2445-2449.
  6. Hlavaty C. Drug company cites abuse, pop culture hype in ending cough syrup production. Houston Chronicle. April 24, 2014. http://blog.chron.com/thetexican/2014/04/drug-company-cites-abuse-pop-culture-hype-in-ending-cough-syrup-production/. Accessed October 15, 2014.
  7. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013;4:75-82.
  8. Nelson LS, Olsen D. Opioids. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, NY: McGraw Hill; 2011:559-578.
  9. Freeman SR, Bray ME, Amos CS, Gibson WP. The association of codeine, macrocytosis and bilateral sudden or rapidly progressive profound sensorineural deafness. Acta Otolaryngol. 2009;129(1):1061-1066.
Issue
Emergency Medicine - 46(11)
Issue
Emergency Medicine - 46(11)
Page Number
501-504
Page Number
501-504
Publications
Publications
Topics
Article Type
Display Headline
Case Studies in Toxicology: Sippin’ on Some “Sizzurp”
Display Headline
Case Studies in Toxicology: Sippin’ on Some “Sizzurp”
Legacy Keywords
Sizzurp, codeine, cough medicine, Dextromethorphan, purple drank, DJ Screw, CPHCS, cough syrup
Legacy Keywords
Sizzurp, codeine, cough medicine, Dextromethorphan, purple drank, DJ Screw, CPHCS, cough syrup
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica

4 pregnant women with an unusual finding at delivery

Article Type
Changed
Display Headline
4 pregnant women with an unusual finding at delivery

THE CASES

CASE 1 A 32-year-old G2P1 with an uncomplicated prenatal course presented for induction at 41 weeks and 2 days of gestation. Fetal heart tracing showed no abnormalities. A compound presentation and a prolonged second stage of labor made vacuum assistance necessary. The infant had both a true umbilical cord knot (TUCK) (FIGURE 1A) and double nuchal cord.

CASE 2 A 46-year-old G3P0 at 38 weeks of gestation by in vitro fertilization underwent an uncomplicated primary low transverse cesarean (C-section) delivery of dichorionic/diamniotic twins. The C-section had been necessary because baby A had been in the breech position. Fetal heart tracing showed no abnormalities. Baby A had a velamentous cord insertion, and baby B had a succenturiate lobe and a TUCK.

CASE 3 A 23-year-old G2P1 with an uncomplicated prenatal course chose to have a repeat C-section and delivered at 41 weeks in active labor. Fetal heart monitoring showed no abnormalities. Umbilical artery pH and venous pH were normal. A TUCK was noted at time of delivery.

CASE 4 A 30-year-old G1P0 with an uncomplicated prenatal course presented in active labor at 40 weeks and 4 days of gestation. At 7 cm cervical dilation, monitoring showed repeated deep variable fetal heart rate decelerations. The patient underwent an uncomplicated primary C-section. Umbilical artery pH and venous pH were normal. A TUCK (FIGURE 1B) and double nuchal cord were found at time of delivery.

DISCUSSION

TUCKs are thought to occur when a fetus passes through a loop in the umbilical cord. They occur in <2% of term deliveries.1,2 TUCKs differ from false knots. False knots are exaggerated loops of cord vasculature.

Risk factors that have been independently associated with TUCK include advanced maternal age (AMA; >35 years), multiparity, diabetes mellitus, gestational diabetes, polyhydramnios, and previous spontaneous abortion.1-3 In one study, 72% of women with a TUCK were multiparous.3 Hershkovitz et al2 suggested that laxity of uterine and abdominal musculature in multiparous patients may contribute to increased room for TUCK formation.

The adjusted odds ratio of having a TUCK is 2.53 in women with diabetes mellitus.3 Hyperglycemia can contribute to increased fetal movements, thereby increasing the risk of TUCK development.2 Polyhydramnios is often found in patients with diabetes mellitus and gestational diabetes.3 The incidence is higher in monoamniotic twins.4

Being a male and having a longer umbilical cord may also increase the risk of TUCK. On average, male infants have longer cords than females, which may predispose them to TUCKs.3 Räisänen et al3 found that the mean cord length in TUCK infants was 16.9 cm longer than in infants without a TUCK.

Of our 4 patients, one was of AMA, 2 were multiparous, and 3 of the 4 infants who developed TUCK were male.

TUCK is usually
 diagnosed at delivery


Most cases of TUCK are found incidentally at the time of delivery. Antenatal diagnosis is difficult, because loops of cord lying together are easily mistaken for knots on ultrasound.5 Sepulveda et al6 evaluated the use of 3D power Doppler in 8 cases of suspected TUCK; only 63% were confirmed at delivery. Some researchers have found improved detection of TUCK with color Doppler and 4D ultrasound, which have demonstrated a “hanging noose sign” (a transverse section of umbilical cord surrounded by a loop of cord) as well as views of the cord under pressure.7-10

Outcomes associated with TUCK vary greatly. Neonates affected by TUCK have a 4% to 10% increased risk of stillbirth, usually attributed to knot tightening.2,4,11,12

In addition, there is an increased incidence of fetal heart rate abnormalities during labor.1,3,12,13

Infants with true umbilical cord knots have an increased incidence of heart rate abnormalities during labor. There is no increase in the incidence of assisted vaginal or C-section delivery.12 And as for whether TUCK affects an infant’s size or weight, one study found TUCK infants had a 3.2-fold higher risk of measuring small for gestational age, potentially due to chronic umbilical cord compromise; however, mean birth weight between study and control groups did not differ significantly.3

Outcomes for our patients and their infants. All 4 cases had good outcomes (TABLE). The umbilical cord knot produced no detectable fetal compromise in cases 1 through 3. In Case 4, electronic fetal monitoring showed repeated variable fetal heart rate decelerations, presumably associated with cord compression.

THE TAKEAWAY

Pregnant women who may be at risk for experiencing a TUCK include those who are older than age 35, multiparous, carrying a boy, or have diabetes mellitus, gestational diabetes, or polyhydramnios. While it is good to be aware of these risk factors, there are no recommended changes in management based on risk or ultrasound findings unless there is additional concern for fetal compromise.

 

 

Antenatal diagnosis of TUCK is challenging, but Doppler ultrasound may be able to identify the condition. Most cases of TUCK are noted on delivery, and outcomes are generally positive, although infants in whom the TUCK tightens may have an increased risk of heart rate abnormalities or stillbirth. 

References

 

1.  Joura EA, Zeisler H, Sator MO. Epidemiology and clinical value of true umbilical cord knots [in German]. Wien Klin Wochenschr. 1998;110:232-235.

2.  Hershkovitz R, Silberstein T, Sheiner E, et al. Risk factors associated with true knots of the umbilical cord. Eur J Obstet Gynecol Reprod Biol. 2001;98:36-39.

3.  Räisänen S, Georgiadis L, Harju M, et al. True umbilical cord knot and obstetric outcome. Int J Gynaecol Obstet. 2013;122: 18-21.

4.  Maher JT, Conti JA. A comparison of umbilical cord blood gas values between newborns with and without true knots. Obstet Gynecol. 1996;88:863-866.

5.  Clerici G, Koutras I, Luzietti R, et al. Multiple true umbilical knots: a silent risk for intrauterine growth restriction with anomalous hemodynamic pattern. Fetal Diagn Ther. 2007;22:440-443.

6.  Sepulveda W, Shennan AH, Bower S, et al. True knot of the umbilical cord: a difficult prenatal ultrasonographic diagnosis. Ultrasound Obstet Gynecol. 1995;5:106-108.

7. Hasbun J, Alcalde JL, Sepulveda W. Three-dimensional power Doppler sonography in the prenatal diagnosis of a true knot of the umbilical cord: value and limitations. J Ultrasound Med. 2007;26:1215-1220.

8. Rodriguez N, Angarita AM, Casasbuenas A, et al. Three-dimensional high-definition flow imaging in prenatal diagnosis of a true umbilical cord knot. Ultrasound Obstet Gynecol. 2012;39:245-246.

9. Scioscia M, Fornalè M, Bruni F, et al. Four-dimensional and Doppler sonography in the diagnosis and surveillance of a true cord knot. J Clin Ultrasound. 2011;39: 157-159.

10. Sherer DM, Dalloul M, Zigalo A, et al. Power Doppler and 3-dimensional sonographic diagnosis of multiple separate true knots of the umbilical cord. J Ultrasound Med. 2005;24: 1321-1323.

11. Sørnes T. Umbilical cord knots. Acta Obstet Gynecol Scand. 2000;79:157-159.

12. Airas U, Heinonen S. Clinical significance of true umbilical knots: a population-based analysis. Am J Perinatol. 2002;19:127-132.

13. Szczepanik ME, Wittich AC. True knot of the umbilical cord: a report of 13 cases. Mil Med. 2007;172:892-894.

Article PDF
Author and Disclosure Information

 

Alexandra R. Johnson, MD
Annamarie Meeuwsen, MD
Morteza Khodaee, MD, MPH
Mark Deutchman, MD

University of Colorado School of Medicine, Department of Family Medicine, Aurora
alexandra.johnson@ucdenver.edu

The authors reported no potential conflict of interest relevant to this article.

Issue
The Journal of Family Practice - 63(11)
Publications
Topics
Page Number
670-672
Legacy Keywords
umbilical cord knot complications; true umbilical cord knot; TUCK; Alexandra R. Johnson, MD; Annamarie Meeuwsen, MD; Morteza Khodaee, MD, MPH; Mark Deutchman, MD
Sections
Author and Disclosure Information

 

Alexandra R. Johnson, MD
Annamarie Meeuwsen, MD
Morteza Khodaee, MD, MPH
Mark Deutchman, MD

University of Colorado School of Medicine, Department of Family Medicine, Aurora
alexandra.johnson@ucdenver.edu

The authors reported no potential conflict of interest relevant to this article.

Author and Disclosure Information

 

Alexandra R. Johnson, MD
Annamarie Meeuwsen, MD
Morteza Khodaee, MD, MPH
Mark Deutchman, MD

University of Colorado School of Medicine, Department of Family Medicine, Aurora
alexandra.johnson@ucdenver.edu

The authors reported no potential conflict of interest relevant to this article.

Article PDF
Article PDF
Related Articles

THE CASES

CASE 1 A 32-year-old G2P1 with an uncomplicated prenatal course presented for induction at 41 weeks and 2 days of gestation. Fetal heart tracing showed no abnormalities. A compound presentation and a prolonged second stage of labor made vacuum assistance necessary. The infant had both a true umbilical cord knot (TUCK) (FIGURE 1A) and double nuchal cord.

CASE 2 A 46-year-old G3P0 at 38 weeks of gestation by in vitro fertilization underwent an uncomplicated primary low transverse cesarean (C-section) delivery of dichorionic/diamniotic twins. The C-section had been necessary because baby A had been in the breech position. Fetal heart tracing showed no abnormalities. Baby A had a velamentous cord insertion, and baby B had a succenturiate lobe and a TUCK.

CASE 3 A 23-year-old G2P1 with an uncomplicated prenatal course chose to have a repeat C-section and delivered at 41 weeks in active labor. Fetal heart monitoring showed no abnormalities. Umbilical artery pH and venous pH were normal. A TUCK was noted at time of delivery.

CASE 4 A 30-year-old G1P0 with an uncomplicated prenatal course presented in active labor at 40 weeks and 4 days of gestation. At 7 cm cervical dilation, monitoring showed repeated deep variable fetal heart rate decelerations. The patient underwent an uncomplicated primary C-section. Umbilical artery pH and venous pH were normal. A TUCK (FIGURE 1B) and double nuchal cord were found at time of delivery.

DISCUSSION

TUCKs are thought to occur when a fetus passes through a loop in the umbilical cord. They occur in <2% of term deliveries.1,2 TUCKs differ from false knots. False knots are exaggerated loops of cord vasculature.

Risk factors that have been independently associated with TUCK include advanced maternal age (AMA; >35 years), multiparity, diabetes mellitus, gestational diabetes, polyhydramnios, and previous spontaneous abortion.1-3 In one study, 72% of women with a TUCK were multiparous.3 Hershkovitz et al2 suggested that laxity of uterine and abdominal musculature in multiparous patients may contribute to increased room for TUCK formation.

The adjusted odds ratio of having a TUCK is 2.53 in women with diabetes mellitus.3 Hyperglycemia can contribute to increased fetal movements, thereby increasing the risk of TUCK development.2 Polyhydramnios is often found in patients with diabetes mellitus and gestational diabetes.3 The incidence is higher in monoamniotic twins.4

Being a male and having a longer umbilical cord may also increase the risk of TUCK. On average, male infants have longer cords than females, which may predispose them to TUCKs.3 Räisänen et al3 found that the mean cord length in TUCK infants was 16.9 cm longer than in infants without a TUCK.

Of our 4 patients, one was of AMA, 2 were multiparous, and 3 of the 4 infants who developed TUCK were male.

TUCK is usually
 diagnosed at delivery


Most cases of TUCK are found incidentally at the time of delivery. Antenatal diagnosis is difficult, because loops of cord lying together are easily mistaken for knots on ultrasound.5 Sepulveda et al6 evaluated the use of 3D power Doppler in 8 cases of suspected TUCK; only 63% were confirmed at delivery. Some researchers have found improved detection of TUCK with color Doppler and 4D ultrasound, which have demonstrated a “hanging noose sign” (a transverse section of umbilical cord surrounded by a loop of cord) as well as views of the cord under pressure.7-10

Outcomes associated with TUCK vary greatly. Neonates affected by TUCK have a 4% to 10% increased risk of stillbirth, usually attributed to knot tightening.2,4,11,12

In addition, there is an increased incidence of fetal heart rate abnormalities during labor.1,3,12,13

Infants with true umbilical cord knots have an increased incidence of heart rate abnormalities during labor. There is no increase in the incidence of assisted vaginal or C-section delivery.12 And as for whether TUCK affects an infant’s size or weight, one study found TUCK infants had a 3.2-fold higher risk of measuring small for gestational age, potentially due to chronic umbilical cord compromise; however, mean birth weight between study and control groups did not differ significantly.3

Outcomes for our patients and their infants. All 4 cases had good outcomes (TABLE). The umbilical cord knot produced no detectable fetal compromise in cases 1 through 3. In Case 4, electronic fetal monitoring showed repeated variable fetal heart rate decelerations, presumably associated with cord compression.

THE TAKEAWAY

Pregnant women who may be at risk for experiencing a TUCK include those who are older than age 35, multiparous, carrying a boy, or have diabetes mellitus, gestational diabetes, or polyhydramnios. While it is good to be aware of these risk factors, there are no recommended changes in management based on risk or ultrasound findings unless there is additional concern for fetal compromise.

 

 

Antenatal diagnosis of TUCK is challenging, but Doppler ultrasound may be able to identify the condition. Most cases of TUCK are noted on delivery, and outcomes are generally positive, although infants in whom the TUCK tightens may have an increased risk of heart rate abnormalities or stillbirth. 

THE CASES

CASE 1 A 32-year-old G2P1 with an uncomplicated prenatal course presented for induction at 41 weeks and 2 days of gestation. Fetal heart tracing showed no abnormalities. A compound presentation and a prolonged second stage of labor made vacuum assistance necessary. The infant had both a true umbilical cord knot (TUCK) (FIGURE 1A) and double nuchal cord.

CASE 2 A 46-year-old G3P0 at 38 weeks of gestation by in vitro fertilization underwent an uncomplicated primary low transverse cesarean (C-section) delivery of dichorionic/diamniotic twins. The C-section had been necessary because baby A had been in the breech position. Fetal heart tracing showed no abnormalities. Baby A had a velamentous cord insertion, and baby B had a succenturiate lobe and a TUCK.

CASE 3 A 23-year-old G2P1 with an uncomplicated prenatal course chose to have a repeat C-section and delivered at 41 weeks in active labor. Fetal heart monitoring showed no abnormalities. Umbilical artery pH and venous pH were normal. A TUCK was noted at time of delivery.

CASE 4 A 30-year-old G1P0 with an uncomplicated prenatal course presented in active labor at 40 weeks and 4 days of gestation. At 7 cm cervical dilation, monitoring showed repeated deep variable fetal heart rate decelerations. The patient underwent an uncomplicated primary C-section. Umbilical artery pH and venous pH were normal. A TUCK (FIGURE 1B) and double nuchal cord were found at time of delivery.

DISCUSSION

TUCKs are thought to occur when a fetus passes through a loop in the umbilical cord. They occur in <2% of term deliveries.1,2 TUCKs differ from false knots. False knots are exaggerated loops of cord vasculature.

Risk factors that have been independently associated with TUCK include advanced maternal age (AMA; >35 years), multiparity, diabetes mellitus, gestational diabetes, polyhydramnios, and previous spontaneous abortion.1-3 In one study, 72% of women with a TUCK were multiparous.3 Hershkovitz et al2 suggested that laxity of uterine and abdominal musculature in multiparous patients may contribute to increased room for TUCK formation.

The adjusted odds ratio of having a TUCK is 2.53 in women with diabetes mellitus.3 Hyperglycemia can contribute to increased fetal movements, thereby increasing the risk of TUCK development.2 Polyhydramnios is often found in patients with diabetes mellitus and gestational diabetes.3 The incidence is higher in monoamniotic twins.4

Being a male and having a longer umbilical cord may also increase the risk of TUCK. On average, male infants have longer cords than females, which may predispose them to TUCKs.3 Räisänen et al3 found that the mean cord length in TUCK infants was 16.9 cm longer than in infants without a TUCK.

Of our 4 patients, one was of AMA, 2 were multiparous, and 3 of the 4 infants who developed TUCK were male.

TUCK is usually
 diagnosed at delivery


Most cases of TUCK are found incidentally at the time of delivery. Antenatal diagnosis is difficult, because loops of cord lying together are easily mistaken for knots on ultrasound.5 Sepulveda et al6 evaluated the use of 3D power Doppler in 8 cases of suspected TUCK; only 63% were confirmed at delivery. Some researchers have found improved detection of TUCK with color Doppler and 4D ultrasound, which have demonstrated a “hanging noose sign” (a transverse section of umbilical cord surrounded by a loop of cord) as well as views of the cord under pressure.7-10

Outcomes associated with TUCK vary greatly. Neonates affected by TUCK have a 4% to 10% increased risk of stillbirth, usually attributed to knot tightening.2,4,11,12

In addition, there is an increased incidence of fetal heart rate abnormalities during labor.1,3,12,13

Infants with true umbilical cord knots have an increased incidence of heart rate abnormalities during labor. There is no increase in the incidence of assisted vaginal or C-section delivery.12 And as for whether TUCK affects an infant’s size or weight, one study found TUCK infants had a 3.2-fold higher risk of measuring small for gestational age, potentially due to chronic umbilical cord compromise; however, mean birth weight between study and control groups did not differ significantly.3

Outcomes for our patients and their infants. All 4 cases had good outcomes (TABLE). The umbilical cord knot produced no detectable fetal compromise in cases 1 through 3. In Case 4, electronic fetal monitoring showed repeated variable fetal heart rate decelerations, presumably associated with cord compression.

THE TAKEAWAY

Pregnant women who may be at risk for experiencing a TUCK include those who are older than age 35, multiparous, carrying a boy, or have diabetes mellitus, gestational diabetes, or polyhydramnios. While it is good to be aware of these risk factors, there are no recommended changes in management based on risk or ultrasound findings unless there is additional concern for fetal compromise.

 

 

Antenatal diagnosis of TUCK is challenging, but Doppler ultrasound may be able to identify the condition. Most cases of TUCK are noted on delivery, and outcomes are generally positive, although infants in whom the TUCK tightens may have an increased risk of heart rate abnormalities or stillbirth. 

References

 

1.  Joura EA, Zeisler H, Sator MO. Epidemiology and clinical value of true umbilical cord knots [in German]. Wien Klin Wochenschr. 1998;110:232-235.

2.  Hershkovitz R, Silberstein T, Sheiner E, et al. Risk factors associated with true knots of the umbilical cord. Eur J Obstet Gynecol Reprod Biol. 2001;98:36-39.

3.  Räisänen S, Georgiadis L, Harju M, et al. True umbilical cord knot and obstetric outcome. Int J Gynaecol Obstet. 2013;122: 18-21.

4.  Maher JT, Conti JA. A comparison of umbilical cord blood gas values between newborns with and without true knots. Obstet Gynecol. 1996;88:863-866.

5.  Clerici G, Koutras I, Luzietti R, et al. Multiple true umbilical knots: a silent risk for intrauterine growth restriction with anomalous hemodynamic pattern. Fetal Diagn Ther. 2007;22:440-443.

6.  Sepulveda W, Shennan AH, Bower S, et al. True knot of the umbilical cord: a difficult prenatal ultrasonographic diagnosis. Ultrasound Obstet Gynecol. 1995;5:106-108.

7. Hasbun J, Alcalde JL, Sepulveda W. Three-dimensional power Doppler sonography in the prenatal diagnosis of a true knot of the umbilical cord: value and limitations. J Ultrasound Med. 2007;26:1215-1220.

8. Rodriguez N, Angarita AM, Casasbuenas A, et al. Three-dimensional high-definition flow imaging in prenatal diagnosis of a true umbilical cord knot. Ultrasound Obstet Gynecol. 2012;39:245-246.

9. Scioscia M, Fornalè M, Bruni F, et al. Four-dimensional and Doppler sonography in the diagnosis and surveillance of a true cord knot. J Clin Ultrasound. 2011;39: 157-159.

10. Sherer DM, Dalloul M, Zigalo A, et al. Power Doppler and 3-dimensional sonographic diagnosis of multiple separate true knots of the umbilical cord. J Ultrasound Med. 2005;24: 1321-1323.

11. Sørnes T. Umbilical cord knots. Acta Obstet Gynecol Scand. 2000;79:157-159.

12. Airas U, Heinonen S. Clinical significance of true umbilical knots: a population-based analysis. Am J Perinatol. 2002;19:127-132.

13. Szczepanik ME, Wittich AC. True knot of the umbilical cord: a report of 13 cases. Mil Med. 2007;172:892-894.

References

 

1.  Joura EA, Zeisler H, Sator MO. Epidemiology and clinical value of true umbilical cord knots [in German]. Wien Klin Wochenschr. 1998;110:232-235.

2.  Hershkovitz R, Silberstein T, Sheiner E, et al. Risk factors associated with true knots of the umbilical cord. Eur J Obstet Gynecol Reprod Biol. 2001;98:36-39.

3.  Räisänen S, Georgiadis L, Harju M, et al. True umbilical cord knot and obstetric outcome. Int J Gynaecol Obstet. 2013;122: 18-21.

4.  Maher JT, Conti JA. A comparison of umbilical cord blood gas values between newborns with and without true knots. Obstet Gynecol. 1996;88:863-866.

5.  Clerici G, Koutras I, Luzietti R, et al. Multiple true umbilical knots: a silent risk for intrauterine growth restriction with anomalous hemodynamic pattern. Fetal Diagn Ther. 2007;22:440-443.

6.  Sepulveda W, Shennan AH, Bower S, et al. True knot of the umbilical cord: a difficult prenatal ultrasonographic diagnosis. Ultrasound Obstet Gynecol. 1995;5:106-108.

7. Hasbun J, Alcalde JL, Sepulveda W. Three-dimensional power Doppler sonography in the prenatal diagnosis of a true knot of the umbilical cord: value and limitations. J Ultrasound Med. 2007;26:1215-1220.

8. Rodriguez N, Angarita AM, Casasbuenas A, et al. Three-dimensional high-definition flow imaging in prenatal diagnosis of a true umbilical cord knot. Ultrasound Obstet Gynecol. 2012;39:245-246.

9. Scioscia M, Fornalè M, Bruni F, et al. Four-dimensional and Doppler sonography in the diagnosis and surveillance of a true cord knot. J Clin Ultrasound. 2011;39: 157-159.

10. Sherer DM, Dalloul M, Zigalo A, et al. Power Doppler and 3-dimensional sonographic diagnosis of multiple separate true knots of the umbilical cord. J Ultrasound Med. 2005;24: 1321-1323.

11. Sørnes T. Umbilical cord knots. Acta Obstet Gynecol Scand. 2000;79:157-159.

12. Airas U, Heinonen S. Clinical significance of true umbilical knots: a population-based analysis. Am J Perinatol. 2002;19:127-132.

13. Szczepanik ME, Wittich AC. True knot of the umbilical cord: a report of 13 cases. Mil Med. 2007;172:892-894.

Issue
The Journal of Family Practice - 63(11)
Issue
The Journal of Family Practice - 63(11)
Page Number
670-672
Page Number
670-672
Publications
Publications
Topics
Article Type
Display Headline
4 pregnant women with an unusual finding at delivery
Display Headline
4 pregnant women with an unusual finding at delivery
Legacy Keywords
umbilical cord knot complications; true umbilical cord knot; TUCK; Alexandra R. Johnson, MD; Annamarie Meeuwsen, MD; Morteza Khodaee, MD, MPH; Mark Deutchman, MD
Legacy Keywords
umbilical cord knot complications; true umbilical cord knot; TUCK; Alexandra R. Johnson, MD; Annamarie Meeuwsen, MD; Morteza Khodaee, MD, MPH; Mark Deutchman, MD
Sections
Disallow All Ads
Alternative CME
Article PDF Media

Radiating low back pain • history of urinary symptoms • past surgery for scoliosis • Dx?

Article Type
Changed
Display Headline
Radiating low back pain • history of urinary symptoms • past surgery for scoliosis • Dx?

THE CASE

A 23-year-old immunocompetent woman was referred to our spinal clinic with a 6-month history of low back pain that radiated to her right flank, buttock, and groin. She’d had intermittent urinary problems, including mild dysuria and frequency, and had been treated with antibiotics for a presumed urinary tract infection on 3 previous occasions, but her pain gradually increased and eventually became constant.

The patient had no history of fever, malaise, or weight loss. She denied consuming unpasteurized milk or undercooked poultry, and hadn’t recently experienced diarrhea or vomiting.

Eight years earlier, she had undergone anterior fusion of her spine for idiopathic scoliosis. At that time, she was at Risser grade 1, and her Cobb angle was 50°; metallic instrumentation was implanted at T10 to L3 to prevent progression of the scoliosis. Her recovery had been uneventful.

During examination, her temperature, pulse, respiratory rate, blood pressure, and nervous system were all normal. Her hips appeared normal, as well, and a straight leg raise was negative bilaterally. The patient had mild midline lumbar tenderness. Spinal range of movement revealed decreased flexion and mild pain.

X-rays (FIGURE 1) showed no changes in the previous metalwork in her spine. There was decreased disk height at the L3/4 level, but no significant bony erosion or soft-tissue shadows. Laboratory testing revealed a C-reactive protein (CRP) level of 240 mg/dL (normal, <1 mg/dL) and her erythrocyte sedimentation rate (ESR) was 102 mm/h—more than 5 times higher than it should have been.1 The patient had a normal peripheral white cell count (WCC). Midstream urine cultures were negative.


   

The patient was admitted to the hospital for further work-up. Magnetic resonance imaging (MRI) of the lumbar spine showed gross abnormality at the L3-L4 disk level with erosion of the end plates, fluid in the disk space, marked enhancing edema, and mild surrounding soft-tissue edematous changes, but no evidence of any epidural abscess (FIGURE 2). The patient had a fluoroscopy-guided needle biopsy of the disk on the same day and received intravenous (IV) ceftriaxone 2 g twice a day. Blood and urine cultures were negative.

THE DIAGNOSIS

We suspected our patient had spondylodiscitis, an infection of the spine that includes spondylitis (inflammation of the vertebrae) and discitis (inflammation of the vertebral disk space). After 48 hours, the biopsy sample grew Salmonella typhimurium and confirmed the diagnosis. The organism was sensitive to ceftriaxone and ciprofloxacin; parenteral ceftriaxone was continued and the patient wore a thoracolumbar brace for immobilization. For 3 days, her inflammatory marker levels were checked daily, then every other day for the rest of that first week, and then 2 more times in the following week.

DISCUSSION

Thoracic and lumbar vertebrae are the most common sites of spondylodiscitis.2 Spondylodiscitis accounts for 3% to 5% of pyogenic osteomyelitis in patients in developed countries.3 The incidence of pyogenic spondylodiscitis may be rising due to an increase in the number of elderly and immunocompromised patients, as well as a rise in invasive medical procedures.4-6

If left untreated, spondylodiscitis can spread longitudinally (involving the adjacent levels), posteriorly (causing bacterial meningitis, abscess formation, and cord compromise), or anteriorly (causing paravertebral abscess). Untreated spondylodiscitis can also send distant infective emboli and cause endocarditis7-9 or mycotic abdominal aneurysm.10

Historically, mortality in patients with vertebral osteomyelitis has been as high as 25%.11 The combination of earlier diagnosis, antibiotics, and surgical debridement and stabilization has decreased mortality to less than 15%.12-14

Risk factors for spondylodiscitis include male sex, IV drug abuse, diabetes, morbid obesity, having had a genitourinary or spinal procedure, and being immunocompromised (eg, from alcohol abuse, malignancy, organ transplantation, chemotherapy, or corticosteroid use).12,15,16

Gram-positive organisms cause most spine infections in both adults and children, with 40% to 90% caused by Staphylococcus aureus.17 Gram-negative organisms (Escherichia coli, Pseudomonas, and Proteus), which can also cause spondylodiscitis, typically occur after genitourinary infections or procedures. IV drug abusers are prone to Pseudomonas infections.18 Anaerobic infections may be seen in patients with diabetes or after penetrating trauma.15 Salmonella species can cause spondylodiscitis, especially in patients with sickle cell disease from an intestinal source.19

Mycobacterium tuberculosis is the most common nonpyogenic infecting agent that also can cause spondylodiscitis. Infection caused by tuberculosis (TB) has had a recent resurgence with resistant strains, especially in patients with human immunodeficiency virus.15 Although less than 10% of patients with TB have skeletal involvement, 50% of the skeletal involvement occurs in the spine.15

The clinical presentation of spondylodiscitis depends on the location of the infection, the virulence of the organism, and the immune status of the patient. Discitis can present as pain in the back, hip, abdomen (especially in children20) and, occasionally, with meningeal involvement.11 Patients with discitis often have a normal temperature.15,21 In patients with discitis, the patient’s WCC will be normal, but the ESR is almost always elevated.15,22 Suspect spondylodiscitis in patients who present with persistent or increasing pain 3 to 4 weeks after back surgery. For such patients, measure inflammatory markers and order imaging of the spine.

 

 

Risk factors for spondylodiscitis include IV drug abuse, diabetes, morbid obesity, and having had a genitourinary or spinal procedure. X-ray findings for patients with spondylodiscitis will include osteolysis and end plate erosions (early) and narrowing and collapse of the disk space (late). (In TB, relative preservation of the disk spaces is seen, with significant vertebral destruction.)

MRI is the modality of choice for diagnosis and assessment of suspected spondylodiscitis because it can provide imaging of the soft tissue, neural elements, and bony changes with a high sensitivity and specificity.23 Once infection is suspected, the diagnosis should be confirmed by fluoroscopic- or computed tomography-guided biopsy before starting antibiotic treatment.

Long-term antibiotics
 are required to prevent recurrence


IV antibiotics are the mainstay of treatment for spondylodiscitis;24 the specific drug used will depend upon the organism identified. Patients typically receive 2 to 6 weeks of IV therapy. Then, once the patient improves and inflammatory markers return to normal levels, the patient receives a course of oral antibiotics for 2 to 6 more weeks. Grados et al19 found recurrence rates of 10% to 15% for patients who were treated 4 to 8 weeks compared to 3.9% in those treated for 12 weeks or longer; therefore, a total duration of 12 weeks is commonly chosen.25-28

To minimize the risk of spondylolisthesis, kyphosis, and fractures of the infected bone, patients are advised to rest and the spine is often immobilized with a spinal brace. Surgery may be needed if antibiotics are not effective, or for patients who develop complications such as fluid collection, neurologic deficits, or deformity.

Our patient’s pain improved after 2 weeks and she became more comfortable wearing the thoracolumbar brace. Her CRP and ESR also improved and there was no radiologic evidence of fluid collection. The patient was discharged with a peripherally inserted central catheter in place and received IV ceftriaxone for 6 more weeks at home. This was followed by 4 weeks of oral ciprofloxacin 750 mg twice daily, thereby completing a 12-week course of antibiotics.

Our patient’s response to treatment was monitored clinically and the inflammatory markers were checked weekly after discharge until the end of treatment and at 6 and 12 months after start of treatment. At 12 months, our patient’s CRP was <1 mg/dL and ESR was 22 mm/h. One year later, our patient remained asymptomatic with normal inflammatory marker levels and no evidence of recurrence.

THE TAKEAWAY

Spondylodiscitis is an important differential diagnosis of lower back, flank, groin, and buttock pain. It’s important to be aware of this diagnosis, especially in patients who have risk factors such as IV drug abuse, diabetes, and morbid obesity. Although previous spinal surgery is a risk factor, spondylodiscitis should be considered in patients with persistent back pain even if they haven’t had spinal surgery. It can be present even when there is no tenderness over the spinous process or any fever.

Checking inflammatory markers is a reasonable next step if a patient’s pain does not resolve after at least 4 weeks. If levels of inflammatory markers such as CRP and ESR are elevated and symptoms continue, MRI can confirm or rule out the presence of spondylodiscitis. Treatments include orthotic support, antibiotics, and surgical intervention when complications arise.

References

 

1. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J. 1983;286:266.

2. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Am. 2005;19:765-786.

3. Sobottke R, Seifert H, Fätkenheuer G, et al. Current diagnosis and treatment of spondylodiscitis. Dtsch Arztebl Int. 2008;105:181-187.

4. Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990-95. Scand J Infect Dis. 2001;33:527-532.

5. Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br. 1979;61: 47-55.

6. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 suppl 3:iii11-iii24.

7. Aoki K, Watanabe M, Ohzeki H. Successful surgical treatment of tricuspid valve endocarditis associated with vertebral osteomyelitis. Ann Thorac Cardiovasc Surg. 2010;16:207-209.

8. Gonzalez-Juanatey C, Testa-Fernandez A, Gonzalez-Gay MA. Septic discitis as initial manifestation of streptococcus bovis endocarditis. Int J Cardiol. 2006;108:128-129.

9. Morelli S, Carmenini E, Caporossi AP, et al. Spondylodiscitis and infective endocarditis: case studies and review of the literature. Spine (Phila Pa 1976). 2001;26:499-500.

10. Learch TJ, Sakamoto B, Ling AC, et al. Salmonella spondylodiscitis associated with a mycotic abdominal aortic aneurysm and paravertebral abscess. Emerg Radiol. 2009;16:147-150.

11. Guri JP. Pyogenic osteomyelitis of the spine. J Bone Joint Surg Am. 1946;28:29-39.

12. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997;79:874-880.

13. Garcia A Jr, Grantham SA. Hematogenous pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1960;42-A:429-436.

14. Eismont FJ, Bohlman HH, Soni PL, et al. Pyogenic and fungal vertebral osteomyelitis with paralysis. J Bone Joint Surg Am. 1983;65:19-29.

15. Tay BK, Deckey J, Hu SS. Spinal infections. J Am Acad Orthop Surg. 2002;10:188-197.

16. Krogsgaard MR, Wagn P, Bengtsson J. Epidemiology of acute vertebral osteomyelitis in Denmark: 137 cases in Denmark 1978-1982, compared to cases reported to the National Patient Register 1991-1993. Acta Orthop Scand. 1998;69:513-517.

17. Francis X. Infections of spine. In: Canale ST, Beaty JH, eds. Campbell’s Operative Orthopaedics. 11th ed. New York, NY: Mosby; 2007:2241.

18. Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: a clinical characterization, diagnosis and therapy. Clin Orthop Relat Res. 1979;(144):238-248.

19. Grados F, Lescure FX, Senneville E, et al. Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine. 2007;74:133-139.

20. Cheyne G, Runau F, Lloyd DM. Right upper quadrant pain and raised alkaline phosphatase is not always a hepatobiliary problem. Ann R Coll Surg Engl. 2014;96:118E-120E.

21. Varma R, Lander P, Assaf A. Imaging of pyogenic infectious spondylodiskitis. Radiol Clin North Am. 2001;39: 203-213.

22. Lehovsky J. Pyogenic vertebral osteomyelitis/disc infection. Baillieres Best Pract Res Clin Rheumatol. 1999;13:59-75.

23. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology. 1985;157:157-166.

24. Amritanand R, Venkatesh K, Sundararaj GD. Salmonella spondylodiscitis in the immunocompetent: our experience with eleven patients. Spine (Phila Pa 1976). 2010;35:E1317-E1321.

25. Govender S. Spinal infections. J Bone Joint Surg Br. 2005;87:1454-1458.

26. Lam KS, Webb JK. Discitis. Hosp Med. 2004;65:280-286.

27. Gasbarrini AL, Bertoldi E, Mazzetti M, et al. Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci. 2005;9: 53-66.

28. Cottle L, Riordan T. Infectious spondylodiscitis. J Infect. 2008;56:401-412.

Article PDF
Author and Disclosure Information

 

Behrooz Haddad, MD, MRCS
Mahbub Alam, MBBS, FRCS
Vishal Prasad, MBBS, FRCS
Wasim Khan, MBBS, FRCS
Stewart Tucker, MBBS, FRCS

Spinal Deformity
 Unit, Royal National Orthopaedic Hospital, London, England
 (Drs. Haddad, Alam, Prasad, Khan, and Tucker); Biomechanics Section, Department of Mechanical Engineering, Imperial College London, England (Dr. Alam)
behrooz.haddad@gmail.com

The authors reported no potential conflict of interest relevant to this article.

Issue
The Journal of Family Practice - 63(11)
Publications
Topics
Page Number
640-642,644
Legacy Keywords
spondylodiscitis; back pain; dysuria; scoliosis; Behrooz Haddad, MD, MRCS; Mahbub Alam, MBBS, FRCS; Vishal Prasad, MBBS, FRCS; Wasim Khan, MBBS, FRCS; Stewart Tucker, MBBS, FRCS
Sections
Author and Disclosure Information

 

Behrooz Haddad, MD, MRCS
Mahbub Alam, MBBS, FRCS
Vishal Prasad, MBBS, FRCS
Wasim Khan, MBBS, FRCS
Stewart Tucker, MBBS, FRCS

Spinal Deformity
 Unit, Royal National Orthopaedic Hospital, London, England
 (Drs. Haddad, Alam, Prasad, Khan, and Tucker); Biomechanics Section, Department of Mechanical Engineering, Imperial College London, England (Dr. Alam)
behrooz.haddad@gmail.com

The authors reported no potential conflict of interest relevant to this article.

Author and Disclosure Information

 

Behrooz Haddad, MD, MRCS
Mahbub Alam, MBBS, FRCS
Vishal Prasad, MBBS, FRCS
Wasim Khan, MBBS, FRCS
Stewart Tucker, MBBS, FRCS

Spinal Deformity
 Unit, Royal National Orthopaedic Hospital, London, England
 (Drs. Haddad, Alam, Prasad, Khan, and Tucker); Biomechanics Section, Department of Mechanical Engineering, Imperial College London, England (Dr. Alam)
behrooz.haddad@gmail.com

The authors reported no potential conflict of interest relevant to this article.

Article PDF
Article PDF
Related Articles

THE CASE

A 23-year-old immunocompetent woman was referred to our spinal clinic with a 6-month history of low back pain that radiated to her right flank, buttock, and groin. She’d had intermittent urinary problems, including mild dysuria and frequency, and had been treated with antibiotics for a presumed urinary tract infection on 3 previous occasions, but her pain gradually increased and eventually became constant.

The patient had no history of fever, malaise, or weight loss. She denied consuming unpasteurized milk or undercooked poultry, and hadn’t recently experienced diarrhea or vomiting.

Eight years earlier, she had undergone anterior fusion of her spine for idiopathic scoliosis. At that time, she was at Risser grade 1, and her Cobb angle was 50°; metallic instrumentation was implanted at T10 to L3 to prevent progression of the scoliosis. Her recovery had been uneventful.

During examination, her temperature, pulse, respiratory rate, blood pressure, and nervous system were all normal. Her hips appeared normal, as well, and a straight leg raise was negative bilaterally. The patient had mild midline lumbar tenderness. Spinal range of movement revealed decreased flexion and mild pain.

X-rays (FIGURE 1) showed no changes in the previous metalwork in her spine. There was decreased disk height at the L3/4 level, but no significant bony erosion or soft-tissue shadows. Laboratory testing revealed a C-reactive protein (CRP) level of 240 mg/dL (normal, <1 mg/dL) and her erythrocyte sedimentation rate (ESR) was 102 mm/h—more than 5 times higher than it should have been.1 The patient had a normal peripheral white cell count (WCC). Midstream urine cultures were negative.


   

The patient was admitted to the hospital for further work-up. Magnetic resonance imaging (MRI) of the lumbar spine showed gross abnormality at the L3-L4 disk level with erosion of the end plates, fluid in the disk space, marked enhancing edema, and mild surrounding soft-tissue edematous changes, but no evidence of any epidural abscess (FIGURE 2). The patient had a fluoroscopy-guided needle biopsy of the disk on the same day and received intravenous (IV) ceftriaxone 2 g twice a day. Blood and urine cultures were negative.

THE DIAGNOSIS

We suspected our patient had spondylodiscitis, an infection of the spine that includes spondylitis (inflammation of the vertebrae) and discitis (inflammation of the vertebral disk space). After 48 hours, the biopsy sample grew Salmonella typhimurium and confirmed the diagnosis. The organism was sensitive to ceftriaxone and ciprofloxacin; parenteral ceftriaxone was continued and the patient wore a thoracolumbar brace for immobilization. For 3 days, her inflammatory marker levels were checked daily, then every other day for the rest of that first week, and then 2 more times in the following week.

DISCUSSION

Thoracic and lumbar vertebrae are the most common sites of spondylodiscitis.2 Spondylodiscitis accounts for 3% to 5% of pyogenic osteomyelitis in patients in developed countries.3 The incidence of pyogenic spondylodiscitis may be rising due to an increase in the number of elderly and immunocompromised patients, as well as a rise in invasive medical procedures.4-6

If left untreated, spondylodiscitis can spread longitudinally (involving the adjacent levels), posteriorly (causing bacterial meningitis, abscess formation, and cord compromise), or anteriorly (causing paravertebral abscess). Untreated spondylodiscitis can also send distant infective emboli and cause endocarditis7-9 or mycotic abdominal aneurysm.10

Historically, mortality in patients with vertebral osteomyelitis has been as high as 25%.11 The combination of earlier diagnosis, antibiotics, and surgical debridement and stabilization has decreased mortality to less than 15%.12-14

Risk factors for spondylodiscitis include male sex, IV drug abuse, diabetes, morbid obesity, having had a genitourinary or spinal procedure, and being immunocompromised (eg, from alcohol abuse, malignancy, organ transplantation, chemotherapy, or corticosteroid use).12,15,16

Gram-positive organisms cause most spine infections in both adults and children, with 40% to 90% caused by Staphylococcus aureus.17 Gram-negative organisms (Escherichia coli, Pseudomonas, and Proteus), which can also cause spondylodiscitis, typically occur after genitourinary infections or procedures. IV drug abusers are prone to Pseudomonas infections.18 Anaerobic infections may be seen in patients with diabetes or after penetrating trauma.15 Salmonella species can cause spondylodiscitis, especially in patients with sickle cell disease from an intestinal source.19

Mycobacterium tuberculosis is the most common nonpyogenic infecting agent that also can cause spondylodiscitis. Infection caused by tuberculosis (TB) has had a recent resurgence with resistant strains, especially in patients with human immunodeficiency virus.15 Although less than 10% of patients with TB have skeletal involvement, 50% of the skeletal involvement occurs in the spine.15

The clinical presentation of spondylodiscitis depends on the location of the infection, the virulence of the organism, and the immune status of the patient. Discitis can present as pain in the back, hip, abdomen (especially in children20) and, occasionally, with meningeal involvement.11 Patients with discitis often have a normal temperature.15,21 In patients with discitis, the patient’s WCC will be normal, but the ESR is almost always elevated.15,22 Suspect spondylodiscitis in patients who present with persistent or increasing pain 3 to 4 weeks after back surgery. For such patients, measure inflammatory markers and order imaging of the spine.

 

 

Risk factors for spondylodiscitis include IV drug abuse, diabetes, morbid obesity, and having had a genitourinary or spinal procedure. X-ray findings for patients with spondylodiscitis will include osteolysis and end plate erosions (early) and narrowing and collapse of the disk space (late). (In TB, relative preservation of the disk spaces is seen, with significant vertebral destruction.)

MRI is the modality of choice for diagnosis and assessment of suspected spondylodiscitis because it can provide imaging of the soft tissue, neural elements, and bony changes with a high sensitivity and specificity.23 Once infection is suspected, the diagnosis should be confirmed by fluoroscopic- or computed tomography-guided biopsy before starting antibiotic treatment.

Long-term antibiotics
 are required to prevent recurrence


IV antibiotics are the mainstay of treatment for spondylodiscitis;24 the specific drug used will depend upon the organism identified. Patients typically receive 2 to 6 weeks of IV therapy. Then, once the patient improves and inflammatory markers return to normal levels, the patient receives a course of oral antibiotics for 2 to 6 more weeks. Grados et al19 found recurrence rates of 10% to 15% for patients who were treated 4 to 8 weeks compared to 3.9% in those treated for 12 weeks or longer; therefore, a total duration of 12 weeks is commonly chosen.25-28

To minimize the risk of spondylolisthesis, kyphosis, and fractures of the infected bone, patients are advised to rest and the spine is often immobilized with a spinal brace. Surgery may be needed if antibiotics are not effective, or for patients who develop complications such as fluid collection, neurologic deficits, or deformity.

Our patient’s pain improved after 2 weeks and she became more comfortable wearing the thoracolumbar brace. Her CRP and ESR also improved and there was no radiologic evidence of fluid collection. The patient was discharged with a peripherally inserted central catheter in place and received IV ceftriaxone for 6 more weeks at home. This was followed by 4 weeks of oral ciprofloxacin 750 mg twice daily, thereby completing a 12-week course of antibiotics.

Our patient’s response to treatment was monitored clinically and the inflammatory markers were checked weekly after discharge until the end of treatment and at 6 and 12 months after start of treatment. At 12 months, our patient’s CRP was <1 mg/dL and ESR was 22 mm/h. One year later, our patient remained asymptomatic with normal inflammatory marker levels and no evidence of recurrence.

THE TAKEAWAY

Spondylodiscitis is an important differential diagnosis of lower back, flank, groin, and buttock pain. It’s important to be aware of this diagnosis, especially in patients who have risk factors such as IV drug abuse, diabetes, and morbid obesity. Although previous spinal surgery is a risk factor, spondylodiscitis should be considered in patients with persistent back pain even if they haven’t had spinal surgery. It can be present even when there is no tenderness over the spinous process or any fever.

Checking inflammatory markers is a reasonable next step if a patient’s pain does not resolve after at least 4 weeks. If levels of inflammatory markers such as CRP and ESR are elevated and symptoms continue, MRI can confirm or rule out the presence of spondylodiscitis. Treatments include orthotic support, antibiotics, and surgical intervention when complications arise.

THE CASE

A 23-year-old immunocompetent woman was referred to our spinal clinic with a 6-month history of low back pain that radiated to her right flank, buttock, and groin. She’d had intermittent urinary problems, including mild dysuria and frequency, and had been treated with antibiotics for a presumed urinary tract infection on 3 previous occasions, but her pain gradually increased and eventually became constant.

The patient had no history of fever, malaise, or weight loss. She denied consuming unpasteurized milk or undercooked poultry, and hadn’t recently experienced diarrhea or vomiting.

Eight years earlier, she had undergone anterior fusion of her spine for idiopathic scoliosis. At that time, she was at Risser grade 1, and her Cobb angle was 50°; metallic instrumentation was implanted at T10 to L3 to prevent progression of the scoliosis. Her recovery had been uneventful.

During examination, her temperature, pulse, respiratory rate, blood pressure, and nervous system were all normal. Her hips appeared normal, as well, and a straight leg raise was negative bilaterally. The patient had mild midline lumbar tenderness. Spinal range of movement revealed decreased flexion and mild pain.

X-rays (FIGURE 1) showed no changes in the previous metalwork in her spine. There was decreased disk height at the L3/4 level, but no significant bony erosion or soft-tissue shadows. Laboratory testing revealed a C-reactive protein (CRP) level of 240 mg/dL (normal, <1 mg/dL) and her erythrocyte sedimentation rate (ESR) was 102 mm/h—more than 5 times higher than it should have been.1 The patient had a normal peripheral white cell count (WCC). Midstream urine cultures were negative.


   

The patient was admitted to the hospital for further work-up. Magnetic resonance imaging (MRI) of the lumbar spine showed gross abnormality at the L3-L4 disk level with erosion of the end plates, fluid in the disk space, marked enhancing edema, and mild surrounding soft-tissue edematous changes, but no evidence of any epidural abscess (FIGURE 2). The patient had a fluoroscopy-guided needle biopsy of the disk on the same day and received intravenous (IV) ceftriaxone 2 g twice a day. Blood and urine cultures were negative.

THE DIAGNOSIS

We suspected our patient had spondylodiscitis, an infection of the spine that includes spondylitis (inflammation of the vertebrae) and discitis (inflammation of the vertebral disk space). After 48 hours, the biopsy sample grew Salmonella typhimurium and confirmed the diagnosis. The organism was sensitive to ceftriaxone and ciprofloxacin; parenteral ceftriaxone was continued and the patient wore a thoracolumbar brace for immobilization. For 3 days, her inflammatory marker levels were checked daily, then every other day for the rest of that first week, and then 2 more times in the following week.

DISCUSSION

Thoracic and lumbar vertebrae are the most common sites of spondylodiscitis.2 Spondylodiscitis accounts for 3% to 5% of pyogenic osteomyelitis in patients in developed countries.3 The incidence of pyogenic spondylodiscitis may be rising due to an increase in the number of elderly and immunocompromised patients, as well as a rise in invasive medical procedures.4-6

If left untreated, spondylodiscitis can spread longitudinally (involving the adjacent levels), posteriorly (causing bacterial meningitis, abscess formation, and cord compromise), or anteriorly (causing paravertebral abscess). Untreated spondylodiscitis can also send distant infective emboli and cause endocarditis7-9 or mycotic abdominal aneurysm.10

Historically, mortality in patients with vertebral osteomyelitis has been as high as 25%.11 The combination of earlier diagnosis, antibiotics, and surgical debridement and stabilization has decreased mortality to less than 15%.12-14

Risk factors for spondylodiscitis include male sex, IV drug abuse, diabetes, morbid obesity, having had a genitourinary or spinal procedure, and being immunocompromised (eg, from alcohol abuse, malignancy, organ transplantation, chemotherapy, or corticosteroid use).12,15,16

Gram-positive organisms cause most spine infections in both adults and children, with 40% to 90% caused by Staphylococcus aureus.17 Gram-negative organisms (Escherichia coli, Pseudomonas, and Proteus), which can also cause spondylodiscitis, typically occur after genitourinary infections or procedures. IV drug abusers are prone to Pseudomonas infections.18 Anaerobic infections may be seen in patients with diabetes or after penetrating trauma.15 Salmonella species can cause spondylodiscitis, especially in patients with sickle cell disease from an intestinal source.19

Mycobacterium tuberculosis is the most common nonpyogenic infecting agent that also can cause spondylodiscitis. Infection caused by tuberculosis (TB) has had a recent resurgence with resistant strains, especially in patients with human immunodeficiency virus.15 Although less than 10% of patients with TB have skeletal involvement, 50% of the skeletal involvement occurs in the spine.15

The clinical presentation of spondylodiscitis depends on the location of the infection, the virulence of the organism, and the immune status of the patient. Discitis can present as pain in the back, hip, abdomen (especially in children20) and, occasionally, with meningeal involvement.11 Patients with discitis often have a normal temperature.15,21 In patients with discitis, the patient’s WCC will be normal, but the ESR is almost always elevated.15,22 Suspect spondylodiscitis in patients who present with persistent or increasing pain 3 to 4 weeks after back surgery. For such patients, measure inflammatory markers and order imaging of the spine.

 

 

Risk factors for spondylodiscitis include IV drug abuse, diabetes, morbid obesity, and having had a genitourinary or spinal procedure. X-ray findings for patients with spondylodiscitis will include osteolysis and end plate erosions (early) and narrowing and collapse of the disk space (late). (In TB, relative preservation of the disk spaces is seen, with significant vertebral destruction.)

MRI is the modality of choice for diagnosis and assessment of suspected spondylodiscitis because it can provide imaging of the soft tissue, neural elements, and bony changes with a high sensitivity and specificity.23 Once infection is suspected, the diagnosis should be confirmed by fluoroscopic- or computed tomography-guided biopsy before starting antibiotic treatment.

Long-term antibiotics
 are required to prevent recurrence


IV antibiotics are the mainstay of treatment for spondylodiscitis;24 the specific drug used will depend upon the organism identified. Patients typically receive 2 to 6 weeks of IV therapy. Then, once the patient improves and inflammatory markers return to normal levels, the patient receives a course of oral antibiotics for 2 to 6 more weeks. Grados et al19 found recurrence rates of 10% to 15% for patients who were treated 4 to 8 weeks compared to 3.9% in those treated for 12 weeks or longer; therefore, a total duration of 12 weeks is commonly chosen.25-28

To minimize the risk of spondylolisthesis, kyphosis, and fractures of the infected bone, patients are advised to rest and the spine is often immobilized with a spinal brace. Surgery may be needed if antibiotics are not effective, or for patients who develop complications such as fluid collection, neurologic deficits, or deformity.

Our patient’s pain improved after 2 weeks and she became more comfortable wearing the thoracolumbar brace. Her CRP and ESR also improved and there was no radiologic evidence of fluid collection. The patient was discharged with a peripherally inserted central catheter in place and received IV ceftriaxone for 6 more weeks at home. This was followed by 4 weeks of oral ciprofloxacin 750 mg twice daily, thereby completing a 12-week course of antibiotics.

Our patient’s response to treatment was monitored clinically and the inflammatory markers were checked weekly after discharge until the end of treatment and at 6 and 12 months after start of treatment. At 12 months, our patient’s CRP was <1 mg/dL and ESR was 22 mm/h. One year later, our patient remained asymptomatic with normal inflammatory marker levels and no evidence of recurrence.

THE TAKEAWAY

Spondylodiscitis is an important differential diagnosis of lower back, flank, groin, and buttock pain. It’s important to be aware of this diagnosis, especially in patients who have risk factors such as IV drug abuse, diabetes, and morbid obesity. Although previous spinal surgery is a risk factor, spondylodiscitis should be considered in patients with persistent back pain even if they haven’t had spinal surgery. It can be present even when there is no tenderness over the spinous process or any fever.

Checking inflammatory markers is a reasonable next step if a patient’s pain does not resolve after at least 4 weeks. If levels of inflammatory markers such as CRP and ESR are elevated and symptoms continue, MRI can confirm or rule out the presence of spondylodiscitis. Treatments include orthotic support, antibiotics, and surgical intervention when complications arise.

References

 

1. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J. 1983;286:266.

2. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Am. 2005;19:765-786.

3. Sobottke R, Seifert H, Fätkenheuer G, et al. Current diagnosis and treatment of spondylodiscitis. Dtsch Arztebl Int. 2008;105:181-187.

4. Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990-95. Scand J Infect Dis. 2001;33:527-532.

5. Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br. 1979;61: 47-55.

6. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 suppl 3:iii11-iii24.

7. Aoki K, Watanabe M, Ohzeki H. Successful surgical treatment of tricuspid valve endocarditis associated with vertebral osteomyelitis. Ann Thorac Cardiovasc Surg. 2010;16:207-209.

8. Gonzalez-Juanatey C, Testa-Fernandez A, Gonzalez-Gay MA. Septic discitis as initial manifestation of streptococcus bovis endocarditis. Int J Cardiol. 2006;108:128-129.

9. Morelli S, Carmenini E, Caporossi AP, et al. Spondylodiscitis and infective endocarditis: case studies and review of the literature. Spine (Phila Pa 1976). 2001;26:499-500.

10. Learch TJ, Sakamoto B, Ling AC, et al. Salmonella spondylodiscitis associated with a mycotic abdominal aortic aneurysm and paravertebral abscess. Emerg Radiol. 2009;16:147-150.

11. Guri JP. Pyogenic osteomyelitis of the spine. J Bone Joint Surg Am. 1946;28:29-39.

12. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997;79:874-880.

13. Garcia A Jr, Grantham SA. Hematogenous pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1960;42-A:429-436.

14. Eismont FJ, Bohlman HH, Soni PL, et al. Pyogenic and fungal vertebral osteomyelitis with paralysis. J Bone Joint Surg Am. 1983;65:19-29.

15. Tay BK, Deckey J, Hu SS. Spinal infections. J Am Acad Orthop Surg. 2002;10:188-197.

16. Krogsgaard MR, Wagn P, Bengtsson J. Epidemiology of acute vertebral osteomyelitis in Denmark: 137 cases in Denmark 1978-1982, compared to cases reported to the National Patient Register 1991-1993. Acta Orthop Scand. 1998;69:513-517.

17. Francis X. Infections of spine. In: Canale ST, Beaty JH, eds. Campbell’s Operative Orthopaedics. 11th ed. New York, NY: Mosby; 2007:2241.

18. Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: a clinical characterization, diagnosis and therapy. Clin Orthop Relat Res. 1979;(144):238-248.

19. Grados F, Lescure FX, Senneville E, et al. Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine. 2007;74:133-139.

20. Cheyne G, Runau F, Lloyd DM. Right upper quadrant pain and raised alkaline phosphatase is not always a hepatobiliary problem. Ann R Coll Surg Engl. 2014;96:118E-120E.

21. Varma R, Lander P, Assaf A. Imaging of pyogenic infectious spondylodiskitis. Radiol Clin North Am. 2001;39: 203-213.

22. Lehovsky J. Pyogenic vertebral osteomyelitis/disc infection. Baillieres Best Pract Res Clin Rheumatol. 1999;13:59-75.

23. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology. 1985;157:157-166.

24. Amritanand R, Venkatesh K, Sundararaj GD. Salmonella spondylodiscitis in the immunocompetent: our experience with eleven patients. Spine (Phila Pa 1976). 2010;35:E1317-E1321.

25. Govender S. Spinal infections. J Bone Joint Surg Br. 2005;87:1454-1458.

26. Lam KS, Webb JK. Discitis. Hosp Med. 2004;65:280-286.

27. Gasbarrini AL, Bertoldi E, Mazzetti M, et al. Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci. 2005;9: 53-66.

28. Cottle L, Riordan T. Infectious spondylodiscitis. J Infect. 2008;56:401-412.

References

 

1. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J. 1983;286:266.

2. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Am. 2005;19:765-786.

3. Sobottke R, Seifert H, Fätkenheuer G, et al. Current diagnosis and treatment of spondylodiscitis. Dtsch Arztebl Int. 2008;105:181-187.

4. Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990-95. Scand J Infect Dis. 2001;33:527-532.

5. Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br. 1979;61: 47-55.

6. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 suppl 3:iii11-iii24.

7. Aoki K, Watanabe M, Ohzeki H. Successful surgical treatment of tricuspid valve endocarditis associated with vertebral osteomyelitis. Ann Thorac Cardiovasc Surg. 2010;16:207-209.

8. Gonzalez-Juanatey C, Testa-Fernandez A, Gonzalez-Gay MA. Septic discitis as initial manifestation of streptococcus bovis endocarditis. Int J Cardiol. 2006;108:128-129.

9. Morelli S, Carmenini E, Caporossi AP, et al. Spondylodiscitis and infective endocarditis: case studies and review of the literature. Spine (Phila Pa 1976). 2001;26:499-500.

10. Learch TJ, Sakamoto B, Ling AC, et al. Salmonella spondylodiscitis associated with a mycotic abdominal aortic aneurysm and paravertebral abscess. Emerg Radiol. 2009;16:147-150.

11. Guri JP. Pyogenic osteomyelitis of the spine. J Bone Joint Surg Am. 1946;28:29-39.

12. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997;79:874-880.

13. Garcia A Jr, Grantham SA. Hematogenous pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1960;42-A:429-436.

14. Eismont FJ, Bohlman HH, Soni PL, et al. Pyogenic and fungal vertebral osteomyelitis with paralysis. J Bone Joint Surg Am. 1983;65:19-29.

15. Tay BK, Deckey J, Hu SS. Spinal infections. J Am Acad Orthop Surg. 2002;10:188-197.

16. Krogsgaard MR, Wagn P, Bengtsson J. Epidemiology of acute vertebral osteomyelitis in Denmark: 137 cases in Denmark 1978-1982, compared to cases reported to the National Patient Register 1991-1993. Acta Orthop Scand. 1998;69:513-517.

17. Francis X. Infections of spine. In: Canale ST, Beaty JH, eds. Campbell’s Operative Orthopaedics. 11th ed. New York, NY: Mosby; 2007:2241.

18. Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: a clinical characterization, diagnosis and therapy. Clin Orthop Relat Res. 1979;(144):238-248.

19. Grados F, Lescure FX, Senneville E, et al. Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine. 2007;74:133-139.

20. Cheyne G, Runau F, Lloyd DM. Right upper quadrant pain and raised alkaline phosphatase is not always a hepatobiliary problem. Ann R Coll Surg Engl. 2014;96:118E-120E.

21. Varma R, Lander P, Assaf A. Imaging of pyogenic infectious spondylodiskitis. Radiol Clin North Am. 2001;39: 203-213.

22. Lehovsky J. Pyogenic vertebral osteomyelitis/disc infection. Baillieres Best Pract Res Clin Rheumatol. 1999;13:59-75.

23. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology. 1985;157:157-166.

24. Amritanand R, Venkatesh K, Sundararaj GD. Salmonella spondylodiscitis in the immunocompetent: our experience with eleven patients. Spine (Phila Pa 1976). 2010;35:E1317-E1321.

25. Govender S. Spinal infections. J Bone Joint Surg Br. 2005;87:1454-1458.

26. Lam KS, Webb JK. Discitis. Hosp Med. 2004;65:280-286.

27. Gasbarrini AL, Bertoldi E, Mazzetti M, et al. Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci. 2005;9: 53-66.

28. Cottle L, Riordan T. Infectious spondylodiscitis. J Infect. 2008;56:401-412.

Issue
The Journal of Family Practice - 63(11)
Issue
The Journal of Family Practice - 63(11)
Page Number
640-642,644
Page Number
640-642,644
Publications
Publications
Topics
Article Type
Display Headline
Radiating low back pain • history of urinary symptoms • past surgery for scoliosis • Dx?
Display Headline
Radiating low back pain • history of urinary symptoms • past surgery for scoliosis • Dx?
Legacy Keywords
spondylodiscitis; back pain; dysuria; scoliosis; Behrooz Haddad, MD, MRCS; Mahbub Alam, MBBS, FRCS; Vishal Prasad, MBBS, FRCS; Wasim Khan, MBBS, FRCS; Stewart Tucker, MBBS, FRCS
Legacy Keywords
spondylodiscitis; back pain; dysuria; scoliosis; Behrooz Haddad, MD, MRCS; Mahbub Alam, MBBS, FRCS; Vishal Prasad, MBBS, FRCS; Wasim Khan, MBBS, FRCS; Stewart Tucker, MBBS, FRCS
Sections
Disallow All Ads
Alternative CME
Article PDF Media

Neonatal Physeal Separation of Distal Humerus During Cesarean Section

Article Type
Changed
Display Headline
Neonatal Physeal Separation of Distal Humerus During Cesarean Section

Physeal separation of the distal humerus in a newborn is a rare and severe injury that requires immediate treatment. This fracture was reported as an extremely rare complication of cesarean section.1 The correct diagnosis can be established by clinical and radiologic findings. However, this injury can be easily overlooked and misdiagnosed. Presentation often involves swelling, tenderness, and agitation with movement of the elbow.

We report a case in which neonatal physeal separation of the distal humerus occurred during cesarean section. The diagnosis was based on clinical and radiologic/arthrographic findings and treated with closed reduction and percutaneous fixation. The patient’s guardian provided written informed consent for print and electronic publication of this case report.

Case Report

A full-term (40-week gestation) male neonate weighing 3690 g was born through cesarean section at the mother’s request. Apgar score was 9 at 1 minute and 10 at 5 minutes. The vertex position of the fetus was confirmed with preoperative ultrasonography. This was the mother’s first pregnancy and an in vitro fertilization. On his second day of life, the patient was referred to the orthopedic department for evaluation of local swelling and diminished spontaneous motion of the right elbow.

Examination revealed local tenderness and swelling in the anterior and lateral aspects of the elbow. Passive elbow range of motion (ROM) caused agitation, and elbow instability was present. A complete neurovascular examination was performed, and neurovascular injury and compartment syndrome were ruled out. Hematologic workup showed no signs of septic arthritis. Radiographs showed posteromedial displacement of the humeroulnar joint. The patient was placed in a long-arm splint, and no reduction was attempted initially.

The patient was taken to the operating room the same day. With the patient under general anesthesia, an arthrogram of the right elbow was obtained. It showed posteromedial displacement of the distal humeral epiphysis (Figure 1A). Closed reduction was performed, and the quality of the reduction was confirmed by intraoperative imaging. Percutaneously, a single 2-mm Kirschner wire (K-wire) was placed in an oblique fashion from the inferolateral aspect of the distal fragment to the contralateral metaphysis of the humerus (Figure 1B). The patient was put in a long-arm splint with the elbow flexed at 90° and the forearm in midpronation.

Follow-up visits were scheduled for 1 week, 3 weeks, and 5 weeks after surgery. Three weeks after surgery, callus formation was confirmed, and the K-wire was removed. Five weeks after surgery, the long-arm splint was removed.

At 6-month follow-up, the patient was pain-free and had full elbow ROM, and radiographs (Figures 2A, 2B) confirmed anatomical restoration of the fracture.

Discussion

Madsen2 reported the incidence of birth-related long-bone fractures, including fractures of the humerus, the femur, and the tibia (< 0.1%). According to that review, only 1 of 105,119 patients sustained traumatic physeal separation of the distal humerus.

Different mechanisms have been described for this rare fracture. As the physeal region is the weakest part of the distal humerus, it is prone to injury by rotational shear forces,3,4 hyperextension of the elbow, or a backward thrust on the forearm with the elbow flexed.5 Excessive traction applied during cesarean delivery might cause physeal separation, which was the possible cause in the present case. Most patients have a complicated birth history.

This injury should be suspected in an irritable newborn with swelling, tenderness, and reduced mobility of the upper extremity. Osteomyelitis and septic arthritis should be considered in the differential diagnosis. Brachial plexus injury and dislocation of the elbow joint should also be kept in mind. Child abuse and metabolic bone diseases (eg, osteogenesis imperfecta) should also be considered.

Anteroposterior and lateral plain radiographs of the elbow usually establish the diagnosis. Alteration of humeroulnar alignment and displacement of the proximal forearm are the key points leading to the diagnosis.

The cartilaginous part of the distal humerus and humeroulnar alignment can be demonstrated by ultrasonography.6 Magnetic resonance imaging (MRI) can be helpful in diagnosis but is seldom required,7 and the sedation or general anesthesia used is a disadvantage. Arthrography is useful not only in diagnosis but in determining the quality of the reduction.8 An arthrogram may show that open reduction is unnecessary.

Treatment differs widely. In neonates, who have a tremendous healing capability, this fracture almost always heals uneventfully. An effective treatment method is closed reduction and cast immobilization. However, valgus malalignment and limited elbow ROM were noted in 5% of the patients treated with this method.4

Jacobsen and colleagues4 reported on 6 neonates who sustained traumatic separation of the distal epiphysis of the humerus at birth and who were treated with casting with or without closed reduction. The authors described good results. One patient had varus malalignment, which was attributed to fragment internal rotation caused by rotational instability.

 

 

As our patient’s instability was noted during surgery, we performed percutaneous pinning after arthrography-assisted closed reduction. We considered using 2 lateral pins for fixation, but, after the first pin was placed, fluoroscopic stress testing with the patient under anesthesia demonstrated adequate stability. A second, smaller pin could have been used to control rotation, if needed. Medial pin placement that avoids the ulnar nerve is difficult in the newborn elbow; medial pins should probably be avoided in the newborn, if possible.

Early diagnosis and treatment are essential. Late diagnosis was reported to lead to complications such as varus deformity and restriction of joint ROM.4

Our patient healed without any complications and achieved full ROM. Long-term follow-up is needed to diagnose any physeal bar that might lead to secondary deformities.

Conclusion

Cesarean section is reported to reduce birth complications, but it might cause fractures of the femur and humerus.1 Avoiding application of excessive traction to the forearm can prevent physeal separation of the distal humerus. This entity should be kept in mind as a potential complication of cesarean section. Arthrography is helpful in treatment and may help avoid unnecessary open reduction.

References

1. Sabat D, Maini L, Gautam VK. Neonatal separation of distal humeral epiphysis during caesarean section: a case report. J Orthop Surg (Hong Kong). 2011;19(3):376-378.

2. Madsen ET. Fractures of the extremities in the newborn. Acta Obstet Gynecol Scand. 1955;34(1):41-74.

3. Peterson HA. Physeal fractures. In: Morrey BF, ed. The Elbow and Its Disorders. Philadelphia, PA: Saunders; 1985:222-236.

4. Jacobsen S, Hansson G, Nathorst-Westfelt J. Traumatic separation of the distal epiphysis of the humerus sustained at birth. J Bone Joint Surg Br. 2009;91(6):797-802.

5. Siffert RS. Displacement of distal humeral epiphysis in the newborn. J Bone Joint Surg Am. 1963;45(1):165-169.

6. Davidson RS, Markowitz RI, Dormans J, Drummond DS. Ultrasonographic evaluation of the elbow in infants and young children after suspected trauma. J Bone Joint Surg Am. 1994;76(12):1804-1813.

7. Sawant MR, Narayanan S, O‘Neill K, Hudson I. Distal humeral epiphysis fracture separation in neonates—diagnosis using MRI scan. Injury. 2002;33(2):179-181.

8. Akbarnia BA, Silberstein MJ, Rende RJ, Graviss ER, Luisiri A. Arthrography in the diagnosis of fractures of the distal end of the humerus in infants. J Bone Joint Surg Am. 1986;68(4):599-602.

Article PDF
Author and Disclosure Information

Saygin Kamaci, MD, Murat Danisman, MD, and Salih Marangoz, MD           

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Issue
The American Journal of Orthopedics - 43(11)
Publications
Topics
Page Number
E279-E281
Legacy Keywords
american journal of orthopedics, AJO, online exclusive, case report and literature review, case report, physeal separation, distal humerus, cesarean section, newborn, baby, pregnancy, pregnant, birth, fracture, injury, MRI, magnetic resonance imaging, radiographs, kamaci, danisman, marangoz
Sections
Author and Disclosure Information

Saygin Kamaci, MD, Murat Danisman, MD, and Salih Marangoz, MD           

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Author and Disclosure Information

Saygin Kamaci, MD, Murat Danisman, MD, and Salih Marangoz, MD           

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Article PDF
Article PDF

Physeal separation of the distal humerus in a newborn is a rare and severe injury that requires immediate treatment. This fracture was reported as an extremely rare complication of cesarean section.1 The correct diagnosis can be established by clinical and radiologic findings. However, this injury can be easily overlooked and misdiagnosed. Presentation often involves swelling, tenderness, and agitation with movement of the elbow.

We report a case in which neonatal physeal separation of the distal humerus occurred during cesarean section. The diagnosis was based on clinical and radiologic/arthrographic findings and treated with closed reduction and percutaneous fixation. The patient’s guardian provided written informed consent for print and electronic publication of this case report.

Case Report

A full-term (40-week gestation) male neonate weighing 3690 g was born through cesarean section at the mother’s request. Apgar score was 9 at 1 minute and 10 at 5 minutes. The vertex position of the fetus was confirmed with preoperative ultrasonography. This was the mother’s first pregnancy and an in vitro fertilization. On his second day of life, the patient was referred to the orthopedic department for evaluation of local swelling and diminished spontaneous motion of the right elbow.

Examination revealed local tenderness and swelling in the anterior and lateral aspects of the elbow. Passive elbow range of motion (ROM) caused agitation, and elbow instability was present. A complete neurovascular examination was performed, and neurovascular injury and compartment syndrome were ruled out. Hematologic workup showed no signs of septic arthritis. Radiographs showed posteromedial displacement of the humeroulnar joint. The patient was placed in a long-arm splint, and no reduction was attempted initially.

The patient was taken to the operating room the same day. With the patient under general anesthesia, an arthrogram of the right elbow was obtained. It showed posteromedial displacement of the distal humeral epiphysis (Figure 1A). Closed reduction was performed, and the quality of the reduction was confirmed by intraoperative imaging. Percutaneously, a single 2-mm Kirschner wire (K-wire) was placed in an oblique fashion from the inferolateral aspect of the distal fragment to the contralateral metaphysis of the humerus (Figure 1B). The patient was put in a long-arm splint with the elbow flexed at 90° and the forearm in midpronation.

Follow-up visits were scheduled for 1 week, 3 weeks, and 5 weeks after surgery. Three weeks after surgery, callus formation was confirmed, and the K-wire was removed. Five weeks after surgery, the long-arm splint was removed.

At 6-month follow-up, the patient was pain-free and had full elbow ROM, and radiographs (Figures 2A, 2B) confirmed anatomical restoration of the fracture.

Discussion

Madsen2 reported the incidence of birth-related long-bone fractures, including fractures of the humerus, the femur, and the tibia (< 0.1%). According to that review, only 1 of 105,119 patients sustained traumatic physeal separation of the distal humerus.

Different mechanisms have been described for this rare fracture. As the physeal region is the weakest part of the distal humerus, it is prone to injury by rotational shear forces,3,4 hyperextension of the elbow, or a backward thrust on the forearm with the elbow flexed.5 Excessive traction applied during cesarean delivery might cause physeal separation, which was the possible cause in the present case. Most patients have a complicated birth history.

This injury should be suspected in an irritable newborn with swelling, tenderness, and reduced mobility of the upper extremity. Osteomyelitis and septic arthritis should be considered in the differential diagnosis. Brachial plexus injury and dislocation of the elbow joint should also be kept in mind. Child abuse and metabolic bone diseases (eg, osteogenesis imperfecta) should also be considered.

Anteroposterior and lateral plain radiographs of the elbow usually establish the diagnosis. Alteration of humeroulnar alignment and displacement of the proximal forearm are the key points leading to the diagnosis.

The cartilaginous part of the distal humerus and humeroulnar alignment can be demonstrated by ultrasonography.6 Magnetic resonance imaging (MRI) can be helpful in diagnosis but is seldom required,7 and the sedation or general anesthesia used is a disadvantage. Arthrography is useful not only in diagnosis but in determining the quality of the reduction.8 An arthrogram may show that open reduction is unnecessary.

Treatment differs widely. In neonates, who have a tremendous healing capability, this fracture almost always heals uneventfully. An effective treatment method is closed reduction and cast immobilization. However, valgus malalignment and limited elbow ROM were noted in 5% of the patients treated with this method.4

Jacobsen and colleagues4 reported on 6 neonates who sustained traumatic separation of the distal epiphysis of the humerus at birth and who were treated with casting with or without closed reduction. The authors described good results. One patient had varus malalignment, which was attributed to fragment internal rotation caused by rotational instability.

 

 

As our patient’s instability was noted during surgery, we performed percutaneous pinning after arthrography-assisted closed reduction. We considered using 2 lateral pins for fixation, but, after the first pin was placed, fluoroscopic stress testing with the patient under anesthesia demonstrated adequate stability. A second, smaller pin could have been used to control rotation, if needed. Medial pin placement that avoids the ulnar nerve is difficult in the newborn elbow; medial pins should probably be avoided in the newborn, if possible.

Early diagnosis and treatment are essential. Late diagnosis was reported to lead to complications such as varus deformity and restriction of joint ROM.4

Our patient healed without any complications and achieved full ROM. Long-term follow-up is needed to diagnose any physeal bar that might lead to secondary deformities.

Conclusion

Cesarean section is reported to reduce birth complications, but it might cause fractures of the femur and humerus.1 Avoiding application of excessive traction to the forearm can prevent physeal separation of the distal humerus. This entity should be kept in mind as a potential complication of cesarean section. Arthrography is helpful in treatment and may help avoid unnecessary open reduction.

Physeal separation of the distal humerus in a newborn is a rare and severe injury that requires immediate treatment. This fracture was reported as an extremely rare complication of cesarean section.1 The correct diagnosis can be established by clinical and radiologic findings. However, this injury can be easily overlooked and misdiagnosed. Presentation often involves swelling, tenderness, and agitation with movement of the elbow.

We report a case in which neonatal physeal separation of the distal humerus occurred during cesarean section. The diagnosis was based on clinical and radiologic/arthrographic findings and treated with closed reduction and percutaneous fixation. The patient’s guardian provided written informed consent for print and electronic publication of this case report.

Case Report

A full-term (40-week gestation) male neonate weighing 3690 g was born through cesarean section at the mother’s request. Apgar score was 9 at 1 minute and 10 at 5 minutes. The vertex position of the fetus was confirmed with preoperative ultrasonography. This was the mother’s first pregnancy and an in vitro fertilization. On his second day of life, the patient was referred to the orthopedic department for evaluation of local swelling and diminished spontaneous motion of the right elbow.

Examination revealed local tenderness and swelling in the anterior and lateral aspects of the elbow. Passive elbow range of motion (ROM) caused agitation, and elbow instability was present. A complete neurovascular examination was performed, and neurovascular injury and compartment syndrome were ruled out. Hematologic workup showed no signs of septic arthritis. Radiographs showed posteromedial displacement of the humeroulnar joint. The patient was placed in a long-arm splint, and no reduction was attempted initially.

The patient was taken to the operating room the same day. With the patient under general anesthesia, an arthrogram of the right elbow was obtained. It showed posteromedial displacement of the distal humeral epiphysis (Figure 1A). Closed reduction was performed, and the quality of the reduction was confirmed by intraoperative imaging. Percutaneously, a single 2-mm Kirschner wire (K-wire) was placed in an oblique fashion from the inferolateral aspect of the distal fragment to the contralateral metaphysis of the humerus (Figure 1B). The patient was put in a long-arm splint with the elbow flexed at 90° and the forearm in midpronation.

Follow-up visits were scheduled for 1 week, 3 weeks, and 5 weeks after surgery. Three weeks after surgery, callus formation was confirmed, and the K-wire was removed. Five weeks after surgery, the long-arm splint was removed.

At 6-month follow-up, the patient was pain-free and had full elbow ROM, and radiographs (Figures 2A, 2B) confirmed anatomical restoration of the fracture.

Discussion

Madsen2 reported the incidence of birth-related long-bone fractures, including fractures of the humerus, the femur, and the tibia (< 0.1%). According to that review, only 1 of 105,119 patients sustained traumatic physeal separation of the distal humerus.

Different mechanisms have been described for this rare fracture. As the physeal region is the weakest part of the distal humerus, it is prone to injury by rotational shear forces,3,4 hyperextension of the elbow, or a backward thrust on the forearm with the elbow flexed.5 Excessive traction applied during cesarean delivery might cause physeal separation, which was the possible cause in the present case. Most patients have a complicated birth history.

This injury should be suspected in an irritable newborn with swelling, tenderness, and reduced mobility of the upper extremity. Osteomyelitis and septic arthritis should be considered in the differential diagnosis. Brachial plexus injury and dislocation of the elbow joint should also be kept in mind. Child abuse and metabolic bone diseases (eg, osteogenesis imperfecta) should also be considered.

Anteroposterior and lateral plain radiographs of the elbow usually establish the diagnosis. Alteration of humeroulnar alignment and displacement of the proximal forearm are the key points leading to the diagnosis.

The cartilaginous part of the distal humerus and humeroulnar alignment can be demonstrated by ultrasonography.6 Magnetic resonance imaging (MRI) can be helpful in diagnosis but is seldom required,7 and the sedation or general anesthesia used is a disadvantage. Arthrography is useful not only in diagnosis but in determining the quality of the reduction.8 An arthrogram may show that open reduction is unnecessary.

Treatment differs widely. In neonates, who have a tremendous healing capability, this fracture almost always heals uneventfully. An effective treatment method is closed reduction and cast immobilization. However, valgus malalignment and limited elbow ROM were noted in 5% of the patients treated with this method.4

Jacobsen and colleagues4 reported on 6 neonates who sustained traumatic separation of the distal epiphysis of the humerus at birth and who were treated with casting with or without closed reduction. The authors described good results. One patient had varus malalignment, which was attributed to fragment internal rotation caused by rotational instability.

 

 

As our patient’s instability was noted during surgery, we performed percutaneous pinning after arthrography-assisted closed reduction. We considered using 2 lateral pins for fixation, but, after the first pin was placed, fluoroscopic stress testing with the patient under anesthesia demonstrated adequate stability. A second, smaller pin could have been used to control rotation, if needed. Medial pin placement that avoids the ulnar nerve is difficult in the newborn elbow; medial pins should probably be avoided in the newborn, if possible.

Early diagnosis and treatment are essential. Late diagnosis was reported to lead to complications such as varus deformity and restriction of joint ROM.4

Our patient healed without any complications and achieved full ROM. Long-term follow-up is needed to diagnose any physeal bar that might lead to secondary deformities.

Conclusion

Cesarean section is reported to reduce birth complications, but it might cause fractures of the femur and humerus.1 Avoiding application of excessive traction to the forearm can prevent physeal separation of the distal humerus. This entity should be kept in mind as a potential complication of cesarean section. Arthrography is helpful in treatment and may help avoid unnecessary open reduction.

References

1. Sabat D, Maini L, Gautam VK. Neonatal separation of distal humeral epiphysis during caesarean section: a case report. J Orthop Surg (Hong Kong). 2011;19(3):376-378.

2. Madsen ET. Fractures of the extremities in the newborn. Acta Obstet Gynecol Scand. 1955;34(1):41-74.

3. Peterson HA. Physeal fractures. In: Morrey BF, ed. The Elbow and Its Disorders. Philadelphia, PA: Saunders; 1985:222-236.

4. Jacobsen S, Hansson G, Nathorst-Westfelt J. Traumatic separation of the distal epiphysis of the humerus sustained at birth. J Bone Joint Surg Br. 2009;91(6):797-802.

5. Siffert RS. Displacement of distal humeral epiphysis in the newborn. J Bone Joint Surg Am. 1963;45(1):165-169.

6. Davidson RS, Markowitz RI, Dormans J, Drummond DS. Ultrasonographic evaluation of the elbow in infants and young children after suspected trauma. J Bone Joint Surg Am. 1994;76(12):1804-1813.

7. Sawant MR, Narayanan S, O‘Neill K, Hudson I. Distal humeral epiphysis fracture separation in neonates—diagnosis using MRI scan. Injury. 2002;33(2):179-181.

8. Akbarnia BA, Silberstein MJ, Rende RJ, Graviss ER, Luisiri A. Arthrography in the diagnosis of fractures of the distal end of the humerus in infants. J Bone Joint Surg Am. 1986;68(4):599-602.

References

1. Sabat D, Maini L, Gautam VK. Neonatal separation of distal humeral epiphysis during caesarean section: a case report. J Orthop Surg (Hong Kong). 2011;19(3):376-378.

2. Madsen ET. Fractures of the extremities in the newborn. Acta Obstet Gynecol Scand. 1955;34(1):41-74.

3. Peterson HA. Physeal fractures. In: Morrey BF, ed. The Elbow and Its Disorders. Philadelphia, PA: Saunders; 1985:222-236.

4. Jacobsen S, Hansson G, Nathorst-Westfelt J. Traumatic separation of the distal epiphysis of the humerus sustained at birth. J Bone Joint Surg Br. 2009;91(6):797-802.

5. Siffert RS. Displacement of distal humeral epiphysis in the newborn. J Bone Joint Surg Am. 1963;45(1):165-169.

6. Davidson RS, Markowitz RI, Dormans J, Drummond DS. Ultrasonographic evaluation of the elbow in infants and young children after suspected trauma. J Bone Joint Surg Am. 1994;76(12):1804-1813.

7. Sawant MR, Narayanan S, O‘Neill K, Hudson I. Distal humeral epiphysis fracture separation in neonates—diagnosis using MRI scan. Injury. 2002;33(2):179-181.

8. Akbarnia BA, Silberstein MJ, Rende RJ, Graviss ER, Luisiri A. Arthrography in the diagnosis of fractures of the distal end of the humerus in infants. J Bone Joint Surg Am. 1986;68(4):599-602.

Issue
The American Journal of Orthopedics - 43(11)
Issue
The American Journal of Orthopedics - 43(11)
Page Number
E279-E281
Page Number
E279-E281
Publications
Publications
Topics
Article Type
Display Headline
Neonatal Physeal Separation of Distal Humerus During Cesarean Section
Display Headline
Neonatal Physeal Separation of Distal Humerus During Cesarean Section
Legacy Keywords
american journal of orthopedics, AJO, online exclusive, case report and literature review, case report, physeal separation, distal humerus, cesarean section, newborn, baby, pregnancy, pregnant, birth, fracture, injury, MRI, magnetic resonance imaging, radiographs, kamaci, danisman, marangoz
Legacy Keywords
american journal of orthopedics, AJO, online exclusive, case report and literature review, case report, physeal separation, distal humerus, cesarean section, newborn, baby, pregnancy, pregnant, birth, fracture, injury, MRI, magnetic resonance imaging, radiographs, kamaci, danisman, marangoz
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Concurrent Treatment of a Middle-Third Clavicle Fracture and Type IV Acromioclavicular Dislocation

Article Type
Changed
Display Headline
Concurrent Treatment of a Middle-Third Clavicle Fracture and Type IV Acromioclavicular Dislocation

Acromioclavicular (AC) dislocations and displaced fractures of the middle third of the clavicle rarely occur together. Isolated AC joint separation is often treated nonoperatively with internal coracoclavicular (CC) fixation or reconstruction considered for type IV-VI AC dislocations and some type III injuries.1 Isolated clavicle fractures traditionally have been treated nonoperatively. The current trend is toward internal fixation for displaced and shortened fractures.2 There have been only a handful of reports of concomitant AC dislocation and midshaft clavicle fracture.3-6 Previous treatments have included nonoperative treatment, AC fixation, or internal fixation of the clavicle with ligamentous reconstruction.

We present a previously undescribed technique for internal fixation of this rare shoulder injury. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

While driving an all-terrain vehicle, a healthy 19-year-old right-hand–dominant man hit a bridge and sustained direct impact to his right shoulder. He presented to the emergency department complaining of right shoulder pain and deformity without skin disruption, vascular insufficiency, or neurologic symptoms. Anteroposterior (AP) radiograph showed an oblique, displaced, middle-third clavicle shaft fracture (Figure 1). An associated type IV AC dislocation was confirmed on axillary radiograph (Figure 2) and on an axial cut from a trauma chest computed tomography (CT) scan (Figure 3). The patient was discharged home from the trauma service the next day with a sling for comfort and plans for delayed, elective operative fixation 1 week later.

 

The patient was placed in a beach-chair position. Through a longitudinal incision extending laterally over the AC joint, the clavicle was exposed for fracture reduction, with care taken to retain soft-tissue attachments. The distal clavicle was buttonholed posteriorly through the trapezius muscle and fascia. The distal fracture fragment was devoid of any remaining CC ligamentous attachment. After satisfactory reduction, a low-profile precontoured clavicle plate (Superior Midshaft Clavicle Plate; Acumed, Hillsboro, Oregon) was placed superiorly; the fracture was compressed through the plate and internally fixed with three 3.5-mm bicortical screws on both sides of the fracture. Approximately 5 mm of the distal clavicle was resected at the AC joint to facilitate adequate AC and CC reduction without disruption of the clavicle fracture. With an adequate CC reduction, a 3.5-mm fully threaded cortical screw was placed through the most distal hole in the clavicle plate, clavicle, and coracoid.

After surgery, the patient was placed into an ARC shoulder immobilizer (Bledsoe, Grand Prairie, Texas) for 6 weeks, removing the immobilizer only for elbow and wrist range of motion (ROM) exercises. Radiographs at 3-month follow-up (Figure 4) showed a healed fracture with no loss of AC or CC reduction. Three months after surgery, another procedure was performed to remove the CC screw. One year after the initial surgery, the patient complained of intermittent soreness over the lateral shoulder but was not limited in his activities and was back to performing manual labor without difficulty. He had full ROM in forward flexion, abduction, internal rotation, and external rotation without weakness, tenderness, or any neurovascular deficit. After CC screw removal, no deformity returned at the shoulder. Radiographs showed a healed fracture with minimal superior subluxation at the AC joint without significant change from the 3-month follow-up (Figure 5).

Discussion

The combined injury pattern of a type IV AC dislocation and a displaced middle-third clavicle shaft fracture is rare. The usual mechanism of injury, as seen in the present case, is a direct blow to the shoulder at the tip of the acromion, though indirect forces from a fall on an outstretched hand are also described.7 Disruption of the CC ligaments with AC separation likely dissipates the stress necessary to create a clavicle fracture in most cases,1 explaining the rarity of this injury. It is imperative to evaluate patients for injury to both the osseous and ligamentous structures.

Previous case reports of concomitant AC separation and midshaft clavicle fracture have described a variety of treatment options, but to date our case represents the only episode in which both the clavicle fracture and the AC joint were treated with open reduction and internal fixation (ORIF). Wurtz and colleagues5 reported on a series of 4 patients with AC disruption and middle-third clavicle fracture. Three of the 4 patients had type IV AC separation; all 3 were treated, 2 acutely and 1 chronically, with open reduction of the AC and CC joints; 2 of these patients had CC screw fixation only after reduction, and the third had 2 Steinmann pins placed across the AC joint without CC screw fixation. All hardware was removed after 12 weeks. The fourth patient had a type II AC dislocation and was treated with closed reduction of the clavicle with no intervention for the AC joint. None of the clavicle fractures in this series were treated with internal fixation. All patients had full and pain-free ROM at 1- to 3-year follow-up.

 

 

Juhn and Simonian3 reported on a case of type VI separation with greenstick midshaft clavicle fracture in a hockey player seen 7 days after injury. The patient described some tingling in the upper extremity and had shoulder pain on initial presentation but was noted to have minimal displacement of both the AC joint and the midshaft clavicle fracture. Both injuries were treated nonsurgically with good outcome, and the patient returned to full activity (including hockey) within 14 weeks after injury.

Lancourt4 described the case of a patient with a type V AC dislocation and a displaced midshaft clavicle fracture. The AC joint was treated with Steinmann pin fixation, and the clavicle fracture was treated nonoperatively. The author cited high complication rates of plate fixation for clavicle fractures as the reason for not performing the additional procedure. The pins were removed 8 weeks after surgery. At 3-year follow-up, the patient had good radiographic and clinical outcome.

Yeh and colleagues6 described a patient who sustained a displaced midshaft clavicle fracture and a type IV AC dislocation in a fall from a horse. The patient underwent ORIF of the clavicle fracture with plate fixation. After the procedure, the AC joint was still unstable intraoperatively, and the AC and CC ligaments were reconstructed with semitendinosus allograft. The patient had full and painless ROM at 1-year follow-up.

The present case report serves as a reminder to obtain adequate shoulder radiographs when evaluating “just another clavicle fracture.” The radiographs should include a good axillary view to ensure there is not an associated AC dislocation. Increasingly, some authors have been advocating internal fixation for clavicle fractures, with reports of improved functional outcomes, improved cosmesis, and increased union rates.2 Indications for operative fixation include shortening and 100% displacement,8 and relative indications include open fractures.1 Operative fixation is perhaps more important for younger, athletic, and manual-labor populations. The trend in treatment of clavicle fractures toward operative fixation lends itself well to ORIF of the AC and CC joints; hence, a modern treatment for this rarely described combination injury should include internal plate fixation of the clavicle in addition to CC fixation. This additional procedure requires little extra time and energy in an operative scenario already requiring anesthesia, with easy insertion of the CC screw through the clavicle plate. Use of a CC screw obviates any potential risks associated with use of allograft tissue, and there is no anticipated difficulty with screw removal at 12 weeks.

Alternative options for AC stability include CC reconstruction with ligamentous allograft, ligamentous autograft, or suture/tightrope techniques. A noted advantage of these alternative techniques is less need to return to the operating room for the hardware removal that is recommended with CC screw fixation. However, these procedures potentially increase surgical exposure and operating time. In addition, screw fixation minimizes the possibility of donor-site morbidity from autograft transfers and potential complications from allograft tissue.

Hook plate fixation of the AC joint has also been described. In a recent case report of a similar injury pattern, plate fixation of the clavicle with simultaneous hook plate fixation of the AC joint was described.9 The patient did well but required removal of hardware of the hook plate and the clavicle plate 1 and 3 years after surgery, respectively. Although screw fixation is biomechanically stronger, debate persists about the clinical importance of this increase in strength.1 In the setting of plate fixation for the clavicle, these alternative AC fixations would require technique adjustments, including length of grafts and/or sutures, and raise concerns regarding interaction of the metal with the fixation material.

Critical evaluation of our technique revealed a lucency larger than the screw (Figure 5). However, the screw was not clinically loose at removal. This potential complication, in combination with the bent screw (Figure 4) before removal, highlights the concern for screw breakage with this technique, given the increased construct stiffness caused by the added plate.

Conclusion

As in the other reports mentioned, our patient had an excellent clinical and radiographic outcome. It could be inferred that, if fixation for isolated clavicle fractures demonstrates improved function, better outcomes would be seen for higher-energy fractures associated with AC dislocation. Given the current trend toward surgical fixation for certain clavicle fractures, we recommend that clavicle fractures associated with type IV AC dislocation be treated with ORIF of both injuries.

References

1. Ring D, Jupiter J. Injuries to the shoulder girdle. In: Browner, BD. Skeletal Trauma. Philadelphia, PA: Elsevier Health Sciences; 2008:1755-1778.

2. Altamimi SA, McKee MD; Canadian Orthopaedic Trauma Society. Nonoperative treatment compared with plate fixation of displaced midshaft clavicular fractures. Surgical technique. J Bone Joint Surg Am. 2008;90(suppl 2 pt 1):1-8.

3. Juhn MS, Simonian PT. Type VI acromioclavicular separation with middle-third clavicle fracture in an ice hockey player. Clin J Sports Med. 2002;12(5):315-317.

4. Lancourt JE. Acromioclavicular dislocation with adjacent clavicular fracture in a horseback rider. A case report. Am J Sports Med. 1990;18(3):321-322.

5. Wurtz LD, Lyons FA, Rockwood CA Jr. Fracture of the middle third of the clavicle and dislocation of the acromioclavicular joint. A report of four cases. J Bone Joint Surg Am. 1992;74(1):133-137.

6. Yeh PC, Miller SR, Cunningham JG, Sethi PM. Midshaft clavicle fracture and acromioclavicular dislocation: a case report of a rare injury. J Shoulder Elbow Surg. 2009;18(5):e1-e4.

7. Stanley D, Trowbridge EA, Norris SH. The mechanism of clavicular fracture. A clinical and biomechanical analysis. J Bone Joint Surg Br. 1988;70(3):461-464.

8. Kim W, McKee MD. Management of acute clavicle fractures. Orthop Clin North Am. 2008;39(4):491-505.

9. Woolf SK, Valentine BJ, Barfield WR, Hartsock LA. Middle-third clavicle fracture with associated type IV acromioclavicular separation: case report and literature review. J Surg Orthop Adv. 2013;22(2):183-186.

Article PDF
Author and Disclosure Information

John E. Tidwell, MD, Patrick M. Kennedy, DPT, and E. Barry McDonough, MD

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Issue
The American Journal of Orthopedics - 43(11)
Publications
Topics
Page Number
E275-E278
Legacy Keywords
american journal of orthopedics, AJO, case report and literature review, case report, online exclusive, treatment, clavicle fracture, clavicle, fracture, fracture management, acromioclavicular dislocation, dislocation, AC, treatment, shoulder, joint, shoulder injury, injury, tidwell, kennedy, mcdonough
Sections
Author and Disclosure Information

John E. Tidwell, MD, Patrick M. Kennedy, DPT, and E. Barry McDonough, MD

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Author and Disclosure Information

John E. Tidwell, MD, Patrick M. Kennedy, DPT, and E. Barry McDonough, MD

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Article PDF
Article PDF

Acromioclavicular (AC) dislocations and displaced fractures of the middle third of the clavicle rarely occur together. Isolated AC joint separation is often treated nonoperatively with internal coracoclavicular (CC) fixation or reconstruction considered for type IV-VI AC dislocations and some type III injuries.1 Isolated clavicle fractures traditionally have been treated nonoperatively. The current trend is toward internal fixation for displaced and shortened fractures.2 There have been only a handful of reports of concomitant AC dislocation and midshaft clavicle fracture.3-6 Previous treatments have included nonoperative treatment, AC fixation, or internal fixation of the clavicle with ligamentous reconstruction.

We present a previously undescribed technique for internal fixation of this rare shoulder injury. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

While driving an all-terrain vehicle, a healthy 19-year-old right-hand–dominant man hit a bridge and sustained direct impact to his right shoulder. He presented to the emergency department complaining of right shoulder pain and deformity without skin disruption, vascular insufficiency, or neurologic symptoms. Anteroposterior (AP) radiograph showed an oblique, displaced, middle-third clavicle shaft fracture (Figure 1). An associated type IV AC dislocation was confirmed on axillary radiograph (Figure 2) and on an axial cut from a trauma chest computed tomography (CT) scan (Figure 3). The patient was discharged home from the trauma service the next day with a sling for comfort and plans for delayed, elective operative fixation 1 week later.

 

The patient was placed in a beach-chair position. Through a longitudinal incision extending laterally over the AC joint, the clavicle was exposed for fracture reduction, with care taken to retain soft-tissue attachments. The distal clavicle was buttonholed posteriorly through the trapezius muscle and fascia. The distal fracture fragment was devoid of any remaining CC ligamentous attachment. After satisfactory reduction, a low-profile precontoured clavicle plate (Superior Midshaft Clavicle Plate; Acumed, Hillsboro, Oregon) was placed superiorly; the fracture was compressed through the plate and internally fixed with three 3.5-mm bicortical screws on both sides of the fracture. Approximately 5 mm of the distal clavicle was resected at the AC joint to facilitate adequate AC and CC reduction without disruption of the clavicle fracture. With an adequate CC reduction, a 3.5-mm fully threaded cortical screw was placed through the most distal hole in the clavicle plate, clavicle, and coracoid.

After surgery, the patient was placed into an ARC shoulder immobilizer (Bledsoe, Grand Prairie, Texas) for 6 weeks, removing the immobilizer only for elbow and wrist range of motion (ROM) exercises. Radiographs at 3-month follow-up (Figure 4) showed a healed fracture with no loss of AC or CC reduction. Three months after surgery, another procedure was performed to remove the CC screw. One year after the initial surgery, the patient complained of intermittent soreness over the lateral shoulder but was not limited in his activities and was back to performing manual labor without difficulty. He had full ROM in forward flexion, abduction, internal rotation, and external rotation without weakness, tenderness, or any neurovascular deficit. After CC screw removal, no deformity returned at the shoulder. Radiographs showed a healed fracture with minimal superior subluxation at the AC joint without significant change from the 3-month follow-up (Figure 5).

Discussion

The combined injury pattern of a type IV AC dislocation and a displaced middle-third clavicle shaft fracture is rare. The usual mechanism of injury, as seen in the present case, is a direct blow to the shoulder at the tip of the acromion, though indirect forces from a fall on an outstretched hand are also described.7 Disruption of the CC ligaments with AC separation likely dissipates the stress necessary to create a clavicle fracture in most cases,1 explaining the rarity of this injury. It is imperative to evaluate patients for injury to both the osseous and ligamentous structures.

Previous case reports of concomitant AC separation and midshaft clavicle fracture have described a variety of treatment options, but to date our case represents the only episode in which both the clavicle fracture and the AC joint were treated with open reduction and internal fixation (ORIF). Wurtz and colleagues5 reported on a series of 4 patients with AC disruption and middle-third clavicle fracture. Three of the 4 patients had type IV AC separation; all 3 were treated, 2 acutely and 1 chronically, with open reduction of the AC and CC joints; 2 of these patients had CC screw fixation only after reduction, and the third had 2 Steinmann pins placed across the AC joint without CC screw fixation. All hardware was removed after 12 weeks. The fourth patient had a type II AC dislocation and was treated with closed reduction of the clavicle with no intervention for the AC joint. None of the clavicle fractures in this series were treated with internal fixation. All patients had full and pain-free ROM at 1- to 3-year follow-up.

 

 

Juhn and Simonian3 reported on a case of type VI separation with greenstick midshaft clavicle fracture in a hockey player seen 7 days after injury. The patient described some tingling in the upper extremity and had shoulder pain on initial presentation but was noted to have minimal displacement of both the AC joint and the midshaft clavicle fracture. Both injuries were treated nonsurgically with good outcome, and the patient returned to full activity (including hockey) within 14 weeks after injury.

Lancourt4 described the case of a patient with a type V AC dislocation and a displaced midshaft clavicle fracture. The AC joint was treated with Steinmann pin fixation, and the clavicle fracture was treated nonoperatively. The author cited high complication rates of plate fixation for clavicle fractures as the reason for not performing the additional procedure. The pins were removed 8 weeks after surgery. At 3-year follow-up, the patient had good radiographic and clinical outcome.

Yeh and colleagues6 described a patient who sustained a displaced midshaft clavicle fracture and a type IV AC dislocation in a fall from a horse. The patient underwent ORIF of the clavicle fracture with plate fixation. After the procedure, the AC joint was still unstable intraoperatively, and the AC and CC ligaments were reconstructed with semitendinosus allograft. The patient had full and painless ROM at 1-year follow-up.

The present case report serves as a reminder to obtain adequate shoulder radiographs when evaluating “just another clavicle fracture.” The radiographs should include a good axillary view to ensure there is not an associated AC dislocation. Increasingly, some authors have been advocating internal fixation for clavicle fractures, with reports of improved functional outcomes, improved cosmesis, and increased union rates.2 Indications for operative fixation include shortening and 100% displacement,8 and relative indications include open fractures.1 Operative fixation is perhaps more important for younger, athletic, and manual-labor populations. The trend in treatment of clavicle fractures toward operative fixation lends itself well to ORIF of the AC and CC joints; hence, a modern treatment for this rarely described combination injury should include internal plate fixation of the clavicle in addition to CC fixation. This additional procedure requires little extra time and energy in an operative scenario already requiring anesthesia, with easy insertion of the CC screw through the clavicle plate. Use of a CC screw obviates any potential risks associated with use of allograft tissue, and there is no anticipated difficulty with screw removal at 12 weeks.

Alternative options for AC stability include CC reconstruction with ligamentous allograft, ligamentous autograft, or suture/tightrope techniques. A noted advantage of these alternative techniques is less need to return to the operating room for the hardware removal that is recommended with CC screw fixation. However, these procedures potentially increase surgical exposure and operating time. In addition, screw fixation minimizes the possibility of donor-site morbidity from autograft transfers and potential complications from allograft tissue.

Hook plate fixation of the AC joint has also been described. In a recent case report of a similar injury pattern, plate fixation of the clavicle with simultaneous hook plate fixation of the AC joint was described.9 The patient did well but required removal of hardware of the hook plate and the clavicle plate 1 and 3 years after surgery, respectively. Although screw fixation is biomechanically stronger, debate persists about the clinical importance of this increase in strength.1 In the setting of plate fixation for the clavicle, these alternative AC fixations would require technique adjustments, including length of grafts and/or sutures, and raise concerns regarding interaction of the metal with the fixation material.

Critical evaluation of our technique revealed a lucency larger than the screw (Figure 5). However, the screw was not clinically loose at removal. This potential complication, in combination with the bent screw (Figure 4) before removal, highlights the concern for screw breakage with this technique, given the increased construct stiffness caused by the added plate.

Conclusion

As in the other reports mentioned, our patient had an excellent clinical and radiographic outcome. It could be inferred that, if fixation for isolated clavicle fractures demonstrates improved function, better outcomes would be seen for higher-energy fractures associated with AC dislocation. Given the current trend toward surgical fixation for certain clavicle fractures, we recommend that clavicle fractures associated with type IV AC dislocation be treated with ORIF of both injuries.

Acromioclavicular (AC) dislocations and displaced fractures of the middle third of the clavicle rarely occur together. Isolated AC joint separation is often treated nonoperatively with internal coracoclavicular (CC) fixation or reconstruction considered for type IV-VI AC dislocations and some type III injuries.1 Isolated clavicle fractures traditionally have been treated nonoperatively. The current trend is toward internal fixation for displaced and shortened fractures.2 There have been only a handful of reports of concomitant AC dislocation and midshaft clavicle fracture.3-6 Previous treatments have included nonoperative treatment, AC fixation, or internal fixation of the clavicle with ligamentous reconstruction.

We present a previously undescribed technique for internal fixation of this rare shoulder injury. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

While driving an all-terrain vehicle, a healthy 19-year-old right-hand–dominant man hit a bridge and sustained direct impact to his right shoulder. He presented to the emergency department complaining of right shoulder pain and deformity without skin disruption, vascular insufficiency, or neurologic symptoms. Anteroposterior (AP) radiograph showed an oblique, displaced, middle-third clavicle shaft fracture (Figure 1). An associated type IV AC dislocation was confirmed on axillary radiograph (Figure 2) and on an axial cut from a trauma chest computed tomography (CT) scan (Figure 3). The patient was discharged home from the trauma service the next day with a sling for comfort and plans for delayed, elective operative fixation 1 week later.

 

The patient was placed in a beach-chair position. Through a longitudinal incision extending laterally over the AC joint, the clavicle was exposed for fracture reduction, with care taken to retain soft-tissue attachments. The distal clavicle was buttonholed posteriorly through the trapezius muscle and fascia. The distal fracture fragment was devoid of any remaining CC ligamentous attachment. After satisfactory reduction, a low-profile precontoured clavicle plate (Superior Midshaft Clavicle Plate; Acumed, Hillsboro, Oregon) was placed superiorly; the fracture was compressed through the plate and internally fixed with three 3.5-mm bicortical screws on both sides of the fracture. Approximately 5 mm of the distal clavicle was resected at the AC joint to facilitate adequate AC and CC reduction without disruption of the clavicle fracture. With an adequate CC reduction, a 3.5-mm fully threaded cortical screw was placed through the most distal hole in the clavicle plate, clavicle, and coracoid.

After surgery, the patient was placed into an ARC shoulder immobilizer (Bledsoe, Grand Prairie, Texas) for 6 weeks, removing the immobilizer only for elbow and wrist range of motion (ROM) exercises. Radiographs at 3-month follow-up (Figure 4) showed a healed fracture with no loss of AC or CC reduction. Three months after surgery, another procedure was performed to remove the CC screw. One year after the initial surgery, the patient complained of intermittent soreness over the lateral shoulder but was not limited in his activities and was back to performing manual labor without difficulty. He had full ROM in forward flexion, abduction, internal rotation, and external rotation without weakness, tenderness, or any neurovascular deficit. After CC screw removal, no deformity returned at the shoulder. Radiographs showed a healed fracture with minimal superior subluxation at the AC joint without significant change from the 3-month follow-up (Figure 5).

Discussion

The combined injury pattern of a type IV AC dislocation and a displaced middle-third clavicle shaft fracture is rare. The usual mechanism of injury, as seen in the present case, is a direct blow to the shoulder at the tip of the acromion, though indirect forces from a fall on an outstretched hand are also described.7 Disruption of the CC ligaments with AC separation likely dissipates the stress necessary to create a clavicle fracture in most cases,1 explaining the rarity of this injury. It is imperative to evaluate patients for injury to both the osseous and ligamentous structures.

Previous case reports of concomitant AC separation and midshaft clavicle fracture have described a variety of treatment options, but to date our case represents the only episode in which both the clavicle fracture and the AC joint were treated with open reduction and internal fixation (ORIF). Wurtz and colleagues5 reported on a series of 4 patients with AC disruption and middle-third clavicle fracture. Three of the 4 patients had type IV AC separation; all 3 were treated, 2 acutely and 1 chronically, with open reduction of the AC and CC joints; 2 of these patients had CC screw fixation only after reduction, and the third had 2 Steinmann pins placed across the AC joint without CC screw fixation. All hardware was removed after 12 weeks. The fourth patient had a type II AC dislocation and was treated with closed reduction of the clavicle with no intervention for the AC joint. None of the clavicle fractures in this series were treated with internal fixation. All patients had full and pain-free ROM at 1- to 3-year follow-up.

 

 

Juhn and Simonian3 reported on a case of type VI separation with greenstick midshaft clavicle fracture in a hockey player seen 7 days after injury. The patient described some tingling in the upper extremity and had shoulder pain on initial presentation but was noted to have minimal displacement of both the AC joint and the midshaft clavicle fracture. Both injuries were treated nonsurgically with good outcome, and the patient returned to full activity (including hockey) within 14 weeks after injury.

Lancourt4 described the case of a patient with a type V AC dislocation and a displaced midshaft clavicle fracture. The AC joint was treated with Steinmann pin fixation, and the clavicle fracture was treated nonoperatively. The author cited high complication rates of plate fixation for clavicle fractures as the reason for not performing the additional procedure. The pins were removed 8 weeks after surgery. At 3-year follow-up, the patient had good radiographic and clinical outcome.

Yeh and colleagues6 described a patient who sustained a displaced midshaft clavicle fracture and a type IV AC dislocation in a fall from a horse. The patient underwent ORIF of the clavicle fracture with plate fixation. After the procedure, the AC joint was still unstable intraoperatively, and the AC and CC ligaments were reconstructed with semitendinosus allograft. The patient had full and painless ROM at 1-year follow-up.

The present case report serves as a reminder to obtain adequate shoulder radiographs when evaluating “just another clavicle fracture.” The radiographs should include a good axillary view to ensure there is not an associated AC dislocation. Increasingly, some authors have been advocating internal fixation for clavicle fractures, with reports of improved functional outcomes, improved cosmesis, and increased union rates.2 Indications for operative fixation include shortening and 100% displacement,8 and relative indications include open fractures.1 Operative fixation is perhaps more important for younger, athletic, and manual-labor populations. The trend in treatment of clavicle fractures toward operative fixation lends itself well to ORIF of the AC and CC joints; hence, a modern treatment for this rarely described combination injury should include internal plate fixation of the clavicle in addition to CC fixation. This additional procedure requires little extra time and energy in an operative scenario already requiring anesthesia, with easy insertion of the CC screw through the clavicle plate. Use of a CC screw obviates any potential risks associated with use of allograft tissue, and there is no anticipated difficulty with screw removal at 12 weeks.

Alternative options for AC stability include CC reconstruction with ligamentous allograft, ligamentous autograft, or suture/tightrope techniques. A noted advantage of these alternative techniques is less need to return to the operating room for the hardware removal that is recommended with CC screw fixation. However, these procedures potentially increase surgical exposure and operating time. In addition, screw fixation minimizes the possibility of donor-site morbidity from autograft transfers and potential complications from allograft tissue.

Hook plate fixation of the AC joint has also been described. In a recent case report of a similar injury pattern, plate fixation of the clavicle with simultaneous hook plate fixation of the AC joint was described.9 The patient did well but required removal of hardware of the hook plate and the clavicle plate 1 and 3 years after surgery, respectively. Although screw fixation is biomechanically stronger, debate persists about the clinical importance of this increase in strength.1 In the setting of plate fixation for the clavicle, these alternative AC fixations would require technique adjustments, including length of grafts and/or sutures, and raise concerns regarding interaction of the metal with the fixation material.

Critical evaluation of our technique revealed a lucency larger than the screw (Figure 5). However, the screw was not clinically loose at removal. This potential complication, in combination with the bent screw (Figure 4) before removal, highlights the concern for screw breakage with this technique, given the increased construct stiffness caused by the added plate.

Conclusion

As in the other reports mentioned, our patient had an excellent clinical and radiographic outcome. It could be inferred that, if fixation for isolated clavicle fractures demonstrates improved function, better outcomes would be seen for higher-energy fractures associated with AC dislocation. Given the current trend toward surgical fixation for certain clavicle fractures, we recommend that clavicle fractures associated with type IV AC dislocation be treated with ORIF of both injuries.

References

1. Ring D, Jupiter J. Injuries to the shoulder girdle. In: Browner, BD. Skeletal Trauma. Philadelphia, PA: Elsevier Health Sciences; 2008:1755-1778.

2. Altamimi SA, McKee MD; Canadian Orthopaedic Trauma Society. Nonoperative treatment compared with plate fixation of displaced midshaft clavicular fractures. Surgical technique. J Bone Joint Surg Am. 2008;90(suppl 2 pt 1):1-8.

3. Juhn MS, Simonian PT. Type VI acromioclavicular separation with middle-third clavicle fracture in an ice hockey player. Clin J Sports Med. 2002;12(5):315-317.

4. Lancourt JE. Acromioclavicular dislocation with adjacent clavicular fracture in a horseback rider. A case report. Am J Sports Med. 1990;18(3):321-322.

5. Wurtz LD, Lyons FA, Rockwood CA Jr. Fracture of the middle third of the clavicle and dislocation of the acromioclavicular joint. A report of four cases. J Bone Joint Surg Am. 1992;74(1):133-137.

6. Yeh PC, Miller SR, Cunningham JG, Sethi PM. Midshaft clavicle fracture and acromioclavicular dislocation: a case report of a rare injury. J Shoulder Elbow Surg. 2009;18(5):e1-e4.

7. Stanley D, Trowbridge EA, Norris SH. The mechanism of clavicular fracture. A clinical and biomechanical analysis. J Bone Joint Surg Br. 1988;70(3):461-464.

8. Kim W, McKee MD. Management of acute clavicle fractures. Orthop Clin North Am. 2008;39(4):491-505.

9. Woolf SK, Valentine BJ, Barfield WR, Hartsock LA. Middle-third clavicle fracture with associated type IV acromioclavicular separation: case report and literature review. J Surg Orthop Adv. 2013;22(2):183-186.

References

1. Ring D, Jupiter J. Injuries to the shoulder girdle. In: Browner, BD. Skeletal Trauma. Philadelphia, PA: Elsevier Health Sciences; 2008:1755-1778.

2. Altamimi SA, McKee MD; Canadian Orthopaedic Trauma Society. Nonoperative treatment compared with plate fixation of displaced midshaft clavicular fractures. Surgical technique. J Bone Joint Surg Am. 2008;90(suppl 2 pt 1):1-8.

3. Juhn MS, Simonian PT. Type VI acromioclavicular separation with middle-third clavicle fracture in an ice hockey player. Clin J Sports Med. 2002;12(5):315-317.

4. Lancourt JE. Acromioclavicular dislocation with adjacent clavicular fracture in a horseback rider. A case report. Am J Sports Med. 1990;18(3):321-322.

5. Wurtz LD, Lyons FA, Rockwood CA Jr. Fracture of the middle third of the clavicle and dislocation of the acromioclavicular joint. A report of four cases. J Bone Joint Surg Am. 1992;74(1):133-137.

6. Yeh PC, Miller SR, Cunningham JG, Sethi PM. Midshaft clavicle fracture and acromioclavicular dislocation: a case report of a rare injury. J Shoulder Elbow Surg. 2009;18(5):e1-e4.

7. Stanley D, Trowbridge EA, Norris SH. The mechanism of clavicular fracture. A clinical and biomechanical analysis. J Bone Joint Surg Br. 1988;70(3):461-464.

8. Kim W, McKee MD. Management of acute clavicle fractures. Orthop Clin North Am. 2008;39(4):491-505.

9. Woolf SK, Valentine BJ, Barfield WR, Hartsock LA. Middle-third clavicle fracture with associated type IV acromioclavicular separation: case report and literature review. J Surg Orthop Adv. 2013;22(2):183-186.

Issue
The American Journal of Orthopedics - 43(11)
Issue
The American Journal of Orthopedics - 43(11)
Page Number
E275-E278
Page Number
E275-E278
Publications
Publications
Topics
Article Type
Display Headline
Concurrent Treatment of a Middle-Third Clavicle Fracture and Type IV Acromioclavicular Dislocation
Display Headline
Concurrent Treatment of a Middle-Third Clavicle Fracture and Type IV Acromioclavicular Dislocation
Legacy Keywords
american journal of orthopedics, AJO, case report and literature review, case report, online exclusive, treatment, clavicle fracture, clavicle, fracture, fracture management, acromioclavicular dislocation, dislocation, AC, treatment, shoulder, joint, shoulder injury, injury, tidwell, kennedy, mcdonough
Legacy Keywords
american journal of orthopedics, AJO, case report and literature review, case report, online exclusive, treatment, clavicle fracture, clavicle, fracture, fracture management, acromioclavicular dislocation, dislocation, AC, treatment, shoulder, joint, shoulder injury, injury, tidwell, kennedy, mcdonough
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media